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Summary 
Intestinal inflammation triggered by enteric pathogens or as result of inflammatory bowel diseases leads to 
shifts of the healthy microbiota and expansion of Enterobacteriaceae ("inflammation-inflicted blooms"). 
We investigated the role of colicins in competition of the human pathogenic Salmonella enterica serovar 
Typhimurium strain SL1344 (S. Tm) and commensal Escherichia coli (E. coli) in inflammation-induced 
blooms, employing a mouse model for S. Tm colitis, as well as bacterial gene reporters and a variety of 
bacterial mutants. Members of the Enterobacteriaceae family produce narrow-spectrum protein toxins, 
termed colicins, such as colicin Ib (ColIb) produced by S. Tm. Upon inflammation, S. Tm displayed a 
colicin-dependent competitive advantage over colicin-sensitive E. coli strains. In contrast, an avirulent S. 
Tm strain, which cannot trigger inflammation, failed to outgrow the sensitive competitor. Expression of 
ColIb (cib) is induced by iron limitation and the SOS response. Furthermore, iron limitation triggers 
expression of the outer membrane receptor CirA (cirA) involved in the iron uptake and exploited by ColIb 
for bacterial killing. In vivo studies of a mouse model for S. Tm colitis demonstrated that both, cib and 
cirA are induced in inflammation-inflicted blooms. Moreover, we showed that low iron concentrations 
lead to increased ColIb-sensitivity of E. coli. This explained why a colicin Ib-dependent benefit for S. Tm 
was only observed in the inflamed gut. In summary inflammation-induced Enterobacteriaceae blooms 
were defined as a new ecological niche favoring colicin-dependent bacterial competition due to the 
increased colicin expression and, importantly, elevated colicin-sensitivity. 
Furthermore the mechanism of colicin Ib release was investigated. In contrast to group A colicins, it 
remains unknown how ColIb and other members of group B colicins are released. It was observed that 
ColIb is released only upon induction of the SOS response in S. Tm with the antibiotic mitomycin C. 
Mitomycin C induces DNA damage and is a trigger of the SOS response and lytic cycle of temperate 
phages residing in the bacterial chromosome. Activation of the lytic mode leads to production of phage 
lysis proteins triggering cell lysis and release of infectious phages. We hypothesized that ColIb might be 
released in the context of phage-mediated lysis in S. Tm. S. Tm harbors four temperate phages: Gifsy-1, 
Gifsy-2, SopEΦ and ST64B. We demonstrated that prophage-deficient S. Tm releases significantly less 
ColIb, which correlated with reduced lysis in response to SOS-stress. Moreover, different prophages had 
distinct effects on this process. ST64B-lysis contributed most to the release of ColIb. Further, we showed 
that ColIb-dependent competition of S. Tm against E. coli in vitro is strongly enhanced by prophage-
mediated lysis. Finally, we demonstrated that phage transduction enables the release of ColIb by a 
prophage-deficient E. coli strain, confirming that ColIb release is mediated by phage-dependent lysis. 
Taken together, our results suggest that group B colicins are released as result of phage-mediated lysis.
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In conclusion, a novel role of prophages was identified: prophage-encoded lysis functions are an important 
mechanism leading to release of group B colicins in S. Tm. Thereby, prophages can enhance colicin-
dependent bacterial fitness in competition against sensitive bacteria. 
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Zusammenfassung 
Entzündungen des Verdauungstraktes, die entweder durch darmpathogene Krankheitserreger oder durch 
chronisch-entzündliche Darmerkrankungen verursacht werden, führen zu Veränderungen der gesunden 
Darmmikrobiota und zu einem Überhandnehmen von Enterobacteriazeen was als Entzündungs-
vermitteltes „Blooming“ bezeichnet wird. In diesem Zusammenhang haben wir die Rolle von Colicinen 
für die Fitness des Erregers Salmonella enterica serovar Typhimurium (S. Tm) in Kompetition mit 
kommensalen E. coli Stämmen untersucht. Hierzu wurde ein S. Tm Kolitis-Mausmodel, bakterielle 
Genreporter und verschiedene Bakterienmutanten verwendet. Bakterien der Familie der 
Enterobacteriazeen produzieren Bakteriozine, so genannte Colicine, welche Aktivität gegen nah 
verwandte Arten besitzen. Die Synthese von Colicin Ib (ColIb) verschafft S. Tm SL1344 einen 
kompetitiven Vorteil gegenüber Colicin-sensitiven E. coli Stämmen. Im Gegensatz dazu war ein 
avirulenter S. Tm Stamm, welcher keine Darmentzündung verursachen kann, nicht in der Lage einen 
Wachstumsvorteil gegenüber einem Colicin-sensitiven Konkurrenten zu erlangen. Die Expression von 
ColIb (cib) wird bei Eisenmangel sowie bei der sogenannten SOS Antwort induziert. Zudem wird auch 
der ColIb Rezeptor CirA (cirA), welcher in der äußeren Bakterienmembran lokalisiert ist, vermehrt unter 
Eisenmangel gebildet. In vivo Studien im S. Tm Kolitis-Mausmodel zeigten, dass die Expression beider 
Proteine, ColIb und CirA, in Entzündungs-vermittelten „Blooms“ induziert wird. Überdies konnten wir 
feststellen, dass eine geringe Eisenkonzentration die Sensitivität von E. coli gegenüber ColIb erhöht. 
Diese Beobachtung erklärt, warum S. Tm nur unter Entzündungsbedingungen von ColIb profitiert. 
Zusammenfassend kann festgehalten werden, dass „Blooms“ von Arten der Familie von 
Enterobacteriazeen in Folge einer Darmentzündung eine neue ökologische Nische für Colicin-abhängige 
Kompetition zwischen den Bakterien darstellen.  
Zudem war auch die Untersuchung des Mechanismus der Colicin Ib Freisetzung Gegenstand dieser 
Arbeit. Im Gegensatz zu Gruppen A Colicinen war bisher unklar, wie ColIb und andere Mitglieder der 
Gruppe B Colicine aus den Bakterien freigesetzt werden. Es wurde beobachtet, dass die Freisetzung von 
ColIb nach einer Induktion der bakteriellen SOS-Antwort mit dem Antibiotikum Mitomycin C erfolgte. 
Als ein potentes SOS-Antwort-induzierendes Agens, schädigt Mytomycin C die DNA und löst den 
lytischen Zyklus von Prophagen aus. Die Induktion des lytischen Zyklus führt zur Produktion von Phagen-
kodierten Lysisproteinen, die die Lyse der Bakterienzelle veranlassen was zur Freisetzung von infektiösen 
Phagen führt. Wir vermuteten, dass zwischen der Freisetzung von ColIb und der Phagen-induzierten Lyse 
von S. Tm ein Zusammenhang besteht. S. Tm SL1344 beinhaltet vier lysogene Phagen: Gifsy-1, Gifsy-2,
Zusammenfassung 
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 SopEΦ und ST64B. Wir konnten zeigen, dass ein Phagen-kurierter S. Tm Stamm (enthält keine 
funktionale Prophagen) deutlich weniger ColIb freisetzt was im Zuge einer SOS-Antwort mit einer 
deutlich verringerten Zell-Lyse korrelierte. Außerdem wirkten sich verschiedene Prophagen 
unterschiedlich auf die ColIb Freisetzung aus, wobei die durch ST64B induzierte Zelllyse am meisten zur 
ColIb Freisetzung beitrug. Überdies konnten wir in in vitro Studien zeigen, dass der ColIb-abhängige 
Wachstumsvorteil von S. Tm gegenüber E. coli positiv von einer durch Prophagen-induzierten Lyse 
beeinflusst wird. Zudem ermöglichte die Phagen-Transduktion in einen Prophagen-defizienten E. coli 
Stamm die Freisetzung von ColIb, was die Rolle von Phagen für die ColIb Freisetzung unterstreicht. 
Zusammenfassend konnten wir zeigen, dass Colicine der Gruppe B durch eine durch Phagen-induzierte 
Zelllyse freigesetzt werden können. Mit der Freisetzung von Colicinen der Gruppe B und dem damit 
verbundenen Fitnessvorteil gegenüber sensitiven Bakterien, lässt diese Studie Prophagen in S. Tm eine 
neue Rolle zukommen. 
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1 Introduction 
1.1 The intestinal microbiota – general functions and its central role in 
protection against infections  
The mammalian gastrointestinal tract harbors more than 1012 microorganisms increasing in numbers and 
diversity from the stomach to the distal intestine (Hooper & Macpherson, 2010). A healthy microbiota is 
predominantly composed of species from of the phyla Bacteroidetes and Firmicutes (Turnbaugh et al., 
2008; Turnbaugh, 2009). The intestinal bacterial community retains highly complex metabolic activities 
and can almost be viewed as a distinct organism maintaining a symbiotic relationship with its host (Gill, 
2006). The host provides a nutrient rich environment with constant temperature, whereas the gut 
microbiota acts as a supplier of essential vitamins and enhances host digestion by processing complex 
polysaccharides. Along with these long-known contributions, the intestinal bacteria influence multiple 
processes of the host-organism, including organ development, immunity, cell proliferation, bone mass, 
adiposity and even behavior (Sommer & Backhed, 2013). Another crucial assignment of the gut 
microbiota is prevention of pathogen colonization, termed colonization resistance (Stecher & Hardt, 
2011). This protective effect is achieved via modulation of the host immune system by the microbiota, as 
well as through a direct antagonism of invading pathogens and substrate competition.  
The healthy microbiota modulates intestinal defense mechanisms including expression of various 
chemokines and antimicrobial compounds, as well as secretion of immunoglobulin A (IgA) (Chung et al., 
2012). Resident intestinal bacteria are constantly sensed by the pattern recognition Toll-like (TLRs) and 
NOD-like (NLRs) receptors (Geuking et al., 2014). Ligation of these receptors with bacterial molecules 
leads to expression of different cytokines (e.g. IL22 and pro-IL-1β) and antimicrobial peptides, such as 
RegIIIγ (Cash et al., 2006). 
Direct inhibition of pathogen growth by the beneficial microbiota includes consumption of available 
nutrients such as various dietary and mucosal glycans (Ferreyra et al., 2014). Furthermore, commensal 
bacteria release inhibitory molecules (e.g. bacteriocins) and various metabolites (e.g. short chain fatty 
acids, such as acetate and butyrate) suppressing either pathogen growth or expression of crucial virulence 
factors (Fukuda et al., 2011; Gantois et al., 2006; Riley & Gordon, 1999). 
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Further research will improve our understanding of the fine-tuned host-microbiota interactions leading to 
colonization resistance. Presently, it is established that disturbance of the intestinal microbiota caused by 
diet alteration or antibiotic treatment enhances pathogen invasion (Barthel et al., 2003; Buffie et al., 2012; 
Zumbrun et al., 2013). Strategies of intestinal pathogens to bypass colonization resistance include: (i) 
initiation of gut inflammation, (ii) expression of exploitative competition factors required for survival 
upon inflammation and (iii) release of antibacterial compounds e.g. bacteriocins to kill resident 
commensal bacteria (interference competition) (Winter et al., 2013a). The current work investigates the 
effect of a bacteriocin produced by enteric pathogen Salmonella enterica serovar Typhimurium (S. Tm) 
while “blooming” in the inflamed gut. 
 
1.2 How do pathogens overcome colonization resistance? 
1.2.1 Pathogens can benefit from disruption of the microbiota by antibiotics  
Antibiotic administration leads to an alteration of microbiota composition (Dethlefsen & Relman, 2011). 
Furthermore, it can lead to subclinical inflammation causing disruption of the intestinal barrier (Spees et 
al., 2013; Wlodarska et al., 2011). In addition to the decreased numbers of commensals, antibiotic 
treatment can favor growth of otherwise low-numbered, facultative anaerobes (i.e., Bacilli and 
Proteobacteria) (Hill et al., 2010). The latter include Enterobacteriaceae (class Gammaproteobacteria) 
(Ayres et al., 2012; Lawley et al., 2009). Reduced intestinal bacterial diversity upon antibiotic treatment 
fosters growth of intestinal pathogens (e.g. Clostridium difficile and S. Tm), as well as systemic spread of 
intestinal pathobionts such as E. coli (Lawley et al., 2009; Sekirov et al., 2008). Both the Gram-positive 
C. difficile and the Gram-negative S. Tm expand in the antibiotic-treated gut, utilizing the same nutrient 
source: host mucus-derived sialic acid. In the healthy intestine this monosaccharide is consumed by 
intrinsic commensal bacteria, which are eradicated as a result of antibiotic administration. Growing on the 
accessible sialic acid, C. difficile and S. Tm can reach numbers sufficient for development of pathogen-
inflicted intestinal inflammation (Ng et al., 2013). 
 
1.2.2 Pathogen-induced inflammation re-engineers the gut ecosystem, disrupts 
colonization resistance and induces enterobacterial blooms 
Pathogens belonging to the Enterobacteriaceae family (e.g. Citrobacter rodentium and S. Tm) trigger 
intestinal inflammation. This is characterized by neutrophil transmigration in the gut lumen, secretion of 
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numerous antimicrobials, as well as generation of various anaerobic electron acceptors. These 
environmental alterations tip the microbial balance in favor of the pathogen, along with other members of 
the Enterobacteriaceae family (Garrett et al., 2010; Lupp et al., 2007; Stecher et al., 2007a). This is 
referred to as “Enterobacterial blooms” (Stecher et al., 2013b). The inflammatory milieu generated upon 
pathogen infection or in the context of inflammatory bowel disease (IBD) supports growth of facultative 
anaerobes such as E. coli and Enterococcus spp., on the account of obligate anaerobic bacteria (Lupp et 
al., 2007; Mondot et al., 2011). In the healthy intestine, obligate anaerobes of the phyla Bacteroidetes and 
Firmicutes metabolize carbohydrates and amino acids by fermentation (Faber & Baumler, 2014). Upon 
inflammation, secretion of interferon-gamma (INF-γ) leads to induction of epithelial oxidases and the 
inducible nitric oxide synthase (iNOS). Their activity leads to the generation of antimicrobial reactive 
oxygen species (ROS) and reactive nitrogen species (RNS), respectively (Harper et al., 2005; Kuwano et 
al., 2006; Nathan, 2006). Furthermore, neutrophils delivered at the site of inflammation, likewise produce 
ROS (e.g. superoxide (O2-)) and RNS (Nathan, 2006; Winter et al., 2010). These antimicrobials are 
involved in the generation of oxidized anaerobic electron acceptors, such as tetrathionate, nitrate (NO3−), 
trimethylamine N-oxide (TMAO) and dimethyl S-oxide (DMSO) (Winter et al., 2013a). In contrast to the 
obligate anaerobes, Enterobacteriaceae species (e.g. E. coli, S. Tm and Yersinia enterocolitica) produce 
respiratory reductases, which reduce the anaerobic electron acceptors. Anaerobic respiration confers a 
selective advantage over the obligate anaerobes by facilitating the utilization of various substrates as 
energy and nutrients source (e.g. ethanolamine) (Faber & Baumler, 2014; Winter et al., 2010; Winter et 
al., 2013b). Ethanolamine, an end product of bacterial fermentation, is used as a nitrogen and carbon 
source by various enteric pathogens, including S. Tm, enterohaemorrhagic E. coli (EHEC) and C. difficile 
(Bertin et al., 2011; Pitts et al., 2012; Thiennimitr et al., 2011).  
Another characteristic of the environmental conditions in the inflamed intestine is iron limitation 
(Loetscher et al., 2012; Raffatellu, 2009). Furthermore, apoptotic neutrophils and epithelial cells in the 
inflamed intestine release antimicrobial proteins, which sequester metal ions (e.g. iron and zinc) that are 
essential for bacterial growth. Iron is an essential component of many bacterial enzymes involved (Braun 
& Hantke, 2011). Bacteria can sequester environmental ferric iron (Fe(III)) by producing small molecule 
chelators, termed siderophores. Specific outer membrane receptors of Gram-negative bacteria (e.g. CirA, 
FhuA, FecA) bind and translocate siderophore-Fe(III) complexes across the outer membrane and 
periplasm. The energy-dependent translocation is implemented via TonB along with inner membrane 
proteins ExbB and ExbD (Braun & Hantke, 2011; Miethke, 2013). Upon infection, increased biosynthesis 
of the hormone hepcidin in the liver results in reduction of both intestinal iron uptake and iron release by 
macrophages. Intestinal iron is further restricted by the iron-binding protein lactoferrin and siderophore-
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binding Lipocalin-2 (Lcn-2) released at inflammatory sites (Chu et al., 2010). S. Tm and some other 
members of Enterobacteriaceae can circumvent Lcn-2 activity by expressing a modified siderophore, 
salmochelin, which is not bound by Lcn-2 (Deriu et al., 2013; Raffatellu, 2009). Likewise, S. Tm is 
resistant against other antimicrobial proteins, such as zinc-binding protein calprotectin and C-type lectin 
RegIIIβ (Liu et al., 2012; Stelter et al., 2011). Thus, differential killing of the microbiota and pathogens by 
inflammatory immune response may contribute to the observed microbiota shift in the inflamed gut.  
 
1.3 Salmonella Typhimurium - a model human pathogen to study microbiota-
pathogen interaction in the gut 
1.3.1 Salmonella Typhimurium pathogenesis  
Infections with nontyphoidal Salmonellae (e.g. S. Tm) generally lead to a self-limiting diarrhea, but can be 
particularly dangerous for immunocompromised individuals by causing bacteremia (Gordon et al., 2008). 
Once S. Tm bacterium reaches the small intestine, the pathogen is directed by chemotactic flagella-
mediated motility towards the gut epithelium, penetrating the mucus layer (Figure 1.1A) (Stecher et al., 
2004). S. Tm adheres to the epithelium by employing various fimbriae and non-fimbrial adhesins (Fabrega 
& Vila, 2013; Kaiser et al., 2012). Tissue invasion of S. Tm requires expression of numerous effector 
proteins encoded within the five Salmonella pathogenicity islands (SPIs) (Fabrega & Vila, 2013; Kaiser et 
al., 2012). The type III secretion systems (T3SS-1) encoded by SPI-1 represents a needle-like structure, 
which injects at least 14 different effector proteins into the epithelial cells (Kaiser et al., 2012). Effector 
proteins of T3SS-1 cause actin rearrangement and formation of membrane ruffles leading to pathogen 
engulfment by the cell. Furthermore, some effector proteins induce expression of pro-inflammatory 
cytokines, e.g. interleukin-1 (IL-1) and interleukin-8 (IL-8). This is termed the “classical” pathway for 
initiation of inflammation. In addition to the T3SS-1 mediated invasion mechanism, S. Tm is internalized 
by pathogen-sampling dendritic cells (Stecher & Hardt, 2011). Once inside the cells, pathogens are safely 
encapsulated in a Salmonella-containing vacuole (SCV) (Fabrega & Vila, 2013). Residing in the SCVs, S. 
Tm induces the SPI-2 encoded T3SS-2, which injects effector proteins that trigger the “alternative” 
pathway, which causes tissue-wide inflammation (Kaiser et al., 2012; Stecher & Hardt, 2011). Moreover, 
effector proteins secreted by T3SS-2 support intracellular survival, proliferation and dissemination of S. 
Tm to systemic sites (the mesenteric lymph nodes (MLNs), the spleen, and the liver) (Kaiser et al., 2012). 
Besides T3SS-1 and T3SS-2, numerous proteins encoded by SPI3 - SPI5 and virulence plasmid pSLT 
contribute to the pathogenesis (Fabrega & Vila, 2013). Induction and amplification of the initial pro-
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inflammatory signals by S. Tm results in: granulocyte migration towards the intestinal lumen, T-cell 
activation, mucosal edema, epithelial damage, reduced numbers of mucus-loaded goblet cells and mucin 
secretion (Figure 1.1B,C) (Fabrega & Vila, 2013; Kaiser et al., 2012). 
 
 
 
 
1.3.2 Mechanisms of Salmonella Typhimurium overgrowth in the inflamed gut 
Blooming in the inflamed intestine S. Tm employs various competitive strategies, which ensure not simply 
just survival, but lead to even further displacement of the resident commensal microbiota (Figure 1.2). 
Intestinal sulfate-reducing bacteria release toxic H2S, which is oxidized by the cecal mucosa to thiosulfate 
(Levitt et al., 1999). Nitric oxide (NO) radicals and ROS, release by the inflamed mucosa as part of the 
 
 
Figure 1.1. Salmonella Typhimurium pathogenesis. S. Tm moves towards the gut epithelium, where it adheres to 
epithelial cells, followed by activation of the T3SS-1 and injection of various effector proteins into the cell. 
Effector proteins of T3SS-1 cause expression of pro-inflammatory cytokines, as well as actin rearrangement and 
formation of membrane ruffles leading to pathogen engulfment followed by S. Tm encapsulation in a SCV 
(classical pathway for initiation of inflammation). Encapsulated inside a pathogen-sampling dendritic cell, S. Tm 
activates the T3SS-2. Effector proteins of T3SS-2 cause tissue-wide inflammation (alternative pathway for 
initiation of inflammation) (A). Hematoxylin and eosin (H&E)–stained cecal sections of healthy (B) and S. Tm-
infected mice (C). S. Tm infection leads to granulocyte infiltration, mucosal edema and epithelial damage (C). An 
enlarged section (square) is shown in the right panel. Adapted from (Stecher et al., 2007a). 
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inflammatory response, lead to oxidation of thiosulfate to the anaerobic electron acceptor tetrathionate. 
Unable to use tetrathionate, commensal bacteria rely entirely on energetically less efficient fermentative 
metabolism and are ultimately outcompeted by the pathogen, which can utilize tetrathionate for anaerobic 
respiration (Winter et al., 2010). Switch from tetrathionate to even more energetically efficient nitrate-
respiration, further promotes growth of some epidemic S. Tm strains harboring the T3SS-1 effector 
protein SopE. SopE further enhances production of iNOS in the intestinal mucosa, while suppressing 
expression of tetrathionate utilization genes. iNOS mediates production of NO3−, by generating more NO 
and ROS, which can be used by the pathogen as terminal electron acceptor (Lopez et al., 2012). 
S. Tm-triggered expression of inflammatory pro-cytokines (e.g. IL-22 / IL-17) leads to secretion of 
numerous antimicrobials (e.g. Lcn-2) by intestinal epithelial cells and infiltrating neutrophils. Lcn-2 binds 
siderophores (e.g. enterochelin) and thereby inhibits bacterial iron-uptake. Unlike many commensal 
bacteria, S. Tm maintains a sustainable iron supply by expressing a Lcn-2-resistant glycosylated 
enterochelin derivative, termed salmochelin, encoded on the iroBCDEN gene cluster (Raffatellu, 2009). 
Likewise, S. Tm avoids action of zinc-binding protein calprotectin by production of ZnuABC transporter, 
which enables acquisition of this essential micronutrient even under zinc-limiting conditions (Liu et al., 
2012). In addition, intestinal secretory cells (Paneth cells) release various antimicrobial peptides including, 
α-defensins and C-type lectins RegIIIγ and RegIIIβ (Vaishnava et al., 2008). RegIIIβ kills competing 
commensal bacteria, but is relatively harmless for the inflammation-eliciting pathogen S. Tm due to 
alterations in its peptidoglycan structure and lipopolysaccharide composition (Stecher & Hardt, 2011; 
Stelter et al., 2011).  
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Figure 1.2. Mechanisms of Salmonella Typhimurium overgrowth in the inflamed gut. Under homeostatic 
conditions, Enterobacteriaceae (blue, green) are reduced in numbers as they are overgrown by the obligate anaerobic 
microbiota (violet-blue) (A). S. Tm-triggered inflammation results in transmigration of neutrophils into the gut 
lumen, release of reactive oxygen and nitrogen species (ROS, RNS), production of anaerobic electron acceptors 
(tetrathionate and NO3−), utilized by Enterobacteriaceae. Release of antimicrobials (e.g. RegIIIβ and iron-depleting 
Lcn-2) inhibits growth of resident obligate anaerobic microbiota (B).  
 
 
1.3.3 Salmonella Typhimurium-triggered inflammation leads to enterobacterial 
blooms and horizontal gene transfer  
S. Tm-elicited inflammation leads to parallel blooms of commensal and pathogenic Proteobacteria (Lopez 
et al., 2012; Stecher et al., 2007a). It was shown that expansion of Enterobacteriaceae promotes 
horizontal gene transfer (HGT) by conjugation (Stecher et al., 2012). In contrast to stepwise evolution via 
mutations, HGT can provide rapid evolution and acquisition of entire fitness and virulence genes. This 
transmission of new traits can occur by transformation, phage-mediated transduction and conjugation-
mediated plasmid exchange. Conditions in the intestine are expected to favor the latter two mechanisms. 
Plasmid transfer via the conjugative pilus requires direct cell-cell contact (Frost et al., 2005; Scott, 2002). 
Therefore, high densities of metabolically active bacteria in the gut form the ideal environment for a 
successful conjugation. Indeed, S. Tm-elicited inflammation resulted in an extremely efficient transfer of 
conjugative pCol1B9_SL1344 plasmid (further termed P2) into parallel “blooming” E. coli (Stecher et al., 
2012). This was attributed mostly to the high titers of donor and recipient strains upon pathogen-fostered 
gut inflammation. In the absence of inflammation, overgrowth of obligate anaerobic members of the gut 
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microbiota lead to a decrease in Enterobacteriaceae and thereby interfered with the conjugation Upon 
inflammation P2 conferred a competitive-advantage to the S. Tm over ColIb-sensitive E. coli (Stecher et 
al., 2012). This suggested that ColIb could be an important fitness factor for pathogen growth in the 
inflamed intestine. 
 
1.4 Colicin biology: bacterial warfare 
1.4.1 Colicins: types and functions 
Colicins are relatively large proteins (40 to 80 kDa) belonging to a group bacterial peptide toxins, termed 
bacteriocins. Colicins, as their name suggests, are bacteriocins produced by E. coli and some related 
Enterobacteriaceae species (Cascales et al., 2007). Twenty-four percent and 59% of intestinal E. coli 
isolates of human and mice, respectively produce colicins. These numbers imply that colicinogeny is 
somewhat important in natural bacterial communities (Gordon et al., 1998; Gordon & O'Brien, 2006). 
Colicins are classified into two groups (A and B), based on their uptake mode: Tol- or TonB-mediated 
colicin uptake, respectively (Figure 1.3). Colicins exert their lethal activity to closely related species by 
pore-formation or enzymatic activity. Pore-forming colicins (e.g. ColIb) form channels in the inner 
membrane of the victim, which leads to membrane depolarization, leakage of intracellular ions and 
ultimately cell death (Weaver et al., 1981). Enzymatic colicins mainly target deoxyribonucleic acid 
(DNA) or ribonucleic acid (RNA), with the exception of colicin M, which interferes with peptidoglycan 
biosynthesis in the periplasm (Cascales et al., 2007). Colicins are harmless for the producing bacteria due 
to the expression of cognate colicin immunity proteins, which either form heterodimers with the nuclease 
colicins in the cell cytosol, or insert into the inner membrane and block pore-forming colicins.  
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Figure 1.3. Mechanisms of colicin uptake. Group A and group B colicins bind an outer membrane receptor and are 
further translocated through the outer membrane and periplasm by an outer membrane translocator. The energy-
dependent translocation of group A colicins involves proteins TolA, TolB, TolQ, TolR (A). Group B colicins require 
the protein TonB assisted by ExbB and ExbD (B). Following translocation colicins are either inserted into the inner 
membrane forming a voltage-gated ion channel, or are further directed into the cytoplasm targeting nucleic acids. 
Adapted from (Kleanthous, 2010). 
 
 
Colicins are organized into three domains, each governing a specific function: receptor-binding (R), 
translocation (T) and killing activity (A). The central R-domain and amino-terminal T-domain exploit 
outer membrane receptors and porins (e.g. OmpF, OmpW), as colicin receptors and translocators. Colicin-
receptors are normally involved in uptake of essential bacterial compounds; e.g. vitamin B12 (BtuB), 
siderophores (CirA, FyuA) and ferrichrome (FhuA) (Cascales et al., 2007). Following binding of a 
translocator protein, the colicin T-domain interacts with host proteins located in the periplasm and inner 
membrane, directing colicin translocation. The T-domain of group A colicins recruits Tol proteins (TolA, 
TolB, TolQ, TolR), which are generally involved in outer membrane stabilization during cell division 
(Gerding et al., 2007; Kleanthous, 2010). The uptake mechanism of group B colicins has been 
investigated in detail for the ColIb homologue - colcin Ia (ColIa) (Mankovich et al., 1984). The ColIa R-
domain binds to the outer membrane receptor CirA, while the T-domain engages a second CirA as ColIa 
translocator. ColIa translocation is carried out via TonB (Kleanthous, 2010). TonB assisted by ExbB and 
ExbD proteins (as well as Tol-system), employs inner membrane proton motive force (pmf) for the 
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energy-dependent translocation of their natural ligands and colicins. Following translocation, the third 
colicin domain, carboxy-terminal A-domain, is either inserted into the inner membrane forming a voltage-
gated ion channel (pore-forming colicins), or is directed further towards the cytoplasm (nucleases) 
(Cascales et al., 2007). 
 
1.4.2 Genetic control of colicin expression  
Colicins are associated with two types of plasmids which exhibit differential genetic organization. The 
majority of group A colicins are encoded by small (6-10 kb) high-copy plasmids, reaching up to 30 copies 
per bacterial cell. Group B colicins (e.g. ColIb) are mostly encoded on larger (~ 40 kb), single-copy 
conjugative plasmids.  
The operon of group A nuclease-type colicins includes three genes, the gene encoding colicin activity 
(cxa), followed by immunity protein (cxi) and a lysis protein gene (cxl) (Figure 1.4) (Cascales et al., 
2007). The cxi genes of pore-forming colicins of both A and B groups are encoded on the opposite DNA 
strand (with respect to the cxa gene) and in some cases can be completely absent. Generally, transcription 
of the colicin operon is regulated by a strong negatively controlled common promoter P, conferring 1000-
fold increase of colicin expression upon induction (Zgur-Bertok, 2012), and transcriptional terminators T1 
and T2. Furthermore, the cxi is regulated by its own constitutive promoter Pim ensuring constant 
expression of the immunity protein, thereby protecting the producer cell against colicin activity. The 
transcriptional terminator T1, upstream of the lysis gene of group A colicins, blocks lysis gene expression. 
Lysis protein activity is lethal for the colicinogenic strain; therefore tight regulation of the lysis gene is 
necessary to concede intracellular accumulation of the colicin before the cell death. Expression of colicin 
operons is controlled by LexA protein, which is the major repressor of SOS response system (Zgur-
Bertok, 2012). 
The SOS response is a global cellular response to DNA damage leading to induction of multiple genes 
involved in DNA repair (Little, 1991). Therefore, the SOS response is triggered by many environmental 
factors including: acidic pH, antimicrobial molecules (e.g. hydrogen peroxide and nitric oxide), antibiotics 
(e.g. mitomycin C, ciprofloxacin) and UV light. The key players of the SOS response are LexA, the 
transcriptional repressor and RecA, its activator. LexA homodimers rapidly bind consensus DNA 
sequences in the promoter region of SOS-regulated genes, known as “LexA (SOS) boxes”, thereby 
blocking access of the RNA polymerase (Butala et al., 2008; Shinagawa, 1996). During replication, 
damaged DNA blocks the replication fork, which results in accumulation of single-stranded DNA 
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(ssDNA). RecA proteins bind to ssDNA and assisted by adenosine triphosphate (ATP) form RecA–
ssDNA active filaments (RecA*). RecA* is a co-protease assisting self-cleavage of free LexA dimers, 
which is followed by swift degradation of the cleaved proteins. As a result, LexA levels decrease, which 
leads to dissociation of the LexA repressor from the consensus DNA and expression of the SOS-controlled 
genes. LexA dissociation rates vary between different SOS boxes leading to distinct timing of gene 
expression (Butala et al., 2011). A large group of colicin promoters contains two overlapping SOS boxes 
leading to co-operative repression by two LexA proteins (Gillor et al., 2008). This tight repression of the 
colicin operon, including the lysis gene, gives the cell time to repair the DNA defects and prevents colicin 
release (Zgur-Bertok, 2012).  
 
 
 
Figure 1.4. Organization of colicin operons. The operon of group A nuclease-type colicins is controlled by the 
common promoter P, followed by genes encoding colicin activity protein (cxa) (red arrow) and colicin immunity 
protein (cxi) (green arrow). The latter is additionally controlled by the promoter Pim. The last gene of the operon of 
group A nuclease-type colicins encodes a lysis protein (cxl) (light pink arrow). Transcriptional terminators T1 and T2 
are located before and after the cxl, respectively. The cxa of group B colicins is followed by the transcriptional 
terminator T, while the cxi is located on the opposite DNA strand and is regulated by its own promoter (Pim) and 
terminator (Tim). Adapted from (Cascales et al., 2007). 
 
 
Of note, ColIa and ColIb operons are an exception from the double-LexA repression, as they contain only 
one SOS box (Gillor et al., 2008; Mankovich et al., 1986). Furthermore, expression of some colicins is 
blocked by additional repressors. Some pore-forming colicins (e.g. colicin K and E1) are controlled by the 
global transcriptional repressor IscR, which is liberated upon nutrient depletion (Butala et al., 2012). 
Additionally the cAMP receptor protein (CRP) is shown to regulate colicin expression and 
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downregulation of colicin lysis gene expression is mediated by RNA-binding protein CsrA. This suggests 
that colicin expression is regulated by a complex transcriptional and post-transcriptional mechanism 
(Zgur-Bertok, 2012). 
 
1.4.3 Colicin ecology  
Although, approximately a third of natural Enterobacteriaceae communities are colicinogenic (Riley & 
Gordon, 1999), this number differs according to the habitat of the strain (e.g. only 9% colicinogenic E. 
coli soil isolates against 30% faecal isolates). This variability is associated with the high metabolic costs 
of colicin production, as well as lethality of colicin release. The high cost paid by the producer is an 
important factor influencing the outcome of the competition against colicin-sensitive rivals. The interplay 
between colicin producers and colicin-sensitive strains is further complicated upon introduction of a 
colicin resistant strain, which acquires resistance upon alteration of the colicin uptake machinery by 
mutation. This is a less costly trait compared to colicin production, however it confers a fitness 
disadvantage against colicin-sensitive competitors. The interplay between producer, sensitive and resistant 
strains is compared to the game of Rock, Paper, Scissors, whereby the producer is outcompeting the 
sensitive strain, but being outnumbered by the resistant bacteria, which in turn is outgrown by the 
sensitive strain (Figure 1.5). The dynamic equilibrium established in vivo between these three competitors 
is proposed to support bacterial diversity (Kirkup & Riley, 2004; Riley & Wertz, 2002) 
 
 
  
Figure 1.5. The Rock, Paper, Scissors 
interplay. The colicin-producing strain 
kills the colicin-sensitive strain. The 
sensitive strain, which is not paying the 
costs of resistance, outcompetes the 
resistant strain. The latter is resistant to the 
colicin and it is not burdened by colicin 
production, which allows it to outgrow the 
colicin-producing strain. Adapted from 
(Hibbing et al., 2010) 
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Furthermore, it was shown that a colicinogenic strain invading an environment with randomly distributed 
nutrients at low numbers, loses against the resistant strain, which grows faster due to the absence of 
production costs (Chao & Levin, 1981). In contrast, competition in a more structured environment (e.g. 
the mammalian intestine) is expected to support the colicin producer, which is killing the neighboring or 
invasive colicin-sensitive bacteria, thereby directly liberating niche space and nutrients (Chao & Levin, 
1981; Majeed et al., 2011). 
Of note, under physiological conditions, only a small fraction of the producer’s population expresses the 
colicin (Mulec et al., 2003). The rest of the population benefits from the colicin and nutrients released by 
the lysing producer (Butala et al., 2012). This is referred to as “division of labor”, which is enabled by 
heterogeneous activation of colicin expression due to the impact of stochastic factors, as well as the 
binding affinity of LexA (Kamensek et al., 2010; Mrak et al., 2007).  
 
1.4.4 The enigma of group B colicins release 
Release of group A colicins is mediated by cognate colicin lysis proteins (Cascales et al., 2007). Lysis 
proteins of group A colicins are small lipoproteins, which display sequence homology with exception of 
their N-terminal signal sequence. They kill bacteria in two steps: (i) damage the inner membrane and 
direct translocation of colicin into the periplasm and, (ii) cause membrane perturbation and activate the 
outer membrane phospholipase OmpLA (Chen et al., 2011). OmpLA governs accumulation of 
lysophospholipids which leads to outer membrane permeabilization and release of colicins along with 
other periplasmic and cytoplasmic proteins (Baty et al., 1987). 
Hitherto, the release mechanism of group B colicins remains unclear (Cascales et al., 2007). Group B 
colicin operons do not encode the cxl gene and no signal sequence directing these proteins towards the 
inner membrane for secretion has been identified. In the course of the current work, the mechanism of 
ColIb release in relation to the intracellular protein leakage upon prophage-mediated cell lysis was 
investigated. 
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1.5 Prophages 
1.5.1 General introduction  
Bacterial viruses – bacteriophages - are the most abundant biological form on Earth with an estimated 
number of > 1030 phages in the biosphere (Brussow & Hendrix, 2002). The mammalian gut, which is 
densely populated by bacteria, represents an environment enriched in phages, with viruses (represented 
mainly by bacteriophages) reaching 109 per gram of human feces (Kim et al., 2011). Phages, particularly 
lysogenic phages are able to integrate into the bacterial host genome (prophages) and confer benefit to the 
host bacteria in multiple ways. Prophages block superinfection by lytic phages and they enhance bacterial 
fitness upon host-pathogen interactions (Brussow et al., 2004). Moreover, phages participate in HGT 
through either general transduction, or lysogenic conversion. The latter, drives transfer of extra genes, 
called “morons”, encoded within the prophage genome. These extra genes encode various bacterial fitness 
factors. Morons influence propagation of prophages by enhancing survival and dissemination of the 
lysogen, thereby increasing chances for vertical prophage transfer to the next generation of host cells (by 
bacterial divisions). Many morons are organized into autonomous genetic elements flanked by their own 
promoter and terminator. Thereby, expression of these genes is independent of the prophage life cycle and 
can be coordinated according to the needs of the host bacterium. Moron-encoded virulence factors are 
linked to biofilm formation, sporulation, as well as regulation, expression and release of bacterial toxins 
(e.g. phage-encoded botulinum neurotoxins of Clostridium botulinum and Shiga toxin (Stx) of Shiga-toxin 
producing E. coli (STEC)) (Brussow et al., 2004).  
 
1.5.2 Phage life cycle 
At the first step of the infection phages bind bacterial outer membrane components (e.g. proteins, 
oligosaccharides or lipopolysaccharides). Next, prophage DNA is “injected” into the bacterial cytoplasm 
through the phage tail followed by rapid circularization of the injected DNA to avoid degradation by the 
exonucleases of the host. The internalized prophage redirects host metabolism to serve the phage 
multiplication process, including: (i) phage genome replication, (ii) phage protein production, (iii) 
assembly of infectious particles and (iv) phage release. These events describe the phage lytic cycle, which 
is abolished upon integration of the phage genome into the bacterial chromosome (Figure 1.6). Thereby, 
the prophage is replicated and inherited alongside with the bacterial genome upon cell division (Guttman, 
2005). This dormant existence, termed lysogeny, can be terminated by various conditions jeopardizing the 
host bacterial cell (e.g. nutritional stress, oxidative stress, UV radiation, antibiotic treatment, heat shock, 
Introduction 
15 
 
 
quorum sensing signals), upon which DNA-integrated prophages engage into the lytic cycle to abandon 
the “sinking ship” (Guttman, 2005). 
 
 
 
Figure 1.6. Life cycle of a temperate lambdoid phage. Upon attachment to the host, the phage injects its DNA into 
bacterial cytoplasm. Lysogenic development of the phage takes place upon DNA integration into the host 
chromosome. The prophage is transferred to each new bacterium upon proliferation of the lysogenic strain. The 
switch from lysogenic to lytic mode takes place upon conditions threatening the host bacterial cell (SOS-response). 
The lytic cycle includes synthesis of phage DNA and proteins and, assembly of infectious particles, which is 
followed by lysis and release of phages. Adapted from (Campbell, 2003). 
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A complex interplay between prophage promoters and terminators directs decision in favor of either the 
lytic or the lysogenic infection. Widely studied lambdoid prophages possess two early promoters, pL and 
pR, which initiate transcription of the prophage genes in opposite directions (Figure 1.7) (Court et al., 
2007; N.J. Dimmock, 2001). Following expression of the N gene, located directly downstream of pL, the 
bacterial RNA polymerase is arrested at the terminator tL1. Likewise, only the cro gene is expressed 
following transcription initiation from the pR promoter. Transcription of the pR-downstream located 
replication genes (O, P and ren) and the antiterminator protein encoding Q gene is halted by the 
terminator tR1. The N protein is an antiterminator which, in association with the RNA polymerase and 
Nut host proteins, induces expression of genes downstream of tL1 and tR1. The latter includes the genes 
cII and cIII required for establishment of lysogeny. CII initiates transcription from three promoters pI, 
pRE and pAQ, controlling expression of int, cI genes and an antisense RNA of the Q gene, respectively. 
The CI repressor is critical for establishment and maintenance of lysogeny. CI homodimer binds both, pL 
and pR, repressing expression of all prophage genes, except of its own one by auto-activation of the pRM 
promoter, which is situated upstream of the cI gene. Upon superinfection of a lysogen, CII, CIII and CI 
produced by the resident prophage direct the newly incoming prophage towards lysogenic mode. RecA* 
(Section 1.4.2), the central protein activated in the course of the SOS response acts as co-protease of CI 
leading to cleavage of the CI monomers and de-repression of prophage genes (e.g. cro, Q, int and xis) 
(Cohen et al., 1981). The Cro protein is a week repressor, which binds the operators OL and OR, thereby 
inhibiting expression of the lysogenic mode proteins, CIII and CII. Furthermore, the Q antiterminator 
directs expression of prophage morphogenesis and cell lysis genes located downstream of pR’ promoter, 
which in absence of Q protein is inhibited by the terminator tR’ (Court et al., 2007). 
 
 
 
Figure 1.7. Regulation of a temperate lamdoid phage. Transcription of phage early genes initiated at the pL and 
pR promoters (arrows indicate direction of transcription) is arrested at the terminators tL1 and tR1 (red color). 
Antiterminator N induces expression of genes located downstream of tL1 and tR1 including cIII and cII, respectively. 
CII induces transcription from pI, pRE and pAQ promoters. The antiterminator Q activates expression of phage late 
genes located downstream of the pR’ promoter, which in absence of Q protein is inhibited by the terminator tR’. Cro 
repressor binds operators OL and OR blocking transcription from pL and pR. Adapted from (Court et al., 2007).  
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1.5.3. Function of phage lysis proteins and mechanism of action 
Up to five prophage proteins are engaged in the lysis of the host bacterium. The lysis genes of lambdoid 
prophages are generally organized in a “cassette” located downstream of the prophage late promoter pR’ 
(Figure 1.8A) (Young, 2013). In the “canonical λ prophage holin-endolysin” lysis model (Young, 2014), 
the lysis cassette starts with gene S encoding a small membrane protein holin, followed by R gene 
encoding the muralytic enzyme (endolysin). Late gene expression results in production of holins, which 
are uniformly integrated in the host’s inner membrane (Figure 1.8B). Concomitantly, active R endolysins 
accumulate in the cytoplasm. Upon reaching a critical concentration, multiple holins aggregate in a small 
number of clusters, designated as “rafts”. Raft-formation is thought to cause local membrane 
depolarization that directs assembly of one to three micron-scale holes. The holes are large enough (340 
nm-1 µm) to allow transition of the R endolysin into the periplasm of Gram-negative bacteria, where 
endolysins destroy the peptidoglycan network (Young, 2013).  
 
 
 
  
Figure 1.7. Lambda prophage lysis model. 
The lysis genes of lambdoid prophage S, R, Rz 
and Rz1, encoding S-holin, R-endolysin, i-
spanin and o-spanin, respectively, are 
organized in a “cassette” located downstream 
of the prophage late promoter pR’ (A). Adapted 
from (Young, 2013). Initially, holins integrate 
into the inner membrane, while the endolysins 
accumulate in the cytoplasm (Phase 1). Upon 
reaching a critical concentration, multiple 
holins form a micron-scale hole, which allows 
the endolysins to enter the periplasm and 
destroy the peptidoglycan network (Phase 2). 
Finally, i-spanins and o-spanins (anchored in 
the inner and outer membrane, respectively) 
form heterodimers, which lead to disruption of 
the outer membrane (Phase 3) (B). Adapted 
from Young et al. (2014). 
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Apart from the described model, prophages such as Stx-encoding phages H-19B and 933W follow the 
pinholin-SAR (for signal-anchor-release) endolysin lysis pathway (Neely & Friedman, 1998; Young, 
2013). Phage-encoded SAR endolysins are translocated into the periplasm by the host’s sec secretion 
system. Inactive SAR endolysins accumulate, membrane-tethered in the inner membrane. Pinholins are 
small holins engaged in activation of SAR endolysin (Young, 2014). Pinholins accumulate in the inner 
membrane forming multiple small (~2 nm) heptameric channels. These channels, too small to assist SAR 
endolysin transport, cause the collapse of the pmf leading to release and activation of the muralytic SAR 
enzymes. Both holin and pinholin proteins are inactivated by proteins called antiholins. The latter possess 
a positively charged N-terminal domain, which activates holins and pinholins upon collapse of pmf. 
Together, holins, pinholins and antiholins time lysis of the cell. Two additional lysis proteins encoded by 
the genes rz and rz1 finalize the cell lysis. Rz, also known as i-spanin, is an integral membrane protein, 
while Rz1 (o-spanin) is a lipoprotein. Spanins form heterodimers anchored in the inner and outer 
membrane, respectively. Upon peptidoglycan degradation, i- and o-heterodimers aggregate and trigger 
outer membrane disruption, possibly by causing membrane fusion. Some phages express a single u-spanin 
conducting function of Rz and Rz1 (Young, 2013). Furthermore, some ssDNA and ssRNA phages encode 
only one small lysis protein. Although the exact mechanism of these lysis proteins is still unknown, it is 
suggested that they arrest the peptidoglycan synthesis in actively growing bacteria, causing cell burst 
(Young et al., 2000). 
 
1.5.4 Salmonella Typhimurium SL1344 prophages: Gifsy-1, Gifsy-2, SopEΦ and 
ST64B 
S. Tm strains harbor a set of prophages encoding multiple virulence factors. S. Tm SL1344 along with 
LT2, and ATCC14028 is lysogenic for the lambda-like prophages Gifsy-1 and Gifsy-2 (Figure 1.9) 
(Figueroa-Bossi & Bossi, 1999). Both prophages enhance the establishment of the pathogen and its 
systemic spread in mice, while Gifsy-2 has more profound impact compared to Gifsy-1. The Gifsy-2 
prophage encodes [Cu, Zn] superoxide dismutase SodCI, which converts superoxide radicals to hydrogen 
peroxide, thereby protecting S. Tm against the ROS (Figueroa-Bossi et al., 2001). Gifsy-1 encodes other 
virulence factors, such as the T3SS-2 effector protein SseI and the effector GipA, both supporting 
intracellular survival of the pathogen (Fabrega & Vila, 2013; Miao & Miller, 2000; Stanley et al., 2000). 
Furthermore, S. Tm SL1344 strains harbor a member of P2 family of prophages - SopEΦ (Mirold et al., 
1999). This prophage is found in several epidemic S. Tm strains and encodes the effector protein SopE. 
Exported by T3SS-1, SopE is an important virulence factor, which not only supports nitrate respiration in 
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the inflamed intestine (Section 3.2), but also acts as a cellular invasion factor and triggers release of pro-
inflammatory cytokines (Muller et al., 2009). A fourth prophage encoded within the S. Tm SL1344 
genome is a lambda-like prophage ST64B (Figueroa-Bossi & Bossi, 2004; Mmolawa et al., 2003). A 
reversible frameshift mutation in the ST64B genome leads to expression of tailless prophages, which are 
noninfectious (Figueroa-Bossi & Bossi, 2004). ST64B supports survival of the S. Tm lysogen in the blood, 
suggesting that it might contribute to the systemic spread of the pathogen (Herrero-Fresno et al., 2014). 
Nevertheless, it is possible that ST64B encodes proteins, which as other less characterized prophage-
encoded effector proteins (e.g. GogB of Gifsy-1), enhance S. Tm SL1344 growth in specific hosts or at 
distinct ecological niches inhabited by the pathogen (e.g. the outer environment) (Brussow et al., 2004). 
 
 
Figure 1.9 Prophages of S. Tm SL1344. Arrows indicate direction of transcription of open reading frames (ORF) 
located within the genome of phages Gifsy-1, Gifsy-2, SopEΦ and ST64B. The color code defines genes encoding 
virulence factors (violet), proteins involved in excision and integration of the phage genome (orange), capsid proteins 
(dark blue), tail proteins (green), neck proteins (brown), regulation proteins (light blue) and lysis proteins (red). 
Genes encoding proteins with unknown functions are marked in grey.  
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2 Objectives 
1) S. Tm-elicited inflammation leads to parallel blooms of commensal and pathogenic 
Enterobacteriaceae, which compete for the available nutrients in the intestine (Lupp et al., 2007; Stecher 
et al., 2007a). Members of Enterobacteriaceae family employ protein toxins termed colicins to kill 
colicin-sensitive competitors belonging to the same family (Cascales et al., 2007). One third of the natural 
E. coli population can produce colicins (Riley & Gordon, 1999), suggesting that colicin production should 
be a beneficial trait for colonizing the mammalian intestine. However, experimental results using in vivo 
infection models yielded contradictory results (Ikari et al., 1969; Kirkup & Riley, 2004). It was observed 
that ColIb-producing S. Tm outgrows ColIb-sensitive E. coli upon inflammation, suggesting that 
production of ColIb could be an important fitness trait supporting growth of the pathogen in the inflamed 
intestine (Stecher et al., 2012).  
The first part of this PhD-thesis aimed to determine how S. Tm-elicited inflammation influences ColIb-
dependent competition between S. Tm and E. coli investigating two main questions: does intestinal 
inflammation affect production of ColIb by S. Tm and is ColIb-sensitivity of E. coli enhanced upon 
inflammation. To answer these questions, a mouse model for S. Tm colitis, as well as bacterial gene 
reporters and a variety of bacterial mutants shall be employed.  
2) In contrast to group A colicins, which are released by the activity of a colicin lysis protein, the release 
mechanism of group B pore-forming colicins (e.g. ColIb), lacking the lysis protein, is not known. In the 
course of the current work, it was observed that ColIb can be detected in the culture supernatant only upon 
supplementation of mitomycin C. A DNA damaging antibiotic, mitomycin C is known to activate 
prophages, a process which leads to cell lysis and release of cytoplasmic protein content (Guttman, 2005). 
Therefore, in the second part of this PhD-thesis, the release mechanism of ColIb was investigated in the 
context of phage-mediated lysis. The influence of four prophages encoded within the genome of S. Tm 
SL1344 (Gifsy-1, Gifsy-2, SopEΦ and ST64B) was evaluated with respect to the release of ColIb and 
ColIb-dependent competition of S. Tm against E. coli in vitro.  
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3 Materials and Methods 
3.1 Materials 
3.1.1 Oligonucleotides, plasmids and strains 
Table 1. Oligonucleotides 
Designation  Sequence Application 
K12ΔcirA_rev  GCAGTATTTACTGAAGTGAAAGTCCGCCCGGTTC
GCCGGGCATCTTCTCAtgtgtaggctggagctgcttc 
LPN2 
K12ΔcirA_fwd TGTTCCGGCTTTCTGGGATGATCACCTGCATAAA
AAATAAGTCCACCGCGatatgaatatcctccttagtt 
LPN2 
cirA - up TTCCGGCTTTCTGGGATGATCAC LPN2 
cirA - down  GCGTATTCAGCCGGGATATGATCAC LPN2 
cirA - d1  AGATCCGGGCTACCCACAATCTTAC LPN2 
ΔoriTnikA_rev-val GAAGCCATTGGCACTTTCTC LPN5 
ΔoriTnikA val AGTTCCTCATCGGTCATGTC LPN5 
ssaV-check_fwd GGAGCTCTGGTTACGATT LPN5 
ssaV-check_rev ATATTTCAGCCTCAGACG LPN5 
For_colicin_NheI CCCGCTAGCATGTCTGACCCTGTACGTATT pLPN14 
Re_colicin_XhoI CCCCTCGAGGATACCAATAAGTTTATTG pLPN14 
For_cirA_NheI CCCGCTAGCATGCTGCCGTACGCAAGGGGA pLPN13 
Re_cirA_XhoI CCCCTCGAGGAAGCGATAATCCACTGC pLPN13 
pCirA-BamHI CCCGGATCCCGCGGTGGACTTATTTGTATG pLPN1 
pCirA-Xbal  CCCTCTAGATTCCTCCCTTCCTTGCTAAGC pLPN1 
pColIb-XbaI CCCTCTAGACGTCAGCAGGCTTTCTGA pM1437 
pColIb-BamHI CCCGGATCCTCGGTATCTCCTTCATCC pM1437 
Luc-for-BamHI CCCGGATCCTAAGAAGGAGATATACCATGG A pLPN15, 
LPN16 
Luc-rev-HindIII CGAAAGCTTACAATTTGGACTTTCCGC pLPN15, 
LPN16 
Gifsy-1-for CGCCACCCTTACAGTTCAAT Gifsy-1 
prophage 
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Designation  Sequence Application 
Gifsy-1-rev AGCAGCTTTCGCGTGATTAT Gifsy-1 
prophage 
Gifsy-2-for GCGCTCGATCTGATGTGTTA Gifsy-2 
prophage 
Gifsy-2-rev ACTTTCGTGGTTACGCCATC Gifsy-2 
prophage 
SopE-phi-for GGTTTGGCTACGGTCTACCA SopEΦ 
prophage 
SopE-phi-rev CTGGCGGACACGGTAATACT SopEΦ 
prophage 
ST64B-for ACACGGGCTCTACTGGATTC ST64B 
prophage 
ST64B-rev GCTGTTGCATAAATCGCAGA ST64B 
prophage 
SB51-53_for TCCACTCACCCGATACCCGGGTAAACAGTCTCCC
GGACAGGGGGAGGTCatatgaatatcctccttagtt 
LPN9, LPN14, 
LPN24 
SB51-53_rev ACGAGGCATTTTCATGAAAGTCACTTGTCAAATT
TCTATGTGATGGAATgtgtaggctggagctgcttc 
LPN9, LPN14, 
LPN24 
check_ST64_for STGTTTGGCGGCCTTTTC LPN9, LPN14, 
LPN24 
check2_ST64_rev AAGGCACCGATCACCAAA LPN9, LPN14, 
LPN24,  
check_ST64_1 CTGCTGAAATTGGGATTC LPN9, LPN14, 
LPN24 
check_pKD4_Kan_For ATCTCCTGTCATCTCACC LPN9, LPN14, 
LPN24, LPN25 
,LPN26 
check_pKD4_Kan_Rev CTTGACAAAAAGAACCGGG LPN9, LPN14, 
LPN24, 
LPN25, LPN26 
Lys_Sop_phi_For CATTACGGCGTCAACCACGGCGCAGACCGTCCAG
CTATGGGACTGAATTatatgaatatcctccttagtt 
LPN11, LPN25 
Lys_Sop_phi_Rev CCGCCCAGGCGGCCTCGGTTTCATCCAGCACCGC
GTTCAGATCGCCGTgtgtaggctggagctgcttc 
LPN11, LPN25 
Lys_SopE_Check_Fwd GGCCCATTTTTACCGCAC LPN11, 
LPN25, LPN26 
Lys_SopE_Check_Rev CTGACACGCAATAATCGT LPN11, 
LPN25, LPN26 
strB_For GGGATAGGAGAAGTCGCT LPN28 
strB_Rev TGCCTTCTATCTGCGATT LPN28 
spvB_For GGCCAGTTTCAGGAGATA LPN28 
spvB_Rev CCTTATCTGGCGATGTACT LPN28 
Stx2-Luc fusion Fw TTATATCTGCGCCGGGTCTGGTGCTGATTACTTCA
GCCAAAAGGAACACCTGTATATGgaagacgccaaaaacat
aagaa 
MBK6, MBK7 
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Designation  Sequence Application 
Stx2_Com fusion Rev ATTAACAGAAGCTAATGCAAATAAAACCGCCATA
AACATCTTCTTCATGCTTAACTCCTcgtgtaggctggagct
gcttc 
MBK6 
Stx2 R/S Com fusion 
Rev 
CAGGATTTCGTGTTATCCGTCCAGGTAAGCAAAC
CTCATTTTTCAGCAAAATATTCTTCcgtgtaggctggagct
gcttc 
MBK7 
Stx2 Operon Fw GATCGGTATGTTGAGCGTGA MBK6, MBK7, 
MBK13, 
MBK14, 
LPN21, LPN22 
Stx2 Operon Rev TGCTCAGTCTGACAGGCAAC MBK6, 
MBK13, LPN21 
R/S outside Rev GAGATGCGCAGAAATGACAA MBK7, 
MBK14, LPN22 
 
Table 2. Plasmids 
Plasmid Lab-internal 
plasmid number 
Genotype Reference 
pWKS29 and 
pWKS30 
pWKS29 and 
pWKS30 
 (Wang & 
Kushner, 
1991) 
p2cm p2cm P2::cat (Stecher et 
al., 2012 
pM979 pM979 Constitutive gfpmut2-reporter plasmid 
(ribosomal rpsM promoter) 
(Stecher et 
al., 2004) 
pLB02 pLB02 Firefly-luciferase reporter plasmid (Gunn et al., 
1995) 
pC831-2 pC831-2 expression of the ColIb (cib) immunity 
protein gene imm 
(Stecher et 
al., 2012) 
pLPN13 pLPN13 cirA-6-x-his (Nedialkova 
et al., 2014) 
pLPN14 pLPN14 cib-6-x-his (Nedialkova 
et al., 2014) 
pcirA-luc pLPN15 cirA-promoter firefly-luciferase reporter (Nedialkova 
et al., 2014) 
pcib-luc pLPN16 cib-promoter firefly-luciferase reporter (Nedialkova 
et al., 2014) 
pM1437 pM1437 cib-promoter gfp-reporter (Nedialkova 
et al., 2014) 
pLPN1 pLPN1 cirA-promoter gfp-reporter (Nedialkova 
et al., 2014) 
pcompl. cirA pWRG693-1 cirA complementation vector (Nedialkova 
et al., 2014) 
pcompl. cib pWRG694 cib complementation vector (Nedialkova 
et al., 2014) 
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Table 3. Strains 
S.Tm strains Lab-internal 
strain 
number 
Genotype Reference 
S. Tmwt SB300 S. Tm strain SL1344  (Hoiseth & 
Stocker, 
1981) 
S. TmΔcib M990 P2 cib imm::aphT (Stecher et 
al., 2012) 
S. Tmwt amp SB300 S. Tm carrying plasmid pWKS30 (Wang & 
Kushner, 1991) 
(Stecher et 
al., 2012) 
S. TmΔoriT M1407 P2 ΔoriT nikA::cat (Nedialkova 
et al., 2014) 
S. Tmavir p2cm M996  invG; sseD::aphT P2::cat (Stecher et 
al., 2012) 
S. TmΔoriT cib MAD1 p2 ΔoriT nikA::cat cib imm::aphT  (Stecher et 
al., 2012) 
S. TmΔP2 avir MBK15 invG; sseD::aphT cured of p ColIb plasmid (P2)  (Nedialkova 
et al., 2014) 
S. Tmavir M557 invG; sseD::aphT (Hapfelmeie
r et al., 
2005) 
S. TmΔoriT avir LPN5 invG; sseD::aphT(Hapfelmeier et al., 2005); P2 
ΔoriT nikA::cat 
(Nedialkova 
et al., 2014) 
S. TmMA6118 MA6118 S. Tm strain SL1344  (Figueroa-
Bossi et al., 
2001) 
S. Tm∆G1∆G2 MA6247 ∆Gifsy-1 ∆Gifsy-2  (Figueroa-
Bossi & 
Bossi, 1999) 
S. Tm∆G1∆G2∆ST MA7551 ∆Gifsy-1 ∆Gifsy-2 ST64B::aphT (Figueroa-
Bossi & 
Bossi, 2004) 
S. Tm∆Ph MA7891 ∆Gifsy-1 ∆Gifsy-2 ST64B::aphT SopEΦ::cat (Alonso et 
al., 2005) 
S. Tm∆lysSTNT LPN9 ST64B (SL1344_1955-SL1344_1957)::aphT Unpublished 
S. Tm∆lysSϕCmNT LPN11 SopEΦ (SL1344_2684- SL1344_2687)::cat Unpublished 
S. Tm∆lysST LPN14 ST64B (SL1344_1955-SL1344_1957)::aphT Unpublished 
S. Tm∆G1∆G2∆lysST LPN24 ∆Gifsy-1 ∆Gifsy-2  
ST64B (SL1344_1955-SL1344_1957)::aphT 
Unpublished 
S. Tm∆lysSϕCm LPN15 SopEΦ (SL1344_2684- SL1344_2687)::cat Unpublished 
S. Tm∆G1∆G2∆lysSϕC LPN17 ∆Gifsy-1 ∆Gifsy-2  
SopEΦ (SL1344_2684- SL1344_2687)::cat 
Unpublished 
S. Tm∆lysSϕ LPN19 SopEΦ ∆(SL1344_2684- SL1344_2687) Unpublished 
S. Tm∆G1∆G2∆lysSϕ LPN20 ∆Gifsy-1 ∆Gifsy-2 
SopEΦ ∆(SL1344_2684- SL1344_2687) 
Unpublished 
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S.Tm strains Lab-internal 
strain 
number 
Genotype Reference 
    
S. Tm∆G1∆G2∆lysSϕKNT LPN25 ∆Gifsy-1 ∆Gifsy-2 
SopEΦ (SL1344_2684- SL1344_2687)::aphT 
Unpublished 
S. Tm∆G1∆G2∆lysSϕK LPN26 ∆Gifsy-1 ∆Gifsy-2 
SopEΦ (SL1344_2684- SL1344_2687)::aphT 
Unpublished 
S. Tm∆Ph SmR LPN27 MA7891 pRSF1010-SL1344 Unpublished 
S. Tm∆G1 ∆G2 ∆lysST SmR LPN28 ∆Gifsy-1 ∆Gifsy-2 
ST64B (SL1344_1955-SL1344_1957)::aphT 
pRSF1010-SL1344 
 
S. TmA36 A36 S. Tm wild type isolate no prophage (Mirold et 
al., 1999) 
S. TmM4 M4 S. Tm wild type isolate no prophage 
SopEΦ sopE::aphT 
(Mirold et 
al., 1999) 
S. TmA36 p2cm LPN12 S. TmA36 P2::cat Unpublished 
S. TmM4 p2cm LPN13 S. TmM4 P2::cat Unpublished 
S. Tmwt p2cm M995 SB300 colIB-HA::cat (Stecher et 
al., 2012) 
E. coli strains    
Ec DH5   Invitrogen 
Ec BL21 (DE3)   Stratagene 
Ec Nissle   (Stecher et 
al., 2012) 
Ec8178   (Stecher et 
al., 2012) 
EcMG1655   E. coli K-12 wild type strain MG1655, 
streptomycin-resistant 
(Moller et 
al., 2003) 
EcMG1655 ∆cirA  LPN2 cirA::aphT (Nedialkova 
et al., 2014) 
EcMG1655 amp  E. coli K-12 wild type strain MG1655, 
streptomycin-resistant, carrying plasmid 
pWKS30 (Wang & Kushner, 1991) 
Unpublished 
C600W34  C600 E. coli K12 lysogen of  933W (O'Brien et 
al., 1984) 
MBK6  C600 E. coli K12 lysogen of  
933W stx2A::luc aphT 
M. Koeppel 
MBK7  C600 E. coli K12 lysogen of 
933W (stx2A R S)::luc aphT 
M. Koeppel 
EcStx MBK13 EcMG1655 lysogen of  933W stx2A::luc aph M. Koeppel 
EcStx∆SR MBK14 EcMG1655 lysogen of 933W (stx2A R S)::luc aphT M. Koeppel 
EcStx p2cm LPN21 MBK13 P2::cat Unpublished 
EcStx∆SR p2cm LPN22 MBK14 P2::cat Unpublished 
EcMG1655 p2cm LPN23 EcMG1655 P2::cat Unpublished 
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3.1.2 Chemicals and consumables 
Table 4. Chemicals and consumables 
Item Supplier 
(MgCO3)4Mg(OH)2 x 5H2O Sigma-Aldrich Chemie (Munich) 
Acrylamide 30% Serva (Heidelberg) 
Cell sieve 40 µm Milian 
LumiNunc™ F96 MicroWell™ Plates, 
white, sterile, F-bottom 
Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
TC-Plates 96-well, flat-bottom Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Agar bactoTM Becton, Dickinson and Company (BD) (Heidelberg) 
Albumin factor V Roth (Karlsruhe) 
Aminolink kit Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Antimicrobial susceptibility test discs Oxoid, Thermo Fisher Scientific Biosciences (St. 
Leon-Rot) 
Ammonium persulfate (APS) Roth (Karlsruhe) 
Boric acid Roth (Karlsruhe) 
Bovine serum albumin fraction (BSA), PAA GE Healthcare (Munich) 
Bromphenolblue Roth (Karlsruhe) 
CaCl2 Merck Chemicals (Schwalbach) 
Colistinsulfate Roth (Karlsruhe) 
Chloroform  Roth (Karlsruhe 
Cryotubes Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
D(-) luciferin  Sigma-Aldrich Chemie (Munich) 
ddH2O (Ampuwa) Fresenius Kabi (Bad Homburg) 
D-glucose Roth (Karlsruhe) 
DiBaC4 Invitrogen, Thermo Fisher Scientific Biosciences (St. 
Leon-Rot) 
Diethylenetriamine Pentaacetic Acid (DTPA) Sigma-Aldrich Chemie (Munich) 
dNTP Set Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
DreamTaq PCR Master Mix (2 x) Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Dithiothreitol (DTT) Roth (Karlsruhe) 
ECL detection system  GE Healthcare (Munich) 
Ethylenediaminetetraacetic acid (EDTA) Roth (Karlsruhe) 
Ethylene glycol tetraacetic acid (EGTA) Roth (Karlsruhe) 
Electroporation cuvette (1 mm) Eppendorf (Wesseling-Berzdorf) 
Ethanol ROTIPURAN® ≥99,5 %, p.a  Roth (Karlsruhe 
Restriction enzymes Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
FeCl3 Sigma-Aldrich Chemie (Munich) 
GeneRuler 1kb DNA ladder Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Glycerol  Roth (Karlsruhe) 
Glycine  MP Biomedicals 
Glycylglycin  Roth (Karlsruhe) 
High-fidelity PCR enzyme Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Histidine  Roth (Karlsruhe) 
HisTrap column (5 ml) GE Healthcare (Munich) 
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Item Supplier 
HiTrap desalting column (5 ml) GE Healthcare (Munich) 
Immobilion Western  
Chemoluminescent HRP substrat 
Merck Chemicals (Schwalbach) 
K2HPO4   Roth (Karlsruhe) 
KCl Fluka, Sigma-Aldrich Chemie (Munich) 
KH2PO4 Roth (Karlsruhe) 
L-(+)-Arabinose  Sigma-Aldrich Chemie (Munich) 
Li3-Coenzym A  Sigma-Aldrich Chemie (Munich) 
Lysozyme from chicken egg white Sigma-Aldrich Chemie (Munich) 
MacConkey agar Oxoid, Thermo Fisher Scientific Biosciences (St. 
Leon-Rot) 
MacConkey agar Roth (Karlsruhe) 
Mg-ATP Sigma-Aldrich Chemie (Munich) 
MgSO4  Roth (Karlsruhe) 
Methanol ROTIPURAN® ≥99,5 %, p.a  Roth (Karlsruhe) 
Milk powder Roth (Karlsruhe) 
Mitomycin C  Roth (Karlsruhe) 
Na2HPO4 unhydrated  Roth (Karlsruhe) 
Na2HPO4 x 2H2O Roth (Karlsruhe) 
NaCl Roth (Karlsruhe) 
NH4Cl  Sigma-Aldrich Chemie (Munich) 
Nitrocellulose membrane  GE Healthcare (Munich) 
Nonidet P-40  ICN Biomedicals 
Benzonase nuclease (Novagen)  Merck Chemicals (Schwalbach)  
NucleoSpin Gel and PCR clean-up kit Macherey-Nagel (Düren) 
NucleoSpin Plasmid kit Macherey-Nagel (Düren) 
Tissue-Tek Optimal Cutting Temperature 
(O.C.T.) compound 
Sakura Finetek, (Torrance) 
Page ruler prestained protein ladder  Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
PD-10 desalting column GE Healthcare (Munich) 
Peptone Oxoid, Thermo Fisher Scientific Biosciences (St. 
Leon-Rot) 
Phenylmethylsulfonyl fluoride (PMSF), Serva (Heidelberg) 
Plasmid Plus Midi Kit QIAGEN (Hilden) 
Oligonucleotides  Metabion (Martinsried) 
Protein assay reagent Bio-Rad (Munich) 
Sodium dodecyl sulfate (SDS) Serva (Heidelberg) 
Sodium Azide Merck Chemicals (Schwalbach) 
T4 DNA ligase Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Tergitol Sigma-Aldrich Chemie (Munich) 
Thiamine  Sigma-Aldrich Chemie (Munich) 
Tetramethylethylenediamine (TEMED) Biomol Feinchemikalien (Hamburg) 
Tris  MP Biomedicals (Eschwege) 
Triton X-100 Roth (Karlsruhe) 
Tryptone  Roth (Karlsruhe) 
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Item Supplier 
Tween  Roth (Karlsruhe) 
Urea  MP Biomedicals (Eschwege) 
Yeast extract  MP Biomedicals (Eschwege) 
Zebra Spin desalting columns (5 ml) Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
β –D-thiogalactopyranoside (IPTG)  Roth (Karlsruhe) 
Filter Millex 0.22 µm Merck Chemicals (Schwalbach) 
 
3.1.2.1 Antibodies and supplements 
Table 5. Primary antibodies   
Antibody Origin Supplier Final concentration 
α-ColIb-His  Rabbit Pineda (Berlin) 1:500 
α-CirA-His Rabbit Pineda (Berlin) 1:50 
α - DnaK (E. coli)* Mouse Enzo Life Sciences (Lörrach) 1:1,000 
*Also recognizes S. Tm DnaK due to the high identity.  
 
 
Table 6. Secondary antibodies 
Antibody Origin Supplier Final concentration 
α-rabbit-HRP Goat GE-Healthcare (Munich) 1:10,000 
α -mouse-HRP  Goat Sigma-Aldrich Chemie (Munich) 1:10,000 
 
Table 7. Antibiotics 
Antibiotic Supplier Final concentration 
picillin  Roth (Karlsruhe) 100 µg/ml 
Chloramphenicol Roth (Karlsruhe) 30 µg/ml 
Kanamycinsulfate Roth (Karlsruhe) 30 µg/ml 
Streptomycin Roth (Karlsruhe) 50 µg/ml 
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3.1.3 Buffers and Media 
Table 8. Luria-Bertani (LB) medium 
Component Per liter medium 
NaCl 5 g 
Yeast extract   5 g 
Tryptone  10 g 
All components were dissolved in dH2O 
 
Table 9. LB agar 
Component Per liter medium 
NaCl 5 g 
Yeast Extract  5 g 
Tryptone  10 g 
Agar 15 g 
All components were dissolved in dH2O. 
 
Table 10. LB soft agar 
Component Per liter medium 
NaCl 5 g 
Yeast Extract 5 g 
Tryptone 10 g 
Agar  7 g 
All components were dissolved in dH2O 
 
Table 11. M9 medium 
Component Final concentration  
Na2HPO42H2O 40 mM 
KH2PO4 20 mM 
NaCl 9 mM 
NH4Cl  2 g/l 
D-glucose 2 g/l 
MgSO4  1 mM 
CaCl2 100 µM 
Thiamine  10 mg/ml 
Histidine  500 mg/l 
All components were dissolved in ddH2O (Ampuwa). 
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Table 12. Peptone-glycerol broth 
Component Per 0.5 l broth 
Peptone 10 g 
Glycerol 25 ml 
All components were dissolved in dH2O. 
 
Table 13. Phosphate Buffered Saline (PBS) 10x 
Component Per liter buffer 
NaCl 80 g 
KCl 2 g 
Na2HPO4 anhydrous  6.1 g 
KH2PO4 2.4 g 
All components were dissolved in dH2O. 
 
Table 14. Recombinant protein purification lysis 
buffer 
Component Final concentration 
Na2HPO4 40 mM 
NaCl 0.3 M 
Imidazole 5 mM 
PMSF 2 mM 
Benzonase nuclease  (1:2,000) 
*Urea 6 M 
The pH was adjusted to 7.8 with 1 M NaOH or 1 M 
HCl and the buffer was sterile filtered (22 µm).  
*Urea was added only to buffer applied for CirA-
His purification. 
 
Table 15. Recombinant protein purification 
loading buffer 
Component Final concentration 
Na2HPO4 40 mM 
NaCl 0.3 M 
Imidazole 5 mM 
*Urea 6 M 
The pH was adjusted to 7.8 with 1 M NaOH or 1 M 
HCl and the buffer was sterile filtered (22 µm). 
*Urea was added only to buffer applied for CirA-
His purification. 
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Table 16. Recombinant protein purification 
elution buffer 
Component Final concentration 
Na2HPO4 40 mM 
NaCl 0.3 M 
Imidazole 0.5 M 
*Urea 6 M 
The pH was adjusted to 7.8 with 1 M NaOH or 1 M 
HCl and the buffer was sterile filtered (22 µm). 
*Urea was added only to buffer applied for CirA-
His purification. 
 
Table 17. Recombinant protein purification 
exchange buffer 1 
Component Final concentration  
Na2HPO4 20 mM 
NaCl 100 mM 
*Urea 4 M 
The pH was adjusted to 7.8 with 1 M NaOH or 1 M 
HCl and the buffer was sterile filtered (22 µm). 
*Urea was added only to buffer applied for CirA-
His purification. 
 
Table 18. Recombinant protein purification 
exchange buffer 2 
Component Final concentration 
Boric acid 50 mM 
NaCl 300 mM 
EDTA 2 mM 
The pH was adjusted to 9.0 with 1 M NaOH or 1 M 
HCl and the buffer was sterile filtered (22 µm). 
 
Table 19. 10% resolving gel 
Component Per 10 ml 
dH2O 4 ml 
30% Acrylamide 3.32 ml 
1.5 M Tris HCl pH 8.8 2.5 ml 
20% SDS (in dH2O) 0.05 ml 
10% APS (in dH2O) 0.1 ml 
TMED 0.004 ml 
All components were dissolved in dH2O. 
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Table 20. 5% stacking gel 
Component Per 1 ml 
dH2O 0.68 ml 
30% Acrylamide 0.17 ml 
1.5 M Tris HCl pH 6.8 0.13 ml 
20% SDS (in dH2O) 0.005 ml 
10% APS (in dH2O) 0.01 ml 
TMED 0.001 ml 
All components were dissolved in dH2O. 
 
Table 21. Protein loading buffer 5 x 
Component Final concentration 
1.5.M Tris 250 mM 
DTT  500 mM  
SDS 10% 
Bromphenolblue 0.5% 
Glycerol 50% 
1.5 M Tris 250 mM 
All components were dissolved in dH2O. 
 
Table 22. Running buffer 
Component Final concentration 
Tris  25 mM 
Glycine 250 mM 
SDS 0.1% 
All components were dissolved in dH2O. 
 
Table 23. Transfer buffer 
Component Final concentration 
Tris  25 mM 
Glycine 192 mM 
Methanol 20% 
All components were dissolved in dH2O. 
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Table 24. Immunoblot lysis buffer 
Component Final concentration 
Tris pH 7.5 50 mM 
NaCl 150 mM 
EDTA 5 mM 
Nonidet P-40  0.25% 
Lysozyme 100 mg/ml 
All components were dissolved in dH2O. 
 
Table 25. Luciferase assay lysis buffer 
Component Final concentration 
K2HPO4   100 mM 
KH2PO4  100 mM 
EDTA  2 mM 
Triton X-100 1% 
BSA (PAA) 5 mg/ml 
DTT 1 mM 
Lysozyme 5 mg/ml 
All components were dissolved in ddH2O (Ampuwa). 
 
Table 26. Luciferase reagent 
Component Final concentration 
Tricine  20 mM 
(MgCO3)4Mg(OH)25H2O 1 mM 
EDTA 0.1 M 
D(-) Luciferin  470 µM 
DTT  33 mM 
Li3-Coenzym A  270 µM 
Mg-ATP  530 µM 
Glycylglycin  125 µM 
Tricine  5 mg/ml 
All components were dissolved in ddH2O (Ampuwa). 
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3.2 Methods 
3.2.1 Bacterial growth  
3.2.1.1 Generation of bacterial cryostocks 
Bacteria streaked from -80° C cryostocks were grown overnight (o.n.) on LB agar with the appropriate 
antibiotics at 37° C. A single bacterial colony was inoculated in 3 ml LB medium (supplemented with the 
appropriate antibiotic(s)) and grown o.n. at 37° C on a wheel rotor. Further, o.n. culture was spun down at 
4° C for 15 min and 4,500 rpm. The supernatant was removed and the bacterial pellet were resuspended in 
1 ml peptone-glycerol broth (Table 12) and stored in cryotubes at -80° C. 
3.2.1.2 Growth of bacterial strains for in vitro assays (Section 4.1) 
Bacteria streaked from -80° C cryostocks were grown o.n. on LB agar with the appropriate antibiotics at 
37° C. A single colony grown in a starter culture in LB or M9 media for 12 h and used for inoculation of 
subcultures (1:20), except for the in vitro co-cultures, where subcultures were inoculated to an optical 
density of 600 nm (OD600) of 0.05, measured by using BioPhotometer (Eppendorf). The following 
supplements were used: mitomycin C (to a final concentration of 0.25 µg/ml), 
diethylenetriaminepentaacetic acid (DTPA) (to a final concentration of 100 µM), and FeCl3 (to a final 
concentration of 1 µM, 10 µM, 0.1 mM or 1 mM). All cultures were grown at 37° C on a wheel rotor, 
except of in vitro co-cultures, where subcultures were grown in Erlenmeyer-flasks in a shaker at 200 rpm. 
3.2.1.3 Growth of bacterial strains (Section 4.2) 
Bacteria grown on LB agar without antibiotics from -80° C cryostocks and incubated o.n. at 37° C. 
Bacterial colonies were re-streaked once again on LB agar plates and grown o.n. at 37° C. Three 
individual colonies per strain were used for inoculation of 3 ml LB cultures, which were grown for 12 h at 
37° C on a wheel rotor. These starter cultures were subsequently diluted and normalized to an OD600 of 
0.0025 in 10 ml fresh LB (subculture I). After 3 h growth in Erlenmeyer flasks at 37° C and 180 rpm, 
subculture I was diluted and normalized to an OD600 of 0.0025 in 10 ml fresh LB supplemented with 
0.5µg/ml mitomycin C (subculture II). For the control subculture II no supplements were used. Subculture 
II was incubated for 6 h at 37° C and 180 rpm. Bacterial density (OD600) determined each hour. 
For assays done in 96-well, plates the starter cultures were prepared as described and subsequently diluted 
and normalized to an OD600 of 0.025 in 3 ml fresh LB (subculture I). Following 2 hours growth at 37° C, 
on a wheel rotor, subculture I was diluted and normalized to an OD600 of 0.2 in fresh LB (supplemented or 
with 0.5 µg/ml mitomycin C) and 200 µl/well were transferred to a 96-well plate (subculture II). No 
supplements were used for the control subculture II. All conditions were done in 3-5 replicates. Subculture 
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II was incubated up to 4-5 h at 37° C and 180 rpm. Bacterial density was measured each hour using a 
FLUOstar Optima plate reader (BMG Labtech). 
3.2.1.4 In vitro co-cultures (Section 4.2) 
Bacteria were streaked out on MacConkey agar plate supplemented with selective antibiotic(s) from -80° 
C cryostocks and incubated o.n. at 37° C. Strains were re-streaked on LB agar plates without antibiotics 
and grown o.n. at 37° C. Three individual colonies per strain (S. Tm and E. coli) were used to inoculate 3 
ml LB medium cultures, which were grown for 12 h at 37° C on a wheel rotor. These starter cultures were 
diluted and normalized to an OD600 of 0.025 in 3 ml fresh LB (subculture I). After 2 hours growth at 37° C 
on a wheel rotor subculture I was diluted and normalized to an OD600 of 0.4 and subsequently mixed (1:1). 
Thereafter, the strain mixture was added to fresh LB (1:1) with or without supplements (subculture II). 
The following supplements were added: mitomycin C (to a final concentration of 0.25 µg/ml) and DTPA 
(to a final concentration of 100 µM). For each setup 200 µl/well were transferred in 96-well plate and 
incubated for 6 h at 180 rpm at 37° C. At time point 0 h, 3 h and 6 h OD600 was determined using a 
FLUOstar Optima plate reader (BMG Labtech). At each of the selected time points, 100 µl from a 
replicate for each sample were taken for determination of the colony forming units (cfu). Cultures were 
10-fold diluted up to 10-6 in PBS and plated on MacConkey agar plates without antibioticz and 
supplemented with 100 µg/ml ampicillin. Plates were incubated at 37° C and cfu were determined. 
3.2.1.5 Bacterial live-dead staining and FACS 
Bacteria were streaked out on LB agar plates from -80° C cryostocks and incubated o.n. at 37° C. Next, a 
single colony was inoculated in 3 ml LB medium and grown for 12 h at 37° C on a wheel rotor. This 
starter cultures were used for inoculation of subculture I in 3 ml LB medium (1:20), supplemented with 
100 µM DTPA (subculture I). For the control subculture I no supplements were used. Following 
incubation of 1 to 4 hours (37° C, wheel rotor) subculture I was diluted and normalized to an OD600 of 
0.01 in LB medium (subculture II) supplemented with ColIb-His in recombinant protein purification 
exchange buffer 2 (Table 18) to a final concentration of 7.5 ng/ml or colistin sulphate to a final 
concentration of 0.3 µg/ml. Next, 180 µl of each subculture II were transferred into a 96-well plate. 
Subculture II was incubated for 2 hours at 37° C. To detect dead bacteria, DiBaC4 (Invitrogen) were added 
to a final concentration of 10 µg/ml and after 25 min incubation (room temperature (RT), in darkness) 
each sample was diluted in PBS (1:1) and analyzed by fluorescence-activated cell sorting (FACS) using 
BD FACSCantoTM II (BD Biosciences). 
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3.2.2 Generation of samples for immunoblot 
3.2.2.1 Generation of samples for immunoblot (Section 4.1) 
Bacteria were streaked out on LB agar plates from -80° C cryostocks and incubated o.n. at 37° C. Next, a 
single colony was used for inoculation of a starter culture in 3 ml M9 medium, grown for 12 at 37° C. The 
starter culture was used for inoculation (1:20) of 2 ml M9 medium supplemented with FeCl3 to a final 
concentration of 1 µM, 10 µM, 0.1 mM or 1 mM. These subcultures were grown for 7 h. A starter culture 
of 3 ml LB was grown for 12 h and used for inoculation of 3ml LB. The following supplements were 
used: mitomycin C (to a final concentration of 0.25 µg/ml) and DTPA (to a final concentration of 100 
µM). The subcultures were grown for 4 h. From each subculture, 250 µl (for an OD600 of 1) was taken, 
spun down at at 10, 000 rpm, for 10 min, 4° C. The supernatant was removed and the bacterial pellet was 
frozen in liquid nitrogen and thawn at RT for 15 min ( freeze-thawing was repeated three times), 
resuspended in 100 µl immunoblot lysis buffer (Table 24) and incubated in thermomixer at 550 rpm, for 1 
h, 23° C. Thereafter, the lysate was spun down 10, 000 rpm, for 10 min, 4° C. Total protein was quantified 
in the lysate using aprotein assay reagent (Bio-Rad). Next, the bacterial lysate was added to 1 x protein 
loading buffer (Table 21) and incubated for 10 min at 95° C. For the supernatant fractions 500 µl (for an 
OD600 of 1) of the subculture were spun down twice, supernatant was added to 5 x protein loading buffer 
and incubated for 10 min at 95° C. 
3.2.2.2 Generation of samples for immunoblot (Section 4.2) 
A 100 µl of subculture II grown in a 96-well plate (Section 3.2.1.3) was taken and spun down at 4° C for 
10 min, at 10,000 rpm. Following this, the supernatant was transferred in a new tube, while bacterial 
pellets were resuspended in 100 µl 1 x protein loading buffer (Table 21) and incubated for 10 min at 95° 
C. The supernatant was spun down once more to eliminate all bacteria and 80 µl of the so obtained 
supernatant were added to 20 µl 5 x protein loading buffer (Table 21). Next, samples were incubated for 
10 min at 95° C. Samples from cultures grown in Erlenmeyer flasks were processed in the same way, but 
instead 500 µl were taken from subculture II and resuspended in 250 µl 1x protein loading buffer for cell 
lysate fraction. For supernatant fraction 200 µl from the supernatant were added to 50 µl 5x protein 
loading buffer (Table 21). 
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3.2.3 Colicin-killing assay (Halo-assay) 
3.2.3.1 Colicin-killing assay (Halo-assay) (Section 4.1) 
Bacteria were streaked out on LB agar plates from -80° C cryostocks and incubated o.n. at 37° C. Next, a 
single colony was grown in 3 ml LB medium for 12 h, on a wheel rotor, at 37° C. Cultures were 
subsequently diluted and normalized to an OD600 of 0.025 and 2 µl were spotted on LB agar plates 
supplemented with mitomycin C to a final concentration of 0.25 µg/ml. Plates were incubated o.n. at 37° 
C and consequently overlaid with 6 ml LB soft agar (Table 10) mixed with 100 µl E. coli grown o.n. in 3 
ml LB medium, at 37° C. Following this, plates were incubated o.n. at 37° C and inhibition zone (halo) 
size was measured.  
3.2.3.2 Colicin-killing assay (Halo-assay) (Section 4.2) 
Starter cultures (Section 3.2.1.3) were diluted and normalized to an OD600 of 0.025 and 2 µl for each strain 
were spotted on LB agar plates supplemented with mitomycin C to a final concentration of 0.5 µg/ml. 
Plates were incubated o.n. at 37° C and consequently overlaid with 6 ml LB soft agar (Table 10) mixed 
with 100 µl EcMG1655 grown o.n. in 3 ml LB medium, at 37° C. Next, the plates were incubated o.n. at 37° 
C and inhibition zone (halo) size was measured using Adobe Photoshop CS5 ruler tool on an image of the 
plate taken with ChemiDoc MP System (Bio-Rad), Image Lab software. 
3.2.3.3 Colicin-killing assay using colicin released in the bacterial culture supernatant 
At the final point of the bacterial growth (Section 3.2.1.3) 0.6-1.0 ml from subculture II (in case of 96-
well plate assay, triplicates for each sample were pooled together) were spun down at 10,000 rpm for 10 
min, 4° C. Following this, the supernatant was sterile filtered (0.22 µm filters). LB agar plates were 
overlaid with 6 ml LB soft agar (Table 10) mixed with 100 µl EcMG1655 grown o.n. in 3 ml LB medium, at 
37° C. Antimicrobial susceptibility test discs (Oxoid) were laid on each plate and 6µl sterile spent 
supernatant was spotted on each disc. Plates were incubated o.n. at 37° C and inhibition zone (halo) size 
was measured using Adobe Photoshop CS5 Ruler tool on an image of the plate taken with ChemiDoc MP 
System (Bio-Rad), Image Lab software. 
3.2.4 Luciferase assay 
3.2.4.1 Luciferase assay for samples obtained in vitro (Section 4.1) 
Luciferase assays were performed as described (Gerlach et al., 2007). Briefly, a starter cultures of 3 ml LB 
(supplemented with 100 µg/ml ampicillin) grown for 12 h was used for inoculation of 3 ml LB (1:20) 
(containing 100 µg/ml ampicillin and respective supplements), which were cultured for 4 h. From each of 
these subcultures, 250 µl (of an OD600 of 1) was spun down at 14,000 rpm for 5min, 4° C. The supernatant 
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was removed and the bacterial pellet was frozen at -80° C for 1 h. Next, the pellet was thawn and 
resuspended in 500 µl luciferase assay lysis buffer (Table 25) and incubated for 15 min, at RT while 
vortexing every 3 minutes. Bacterial lysates (25 µl) were transferred in 96-well plates (white) and 50 µl 
luciferase reagent was added to each well. Luminescence was measured using a FLUOstar Optima plate 
reader (BMG Labtech). 
3.2.4.2 Luciferase assay for samples from cecum content (Section 4.1) 
To determine the luciferase activity in bacteria extracted from cecum content, the cecum content was 
harvested from infected mice and stored on ice until further use (1-2 h). The cecum content was 
resuspended in 500 µl PBS (0.1% tergitol) and homogenized in a tissue-lyser (Qiagen; 5 min; 50 Hz). 
Further, the content was filtered through a 40 µm cell-sieve (Milian). Samples were taken to determine the 
cfu/ml of the reporter strain by plating on MacConkey agar with the respective antibiotics. A defined 
volume (i.e. 900 l) was spun down at 14,000 rpm for 2 min, 4° C. The supernatant was removed and the 
pellet was frozen on dry ice and stored at -80  C. The samples were then thawn and processed as described 
above. Only values above detection limit (control cecum content) were considered. The relative 
luminescence units (rlu) per cfu luciferase-reporter strain were calculated. 
3.2.4.3 Luciferase assay (Section 4.2) 
In order to measure luciferase activity in bacterial lysates, 100 µl of each sample from subculture II 
(Section 3.2.1.3) was spun down at 10,000 rpm for 5 min, 4° C. The supernatant was transferred to a new 
tube to be further used for extracellular luciferase activity evaluation. Pelleted bacteria were frozen at -80° 
C for >1 hour. Frozen bacteria were thawn to RT and resuspended in 500 µl luciferase assay lysis buffer 
(Table 25). Samples were left to lyse for 15 min at RT, vortexing shortly each 3 min. luciferase activity 
was measured as described (Section 3.2.5.2). In order to quantify extracellular luciferase activity, the 
supernatant of each sample was spun down one more time and 25 µl from the newly obtained supernatant 
were measured as described for the bacterial lysates. 
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3.2.5 Molecular biology methods 
All methods were developed based on the protocols described by Sambrook et. al. (Sambrook et al., 
1989). 
3.2.5.1 PCR on bacterial lysates 
Polymerase chain reaction (PCR) on bacterial lysates was carried out in order to verify correct 
construction of bacterial mutants. A single bacteria colony was inoculated in 3 ml LB medium 
(supplemented with selective antibiotic(s)) and grown o.n. at 37° C on a wheel rotor. 5 µl of the o.n. 
culture was added to 95 µl ddH2O, incubated at 95° C, for 10 min and placed on ice immediately after 
incubation. One 20 µl PCR reaction contained 1 µl of 10 µM forward primer, 1 µl of 10 µM reverse 
primer, 3 µl ddH2O, 5 µl bacterial lysate and 10 µl of 2 x DreamTaq PCR Master Mix using standard PCR 
protocol, applying a primer-specific annealing temperature. 
3.2.5.2 Gel extraction 
DNA extraction from 1% agarose gel was done using NucleoSpin Gel and PCR Clean-up kit. 
3.2.5.3 DNA ligation 
Extracted from 1% agarose gel vector and insert DNA were mixed in a 1:3 ratio and ligated using T4 
DNA ligase following protocol provided by the supplier adjusted to final reaction volume of 18 µl.  
3.2.5.4 Plasmid extraction 
Plasmid extraction was done using NucleoSpin Plasmid kit according to the manufacturer’s instruction. In 
case of Large-scale preparation was performed using Plasmid Plus kit. 
3.2.5.5 Preparation of electro-competent bacteria 
A single bacterial colony was inoculated in 3-10 ml LB medium and grown o.n. at 37° C on a wheel rotor. 
Further, o.n. culture was used to inoculate (1:20) 10-100 ml LB medium, incubated at 37° C and 180 rpm. 
At an OD600 of 0.5-0.8, the culture was chilled on ice for 30 min and subsequently spun down at 4° C, 15 
min and 4,500 rpm. The supernatant was removed and pelleted cells were washed three times in 1x culture 
volume (Vc) of sterile ice-cold dH2O, one time in ½ Vc dH2O and one time in 1/10 Vc sterile ice cold 
10% glycerol, respectively. After each step bacteria were spun down at 4° C, 15 min and 4,500 rpm. 
Finally, bacteria were resuspended in 1/50 Vc ice-cold 10% glycerol, distributed into 80 µl aliquots, which 
were shock-frozen in liquid nitrogen and stored at -80° C. 
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3.2.5.6 Electro-transformation of DNA 
A frozen stock of electro-competent cells was thawn on ice and 1-10 µl of the plasmid or linear DNA was 
added. Bacteria were incubated for 10 min on ice, subsequently transferred into an ice-cold 1 mm 
electroporation cuvette and pulsed at 1800 V/cm, 5 ms using Gene Pulser Xcell (Bio-Rad). Following this, 
900 µl LB medium was added and bacteria were incubated for 1 h in a thermomixer at 37° C, 850 rpm. 
Afterwards, bacteria were spun down at RT for 2 min, 10,000 rpm and 900 µl from the supernatant were 
removed. The bacterial pellet was resuspended in the remaining liquid and plated on LB agar plates 
supplemented with the appropriate antibiotic(s). 
3.2.5.7 P22-transduction 
Preparation of P22–lysates: A single colony of the donor strain was inoculated in 3 ml LB medium 
supplemented with 5 mM CaCl2 and grown o.n. at 37° C on a wheel rotor. Further, 500 µl of the o.n. 
culture were added to 10 µl P22-lysate (kindly provided by Prof. Dr. M. Hensel) and incubated for 15 min 
at 37° C. Next, the mixture was used to inoculate 5 ml LB culture, which was incubated o.n. at 37° C on a 
wheel rotor. On the next day 50 µl chloroform were added to the o.n. culture followed by an incubation 
for 30 min at 37° C. Next, the culture was spun down at 4° C, for 10 min at 4,500 rpm and the supernatant 
was filtered through (0.45 µm) and 20 µl chloroform were added to the 1.5 ml filtrate. Filtered lysate was 
stored at 4° C for further use. Sterility of the lysate was verified by plating 50 µl on LB agar followed by 
an o.n. incubation at 37° C. 
P22-transduction: A single colony of the recipient strain was inoculated in 3 ml LB medium 
supplemented with 5 mM CaCl2 and grown o.n. at 37° C on a wheel rotor. Next, 100 µl of the o.n. culture 
were added to 10 µl P22-lysate of the donor strain and incubated for 15 min at 37° C. Subsequently, the 
bacteria-phage mixture was added to 900 µl LB medium supplemented with 10mM EGTA and incubated 
in a thermomixer at 37° C and 850 rpm. After 1 h incubation, the bacterial culture was spun down at RT 
for 2 min at 10,000 rpm and 900 µl of the supernatant were removed. Pelleted bacteria were resuspended 
in the remaining liquid and plated on 10 mM EGTA LB agar plates supplemented with the appropriate 
antibiotic(s). 
3.2.5.8 Conjugation 
A single colony of the donor and the recipient strain were inoculated in 3 ml LB medium cultures, 
respectively, supplemented with the appropriate antibiotics and grown at 37° C o.n. on a wheel rotor. 
Next, 1 ml of each o.n. culture was spun down at RT for 1 min, 8,000 rpm, supernatant was removed and 
bacteria were washed with 1 ml LB medium and subsequently spun down for 1 min at 8,000 rpm. The 
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washing step was repeated three more times. Following this, bacterial pellets of donor and recipient were 
pooled together and resuspended in 100 µl LB medium. The mixture was spread on an LB agar plate and 
bacteria were grown o.n. at 37° C. On the next day bacteria were washed from the plate with 2 ml LB 
medium. Bacteria were plated on MacConkey agar (supplemented with selective antibiotics for the 
conjugated recipient strain) at different dilutions and grown at 37° C to obtain single colonies. 
3.2.5.9 Generation of deletion mutants by lambda Red recombination 
Lambda Red recombination described by Datsenko and Wagner (Datsenko & Wanner, 2000) was applied 
for introduction of an antibiotic-resistance cassettes into S. Typhimurium and E. coli genomes, in frame 
gene deletions and generation of luciferase-reporter strain. Oligonucleotides, used for amplification of the 
cassettes from template plasmids pKD3, pKD4 and pWRG, were designed to be homologous to circa 50 
bp upstream from the start codon of the targeted gene(s) and 50 bp downstream from the stop codon of the 
gene(s), respectively. To verify correct insertion of the antibiotic resistance cassette, control 
oligonucleotides were designed to bind 20 bp upstream and downstream of the PCR fragment. For PCR, 
the following reaction components (Table. 27) and program (Table. 28) were applied. 
 
 
Table 27. Lambda Red PCR reaction components 
Reagent Per 50 µl reaction mixture 
ddH2O 29.75 µl 
High-fidelity buffer  
7.5 mM MgCl2 (5x) 
5 µl 
2.5 mM dNTPs 4 µl 
10 µM Forward primer 5 µl 
10 µM Reverse primer 5 µl 
Template plasmid 
(pKD3/4) (50ng/µl) 
1 µl 
High-fidelity PCR 
polymerase (5 U/µl) 
0.25 µl 
 
Table 28. Lambda Red PCR program 
Step Temperature [ °C] Time 
1 95 5 min 
2 95 45 sec 
3 58 45 sec 
4 72 2-3 min 
5 95 45 sec 
6 68 45 sec 
7 72 2-3 min 
8 72 10 min  
9 8 hold 
Steps 2 to 4 were repeated for 3 cycles; 
steps 5 to 7 for 27 cycles. 
 
In order to purify and concentrate the amplified DNA, 1/10 volumes 3 M NaAc (ddH2O solution) and 2 
volumes ethanol p.a. were added to 250 µl PCR product. The mixture was mixed gently and DNA was 
precipitaed at 4° C, 30 min at 14,000 rpm. The supernatant was removed and the pellet was washed with 
500 µl 70% ethanol and spun down at 4° C, 15 min at 14,000 rpm. The supernatant was immediately 
removed and the precipitated DNA was dried for 30 min at RT. DNA was subsequently resuspended in 
Materials and Methods 
42 
 
 
20-30 µl ddH2O. Nucleic acid concentration of purified DNA was spectrophotometrically assessed using 
NanoDrop Spectrophotometer ND-1000 (PEQLAB Biotechnology). 
The bacterial strain to be mutagenised was transformed with pKD46 (Datsenko & Wanner, 2000) (Section 
3.2.5.6). Transformed bacteria were grown at 30° C. In order to prepare electro-competent bacteria of the 
pKD46 carrying strain, 3 ml LB medium supplemented with 100 µg/ml ampicillin were inoculated and 
grown o.n. at 30° C at 180 rpm. On the next day, the o.n. culture was diluted (1:20) in LB medium 
supplemented with 10 mM L-(+)-arabinose and 100 µg/ml ampicillin and grown for 3 h at 30° C, 180 rpm 
until OD600 of 0.5-0.6 was reached. Further, to harvest the cells, 4 ml of the arabinose-induced culture was 
spun down at 4° C, for 2 min and 10,000 rpm. The supernatant was removed and pelleted bacteria were 
washed with 1 ml ice cold sterile dH2O. Washing was repeated for three times. Finally, bacteria were 
resuspended in 80 µl dH2O and were electroporated with 6-10 µl of the purified 1 µg/ml PCR product 
(Section 3.2.5.5).  
3.2.5.10 Elimination of antibiotic resistance genes using the Flp-recombinase 
The mutant strain, containing FRT-flanked antibiotic-resistance cassette, were transformed with 1 µg 
pCP20 (Section 3.2.5.5). After electroporation bacteria were immediately recovered in 1 ml pre-warmed 
to LB medium (30° C). Following 1 h incubation in a thermomixer at 30° C, 850 rpm, bacterial culture 
was spun down at RT for 2 min, 10,000 rpm and 900 µl of the supernatant were removed. The bacterial 
pellet were resuspended in the liquid left and plated on LB agar plate supplemented with 100 µg/ml 
ampicillin, followed by o.n. incubation at 30° C to maintain pCP20. On the next day, 20 colonies were 
picked, streaked on LB agar plates and incubated o.n. at 42° C to induce the Flp-mediated recombination. 
Next, antibiotic sensitive colonies were identified by double plaiting. In order to cure the strain from the 
temperature-sensitive pCP20 selected clones were re-streaked twice on LB plates and incubated each time 
at 37° C.  
 
3.2.6 Construction of plasmids and bacterial strains 
Bacterial plasmids and strains generated in this study are listed in Table 2 and Table 3, respectivly. 
3.2.6.1 Identification of regulator binding sites 
For annotation of transcription factor binding sites (Fur and LexA regulon), all known transcription factor 
binding sites of each family one were taken from RegulonDB (version 8.0) (Salgado et al., 2013) and a 
binding motif was created using MEME (Bailey & Gribskov, 1998). The nucleotide sequences of the cib 
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(S. Tm SL1344; EMBL accession no. FQ312003) and cirA promoter regions (E. coli MG1655 genome 
accession no. NC_000913.2) were searched for the computed MEME binding site motifs using MAST 
(Bailey & Gribskov, 1998). 
3.2.6.2 Annotation of prophage genomes in S. TmMA6118 (S. Tm SL1344)  
Sequences of Gifsy-1(accession no. NC_010392.1) and Gifsy-2 (accession no. NC_010393), (McClelland 
et al., 2001), SopEΦ (accession no. AY319521.1) (Pelludat et al., 2003) and ST64B (accession no. 
AY055382.1) (Mmolawa et al., 2003) prophages were aligned to S. Tm SL1344 genome (accession no. 
FQ312003), using Mauve Genome Alignment software (Darling et al., 2004). Open reading frames 
(ORFs) for each prophage were localized within S. Tm SL1344 genome and annotated with the 
corresponding systematic ID for S. Tm SL1344 (Kroger et al., 2012) (Figure 1.9 and Table 29). These 
annotations were used for construction of deletions within the SopEΦ (Figure 3.1A,B; Table 30) and 
ST64B (Figure 3.1C,D; Table 31) prophages (Section 3.2.7.2).  
 
 
 
 
 
  
Table 29. Systematic IDs of prophages 
Prophage Systematic ID of ORFs in  
S. Tm SL1344 
Gifsy-1 SL1344_2546-SL1344_2600 
Gifsy-2 SL1344_0942-SL1344_0996 
SopEΦ  SL1344_2665-SL1344_2710 
ST64B SL1344_1927-SL1344_1976 
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Figure 3.1. Construction of deletions within the SopEΦ and ST64B prophages. Arrows indicate direction of 
transcription of open reading frames (ORF). SopEΦ genes encoding lysis proteins (red) (SL1344_2684-
SL1344_2687) (A) were substituted with chloramphenicol-resistance (cat) cassette (black and dark green), 134 bp of 
the (3') end of SL1344_2683 gene remain intact in the new construct. (B). ST64B genes encoding lysis proteins (red) 
(SL1344_1955-SL1344_1957) (C) were substituted with kanamycin-resistance (aphT) cassette (black) (D). The color 
code defines genes encoding capsid proteins (dark blue), tail proteins (green) and regulation proteins (light blue). 
Genes encoding proteins with unknown function are marked in grey.  
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Table 30. Genes of SopEΦ reported to encode lysis proteins 
S. Tm SL1344  
ORF (FQ312003) 
(Kroger et al., 
2012). 
GenBank 
product 
EMBL 
 product 
Corresponding 
ORF (AY319521.1) 
(Pelludat et al., 
2003) 
GenBank product 
SL1344_2683 Hypothetical 
protein 
Hypothetical 
conserved 
bacteriophage 
protein (thought 
to be involved in 
host lysis) 
orf26 Similar to gpR (tail 
completion) 
orf25 Similar to lysis 
protein LysB 
SL1344_2684 Lysis-like 
protein 
Hypothetical 
regulatory protein 
orf25 Similar to lysis 
protein LysB 
SL1344_2685 Not annotated Predicted 
bacteriophage 
protein 
Not annotated Not annotated  
SL1344_2686 Not annotated Hypothetical 
lysozyme 
orf24 Similar to gp17 
lysozyme 
SL1344_2687 Phage-holin-
like protein 
Possible secretion 
protein 
orf23 Possible secretion 
protein 
SL1344_2688 Phage tail-like 
protein 
Hypothetical 
bacteriophage tail 
protein 
orf22 Similar to gpX 
Deletion of SopEΦ lysis genes were generated by deletion of orf23-orf25 reported to be involved in cell lysis 
(Pelludat et al., 2003). The same study assigned orf22 as a lysis-related gene. However, this was not confirmed by 
annotation of the GeneBank database and orf22 was left intact. Alignment of annotated SopEΦ lysis between two 
different studies (Pelludat et al., 2003), (Kroger et al., 2012) identified a disagreement: in the latter study (Kroger et 
al., 2012) a new ORF (SL1344_2683) was annotated as a lysis-related gene (Figure 3.1A). SL1344_2683 (204 bp) 
was not considered during the deletion of the SopEΦ lysis genes, which was done based on the earlier annotations 
(Pelludat et al., 2003). Nevertheless, orf25 is overlapping 70 bp of the (5’) end of SL1344_2683. Therefore, this 
sequence is missing in the strains with deleted SopEΦ lysis genes, with the consequence that presumably no 
functional product of SL1344_2683 is expressed. However, there is no available structural information on 
SL1344_2683 encoded protein, to confirm that. 
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Table 31. Genes of ST64B reported to encode lysis proteins 
S. Tm SL1344  
ORF (FQ312003) 
(Kroger et al., 
2012). 
GenBank 
product 
EMBL 
 product 
Corresponding 
ORF (AY319521.1) 
(Pelludat et al., 
2003) 
GenBank product 
SL1344_1955 Hypothetical 
protein 
Hypothetical 
bacteriophage 
endopeptidase 
sb53 Lysis protein 
SL1344_1956 Not annotated Hypothetical 
bacteriophage 
encoded lysozyme 
sb52 Lytic enzyme 
(putative 
glycohydrolase) 
SL1344_1957 Hypothetical 
protein 
Hypothetical 
bacteriophage holin 
sb51 Lysis protein 
(holin) 
In order to create a ST64B lysis-genes deficient mutant, sb53-sb53 reported to be involved in cell lysis were deleted 
(Figure 3.1C) (Mmolawa et al., 2003). Of note, sb51 does not align completely to SL1344_1957. In contrast sb53, 
sb52 align to the SL1344_1955, SL1344_1956 with 100% similarity. 
 
3.2.6.3 Construction of plasmids 
Generation of pLPN13 and pLPN14: Correct insertion was verified by PCR using oligonucleotides 
ΔoriTnikArev_val/ΔoriTnikA_val (Table 1). For the generation of c-terminal CirA-His-tag fusion, the 
open reading frame of cirA was amplified from E. coli Nissle genomic DNA by PCR, using 
Fow_cirA_NheI and Re_cirA_XhoI oligonucleotides (Table 1) and cloned into pET-24c (Novagen) via 
NheI and XhoI to yield pLPN13. For the generation of c-terminal ColIb-His-tag fusion, the ColIb gene cib 
was amplified from S. Tmwt genomic DNA by PCR, using oligonucleotides Fow_colicin_NheI and 
Re_colicin_XhoI (Table 1) and cloned into pET-24c via NheI and XhoI to yield pLPN14. 
Generation of pLPN1: To generate pLPN1, the cirA promoter was amplified from E. coli Nissle using 
oligonucleotides pcirA-BamHI/pcirA-XbaI (Table 1) and inserted in BamHI and XbaI digested pM979 
(Stecher et al., 2004). 
Generation of pM1437: For generation of pM1437, the cib promoter from E. coli8178 was amplified using 
oligonucleotides pColIb-XbaI, pColIb-BamHI (Table 1) and inserted in pM968 (Stecher et al., 2004) via 
restriction with XbaI and BamHI. The cib promoter sequence of E. coli8178 is identical to the one of S. 
Tmwt (SB300). 
Generation of pLPN15 and pLPN16: To generate pLPN15 and pLPN16, the firefly-luciferase gene luc 
from pLB02 (Gunn et al., 1995) was amplified with oligonucleotides Luc-for-BamHI and Luc-rev-HindIII 
(Table 1) and inserted into the BamHI/HindIII digested plasmids pLPN1 or pM1437, respectively. 
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Construction of cirA and colIb complementation plasmids: Oligonucleotides pWSK29-Gbs-for and 
pWSK29-Gbs-rev (Table 1) were used in a PCR with pWSK29 (Wang & Kushner, 1991) as a template to 
amplify the low-copy-number plasmid (Table 1). Oligonucleotides CirA-pWSK29-Gbs-for and CirA-
pWSK29-Gbs-rev were used in a PCR with chromosomal DNA of EcMG1655 as a template to amplify cirA 
including its natural promoter. Oligonucleotides Cib-Imm-pWSK29-Gbs-for and Cib-Imm-pWSK29-Gbs-
rev were used in a PCR with S. Tmwt (SB300) plasmid pCol1B9_SL1344 as a template to amplify the 
cib/imm locus including both natural promoters. The pWSK29 PCR fragment was combined with the cirA 
or cib/imm fragment in a Gibson assembly reaction (Gibson et al., 2009). Four microliters of the Gibson 
assembly mix were transformed into chemically competent E. coli Mach1 T1 cells (Life Technologies). 
Constructs were verified using colony PCR, restriction analysis and sequencing. The complementatiom 
plasmids were generated by Thorsten Wille (Robert Koch-Institut, Wernigerode Branch, Junior Research 
Group 3, Wernigerode, Germany). 
 
3.2.6.4 Construction of mutant strains 
Construction of EcMG1655 ∆cirA (LPN2): EcMG1655 ∆cirA (LPN2) was constructed using the lambda Red 
recombinase system as described (Section 3.2.5.9) using pKD4 as template for the kanamycin-resistance 
gene including the FRT-sites (Datsenko & Wanner, 2000). Briefly, EcMG1655 was transformed with the 
plasmid pKD46. The kanamycin resistance cassette from plasmid pKD4 was amplified by PCR using 
oligonucleotides K12ΔcirA_Fwd/K12ΔcirA_Re and transferred in EcMG1655 pKD46. Correct recombination 
was verified by PCR using oligonucleotides cirA-up/cirA-down and cirA-up/cirA-d1 (Table. 1). 
Construction of S. Tmavir ΔoriT (LPN5): S. Tmavir ΔoriT (LPN5) was generated by P22-transduction of the 
ΔoriTnikA::cat allele from M1407 into M557 (Hapfelmeier et al., 2005). Correct insertion was verified by 
PCR using oligonucleotides ΔoriTnikArev_val/ΔoriTnikA_val d1 (Table 1). 
Confirmation of prophage deletions in S. TmMA6118 and derivatives: For all strains included in the 
ColIb release study (Section 4.2) presence and absence of respective prophages (Gifsy-1, Gifsy-2, SopEΦ 
and ST64B) was verified by PCR using oligonucleotides Gifsy-1-for/Gifsy-1-rev, Gifsy-2-for/Gifsy-2-rev, 
SopE-phi-for/SopE-phi-rev and ST64B-for/ST64B-re (Table 1), respectively. 
Construction of S. Tm∆lysSTNT (LPN9): In order to delete ST64B lysis genes (SL1344_1955-
SL1344_1957) lambda Red recombinase system was used (Datsenko & Wanner, 2000). The kanamycin-
resistance cassette was amplified by PCR from pKD4 using oligonucleotides SB51-53_for/SB51-53_rev 
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and subsequently transformed in S. TmMA6118 carrying pKD46. Correct recombination in S. Tm∆lysSTNT 
(LPN9) was verified by PCR using oligonucleotides check_ST64_for/check_pKD4_Kan_For, 
check_pKD4_Kan_Re/check_ST64_rev and check_ST64_for/ check_ST64_1 (Table 1). 
Construction of S. Tm∆lysSϕCNT (LPN11): In order to replace SopEΦ lysis genes (SL1344_2684-
SL1344_2687) lambda Red recombinase system was used (Datsenko & Wanner, 2000). Oligonucleotides 
Lys_Sop_phi_For/Lys_Sop_phi_Rev were used to amplify chloramphenicol-resistance cassette from 
plasmid pKD3. Further, purified PCR product was transformed in S. TmMA6118 carrying pKD46. Correct 
recombination in S. Tm∆lysSϕCNT (LPN11) was verified by PCR using oligonucleotides 
Lys_SopE_Check_Fwd / Lys_SopE_Check_Rev (Table 1). 
Construction of S. Tm∆lysST (LPN14) and S. Tm∆G1∆G2∆lysST (LPN24): P22-transduction of the 
(SL1344_1955-SL1344_1957)::aphT allele from Tm∆lysSTNT  into S. TmMA6118 and S. Tm∆G1∆G2
  was used 
for generation of S. Tm∆lysST (LPN14) and S. Tm∆G1∆G2∆lysST (LPN24), respectively. Correct insertion of the 
allele was verified by PCR using oligonucleotides check_ST64_for/check_pKD4_Kan_For, 
check_pKD4_Kan_Re/check_ST64_rev and check_ST64_for/ check_ST64_1 (Table 1). 
Construction of S. Tm∆lysSϕC (LPN15) and S. Tm∆G1∆G2∆lysSϕC (LPN17): P22-transduction of the 
(SL1344_2684- SL1344_2687)::cat allele of S. Tm∆lysSϕCNT into S. TmMA6118 and S. Tm∆G1∆G2 (MA6247) 
was done in order to generate S. Tm∆lysSϕC (LPN15) and S. Tm∆G1∆G2∆lysSϕC (LPN17), respectively. Correct 
instertion of the allele was verified by PCR using oligonucleotides 
Lys_SopE_Check_Fwd/Lys_SopE_Check_Rev (Table 1). 
Construction of S. Tm∆lysSϕ (LPN19) and S. Tm∆G1∆G2∆lysSϕ (LPN20): pCP20 was transformed in LPN15 
and LPN17 in order to eliminate the chloramphenicol-resistance gene (Section 3.2.6.10). Deletion of the 
antibiotic-resistance gene in S. Tm∆lysSϕ (LPN19) and S. Tm∆G1∆G2∆lysSϕ (LPN20), respectively, was 
confirmed by PCR using oligonucleotides Lys_SopE_Check_Fwd/Lys_SopE_Check_Rev (Table 1). 
Construction of S. Tm∆G1∆G2∆lysSϕKNT (LPN25): In order to engineer S. Tm∆G1∆G2∆lysSϕKNT (LPN25), 
oligonucleotides Lys_Sop_phi_For/Lys_Sop_phi_Rev were used to amplify pKD4 kanamycin-resistance 
cassette. The purified PCR product was transformed in S. Tm∆G1∆G2 carrying pKD46. Correct 
recombination was verified by PCR using oligonucleotides 
Lys_SopE_Check_Fwd/check_pKD4_Kan_For and Lys_SopE_Check_Rev/check_pKD4_Kan_rev 
(Table 1). 
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Construction of S. Tm∆G1∆G2∆lysSϕK (LPN26): To generate S. Tm∆G1∆G2∆lysSϕK (LPN26), the P22-
transduction of the (SL1344_2684- SL1344_2687)::aphT allele of S. Tm∆G1∆G2∆lysSϕKNT into S. Tm∆G1∆G2 
was done. Correct insertion was confirmed by PCR using oligonucleotides Lys_SopE_Check_Fwd/ 
Lys_SopE_Check_Rev (Table 1). 
Construction of S. TmA36 p2cm (LPN12) and S. TmA36 p2cm (LPN13): Plasmid pCol1B9_SL1344 
carrying chloramphenicol resistance (Stecher et al., 2012) was conjugated from M995 into S. TmA36 and S. 
TmM4 (Mirold et al., 1999) to construct S. TmA36 p2cm (LPN12) and S. TmA36 p2cm (LPN13), respectively 
(Section Conjugation). Single colonies were selected on chloramphenicol-supplemented LB agar plates. 
Functional transfer of p2cm was confirmed by testing ColIb expression by a colicin-killing assay. 
Construction of MBK6 and MBK7: C600W34 (kindly provided by Prof. Dr. Dr. Jürgen Heesemann) is 
a C600 E. coli K12 strain lysogenized with Shiga toxin 2 phage 933W (originally isolated from EHEC 
strain O157:H7 EDL933) (O'Brien et al., 1984). Lambda Red recombination was used to replace stx2A 
gene (Shiga toxin 2 subunit A) of the 933W phage with the firefly luciferase gene (luc) and a kanamycin-
resistance cassette (aphT) flanked by FRT-sites to create MBK6. The same method was applied to replace 
the stx2A gene and the two lysis genes (S and R) located downstream in order to construct MBK7. Shortly, 
C600W34 was transformed with the temperature sensitive plasmid pKD46 containing the lambda Red 
recombinase system (Datsenko & Wanner, 2000). The luciferase reporter gene and the kanamycin-
resistance cassette were amplified from plasmid p3121 (Gerlach et al., 2007) by PCR using 
oligonucleotides “Stx2-luc fusion Fw/Stx2_Com fusion Rev” for replacement of stx2A gene and “Stx2-luc 
fusion Fw/Stx2 R/S Com fusion Rev” for stx2A, S and R gene replacement. Correct recombination was 
verified by PCR using “Stx2 operon Fw/Stx2 Operon Rev” oligonucleotides for MBK6 and “Stx2 Operon 
Fw/R/S outside Rev” for MBK7 (Table 1). 
Construction of MBK13 and MBK14: MBK13 was created via lysogenization of EcMG1655 with the 
luciferase-reporter phage from MBK6. Likewise, MBK14 was created via lysogenization of EcMG1655 with 
the reporter phage from MBK7. To generate the phage lysate, MBK6 (MBK7) was grown in 3 ml LB 
medium o.n. at 37° C, on a wheel rotor. This starter culture was used for inoculation (1:20) of 5 ml LB 
medium and grown until log-phase culture (OD600 of 0.5). The prophage was induced by addition of 0.5 
µg/ml mitomycin C to the culture and subsequent incubation o.n. at 37° C, on a wheel rotor. On the next 
day, 100 µl chloroform was added to the culture and incubated for 10 min at RT, while vortexing. Further, 
the lysate was spun down (4° C, 10 min at 6,000 rpm), the supernatant was filtered (0.45 µm filter) and 
100 µl chloroform was added to the filtrate for short term storage at 4° C. For the phage transduction 100 
µl of a 1:1,000 dilution of an o.n. culture of EcMG1655 (grown in 3 ml LB medium) was mixed with 500 µl 
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phage lysates (low titer), 100 µl 0.1 M CaCl2 and LB medium was added to final volume of 2 ml. This 
culture was then grown at 37° C o.n. on a wheel rotor. Finally, the o.n. culture was diluted and plated onto 
LB-agar plates supplemented with kanamycin. Single grown colonies were isolated and checked for 
lysogeny by PCR using the oligonucleotides “Stx2 Operon Fw/Stx2 Operon Rev” for MBK13 and “Stx2 
Operon Fw/R/S outside Rev” for MBK14 (Table 1). 
Construction of EcStx p2cm (LPN21), EcStx∆SR p2cm (LPN22), Ec p2cm (LPN23): p2cm from donor strain 
M995 (Stecher et al., 2012) was conjugated into MBK13, MBK14 and EcMG1655, to construct EcStx p2cm 
(LPN21), EcStx∆SR p2cm (LPN22) and Ec p2cm (LPN23), respectively. Acquisition of p2cm was confirmed by 
testing ColIb expression via a colicin-killing assay. 
Construction of S. Tm∆Ph smR (LPN27) and S. Tm∆G1∆G2∆lysST smR (LPN28): Presence of the 
streptomycin-resistance plasmid (pRSF1010-SL1344) and virulence plasmid (pSLT-SL1344) of S. Tm 
SL1344 were detected by PCR (using strB_for/strB_rev and spvB_for/spvB_rev oligonucleotides, 
respectively) for S. TmMA6118. pRSF1010-SL1344 was found to be absent in S. Tm∆G1∆G2, S. Tm∆G1∆G2∆ST 
and S. Tm∆Ph. Both plasmids were extracted from S. TmMA6118 using Plasmid Plus kit, in order to construct 
streptomycin-resistant LPN27 (S.Tm∆Ph smR) and LPN28 (S. Tm∆G1∆G2∆lysST smR), the plasmids were 
trandsformed in S. Tm∆Ph and S. Tm∆G1∆G2∆lysST, respectively. Successful transfer of pRSF1010-SL1344 
transformation was confirmed by PCR using strB_for/strB_rev oligonucleotides (Table 1). 
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3.2.7 Biochemical methods 
3.2.7.1 Generation and affinity purification of recombinant His-tagged proteins 
For generation of ColIb-His, E. coli BL21 (DE3) transformed with pC831-2 (expression of the ColIb 
immunity protein gene imm (Stecher et al., 2012)) and pLPN14 (Table.26) was used. For generation of 
CirA-His, E. coli BL21 (DE3) was used, transformed with pLPN13 (Table. 26). Bacterial cultures grown 
o.n. at 180 rpm, 37° C in LB medium containing antibiotics were used for inoculation of 1-2 L LB 
(dilution 1:20). At an OD600 between 0.6-0.8, this subculture was induced with 0.1 mM isopropyl β–D-
thiogalactopyranoside (IPTG) and incubated at 180 rpm for 4 h, 37° C. Bacteria were harvested (at 4,500 
rpm for 30 min, 4° C), resuspended in 40 ml 1x PBS and spun down at 4,500 rpm for 20 min, 4° C. The 
pellet was frozen at -20° C. Thereafter, the pellet was thawn and resuspended in 25 ml recombinant 
protein purification lysis buffer supplemented with 2 mM phenylmethylsulfonyl fluoride (PMSF) and 
benzonase nuclease (Table 14). Bacteria were lysed in the French Press (1,000 PSI). The lysate was spun 
down at the supernatant was filtered (0.22 µm). Further, the lysate was loaded on a 5 ml HisTrap column, 
and purified using the ÄKTA system (GE Healthcare, Munich) applying recombinant protein loading 
buffer (Table 15). ColIb-His was eluted with recombinant protein elution buffer (Table 16). The fractions 
containing the protein were desalted on a 5 ml HiTrap desalting column, using the ÄKTA system and 
recombinant protein purification exchange buffer 1 or 2 (Table 17 and Table 18). The protein purification 
exchange buffer 2 was applied, as the recombinant protein was found to be unstable when stored for 
several months in recombinant protein purification exchange buffer 1 (Table 17). CirA-His was purified 
as outlined above for ColIb-His, but with following exceptions: the recombinant protein purification 
lysis(Table 14), loading(Table 15), elution (Table 16) and exchange buffer(Table 17), each contained 6 
M urea and the protein purification exchange buffer 1 contained 4 M urea. Rabbit antisera against ColIb-
His and CirA-His were raised using standard protocols (Pineda Antikörper-Service, Berlin, Germany). In 
order to do this, 6 mg/ml ColIb-His (in 20 mM Na2HPO4, 100 mM NaCl, pH 7.4) and 6 mg/ml CirA-His 
(in 20 mM Na2HPO4, 100 mM NaCl, 4 M Urea, pH 7.4) were used for rabbit immunization. Control and 
immune sera were received from bleedings at day 61, 90 and 135 post-immunisation. 
 
3.2.7.2 Affinity purification of rabbit-antisera 
Affinity purification of polyclonal rabbit α-ColIb-His antiserum was done using the Aminolink kit 
(Thermo Fisher Scientific) following the manufacturer’s protocol with some minor modifications: PBS 
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was used as binding/wash buffer and 1 M glycine, pH 2.7 was used as elution buffer. ColIb-His (stored in 
20 mM Na2HPO4, 100 mM NaCl, pH 7.4) was added to the binding buffer at 1:3 ratio. Next, desalting of 
the affinity-purified rabbit-α-ColIb-His antiserum was done using PD-10 desalting columns (GE 
Healthcare) with PBS used as exchange buffer. The Aminolink kit was likewise used for the affinity 
purification of polyclonal rabbit α-CirA-His antiserum. His-tagged CirA (20 mM Na2HPO4, 100 mM 
NaCl, 4M urea, pH 7.4) was dialyzed against PBS using 5 ml Zebra Spin (Thermo Fisher Scientific) 
desalting columns shortly before coupling. Coupling of the His-tagged to the chromatographic column 
was done with the Aminolink kit coupling buffer supplemented with 4 M urea. Next, desalting of the 
affinity-purified rabbit-α-CirA-His was done with the Zebra Spin desalting columns using PBS 
containing. Purified antisera were supplemented with sodium azide to 0.01% and stored at -80° C. 
 
3.2.7.3 SDS-polyacrylamide gel electrophoresis (PAGE) and immunoblot 
Proteins were separated by SDS gel electrophoresis (Laemmli, 1970). Acrylamide was used for the 10% 
resolving (Table 19) and the 5% stacking gel (Table 20). Proteins were transferred onto a nitrocellulose 
membrane at 300 mA for 2 h, using the transfer buffer (Table 23). The membrane was blocked in PBS 
(0.1% tween; 5% milk powder) and probed with either affinity-purified rabbit α-CirA-His, affinity-
purified rabbit α-ColIb-His, or mouse monoclonal -E. coli DnaK (Table 5). Goat-α-rabbit-HRP and 
goat--mouse-HRP were used as secondary antibodies (Table 6). Blots were developed with ECL 
detection system (GE Healthcare) or Immobilion Western Chemoluminescent HRP substrate (Merck 
Chemicals). The relative quantity of ColIb and DnaK was determined by densitometry using Image Lab 
software (Bio-Rad). 
 
3.2.8 Animal experiments 
3.2.8.1 Ethics statement 
All animal experiments were approved by the Regierung von Oberbayern and the Kantonales 
Veterinäramt Zürich and performed according to local guidelines (Deutsches TschG; Schweizer Kantonale 
Tsch). 
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3.2.8.2 Infection experiments, determination of bacterial loads and histopathological 
analysis 
All mice used in the study were on C57BL/6J background and bred at the Rodent Center, ETH Zürich and 
the Max-von-Pettenkofer Institute, LMU Munich under SPF conditions in individually ventilated cages. 
Low-complexity microbiota (LCM) mice were generated by associating germfree mice with members of 
the altered Schaedler Flora (Dewhirst et al., 1999) as described previously (Stecher et al., 2010). 
Conventional SPF C57BL/6J mice were purchased from Janvier, Le Genest-Saint-Isle. For infections, 
conventional and LCM mice were pretreated with streptomycin and infected by gavage with 5107 cfu S. 
Tm or mixtures of S. Tm and E. coli as described (Stecher et al., 2012). For in vivo luciferase-assays, 
LCM mice were pretreated with ampicillin (20 mg/animal 24 h prior to infection). Live bacterial loads in 
the cecal content were determined by plating on MacConkey-agar (Roth or Oxoid) with respective 
supplements (streptomycin 100 μg/ml; kanamycin 30 μg/ml; chloramphenicol 30 μg/ml; ampicillin 100 
μg/ml and tetracycline 12.5 μg/ml). Histology of the cecum was done at necropsy. Cecum tissue was 
embedded in O.C.T. and flash frozen. Cryosections (5 μm) of the cecal tissue were H&E-stained and 
scored as described in detail in (Stecher et al., 2007b). The parameters submucosal edema, 
polymorphonuclear neutrophils (PMNs) infiltration, loss of goblet cells and epithelial damage were scored 
according to the severity of inflammatory symptoms yielding a total score of 0–13 points. For infections, 
E. coli and S. Tm strains were grown as previously described (Hapfelmeier et al., 2004). Briefly, cultures 
in LB supplemented with 0.3 M NaCl were inoculated with 2-3 bacterial colonies from plates. Bacteria 
were grown o.n. for 12 h and subcultures (1:20) for an additional 4 h. Bacteria were mixed (as indicated) 
washed in PBS and applied to the mice in a total volume of 50 μl by oral gavage. 
 
3.2.9 Statistical analysis 
Statistical analysis of data obtained from the in vivo experiments were performed using the exact Mann-
Whitney U Test (Graphpad Prism Version 5.01). Statistical analysis of data obtained from the in vitro 
studies was analysed by one-way analysis of variance (ANOVA) and unpaired Student's t-test (Graphpad 
Prism Version 5.01). P-values less than 0.05 (2-tailed) were considered as statistically significant. 
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4 Results 
4.1 ColIb-dependent competition of Salmonella Typhimurium and E. coli 
4.1.1 ColIb affords S. Tm a growth advantage over colicin-sensitive E. coli strains in 
the inflamed, but not in the normal gut 
It has been shown previously that production of ColIb grants significant competitive advantage to S. Tm 
over colicin-sensitive E. coli strains (Stecher et al., 2012). Sensitivity to ColIb of two E. coli strains was 
tested in vitro. The probiotic E. coli Nissle (EcNissle) strain showed intermediate susceptibility to ColIb by 
formation of a turbid inhibition zone (Figure 4.1). However, a K-12 strain E. coli MG1655 (in the 
following termed EcMG1655) displayed high sensitivity producing a clear inhibition zone in the vicinity of S. 
Tm (Figure. 4.1). Based on these results, EcMG1655 was selected for further studies. 
 
 
Co-infection experiments with S. Tm strains and EcMG1655 in the streptomycin Salmonella mouse colitis 
model (Barthel et al., 2003) were conducted to test whether ColIb confers a fitness benefit to S. Tm. 
Initially, gnotobiotic mice colonized with a LCM were confirmed to harbour no Enterobacteriaceae 
Figure 4.1. Halo-assay to determine 
phenotypes of ColIb susceptibility. ColIb 
susceptibility of EcNissle and EcMG1655 was 
tested. S. Tmwt was spotted on LB agar 
plates containing mitomycin C and 
incubated o.n. to induce ColIb secretion. 
EcNissle and EcMG1655 were cultivated in LB 
medium o.n., mixed with soft agar and 
overlaid on the agar plates. The 
experiments were done in triplicates and 
the diameter of the ColIb inhibition zone 
(halo) was measured after 24 hours. The 
detection limit (dotted line) is the average 
size of the S. Tmwt colony. 
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species which can affect the outcome of the experiments, i.e. by producing other colicins. Streptomycin 
was administrated to the LCM mice 24 h before infection. This was done in order to disturb the residual 
microbiota which can otherwise prevent development of enteric salmonellosis due to colonization 
resistance (Stecher et al., 2007a). In regard to the high levels of intrinsic transfer of P2-plasmid from S. 
Tm to the co-colonizing E. coli strains in the gut (Stecher et al., 2012), all S. Tm strains used in this study 
carried a mutation in the origin of transfer of P2 (ΔoriT). Thereby, the P2 transconjugation was blocked. 
LCM mice (pre-treated with streptomycin) were co-infected with 1:1 mixtures of EcMG1655 and either 
ColIb-producing (S. TmΔoriT) or ColIb-deficient strains (S. TmΔoriT Δcib). By day 4 post infection (p.i.) 
EcMG1655 was remarkably outnumbered by S. TmΔoriT. In contrast, the ColIb-deficient pathogen (S. TmΔoriT 
cib) was unable to surpass its comptetitor (Figure 4.2A,B).  
 
 
 
Figure 4.2. Colicin-dependent competition of S. Tm and E. coli in the gut in inflammation-induced “blooms” 
in gnotobiotic LCM mice. Streptomycin-treated LCM-mice were co-infected with 1:1 mixtures of S. TmΔoriT and 
EcMG1655, S. TmoriT Δcib and EcMG1655 or S. TmΔoriT avir and EcMG1655. (A) S. Tm (black) and E. coli (white) colonization 
density was determined at day 4 p.i. in the cecum content (cfu/g). (B) Competitive indices (CI; ratio of S. Tm / E. 
coli) as determined for individual mice shown in (A). Bars show the median. (C) Histopathological analysis of cecal 
tissue of the infected mice shown in (A). Cecal tissue sections of the mice were stained with hematoxylin/eosin and 
the degree of submucosal edema, neutrophil infiltration, epithelial damage and loss of goblet cells was scored. 
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However, both S. Tm strains induced similar degrees of gut inflammation (Figure 4.2C). These results 
indicated that the competitive advantage of S. Tm over EcMG1655 in the inflamed intestine is mainly ColIb-
dependent. Further, to test whether ColIb is beneficial to the pathogen in the absence of inflammation, 
LCM mice were co-infected an avirulent Salmonella strain (S. TmΔoriT avir). For the reason that S. TmΔoriT avir 
(Table 3) is lacking functional type three secretion systems, it is inept to trigger an inflammatory response 
(Hapfelmeier et al., 2005). Although S. TmΔoriT avir is a ColIb-producer (Figure 4.5), the pathogen was 
incapable to overgrow EcMG1655 in absence of gut inflammation (Figure 4.2). 
LCM mice serve as valuable experimental tool to investigate intrinsic bacterial and bacteria–host 
dynamics avoiding complexity of the species-rich natural gut microflora (Stecher et al., 2013a). However, 
this model does not mimick the the whole diversity of the processes taking place in a conventional 
microbiota (Brown et al., 2013). Furthermore, previous studies of colicin-dependent bacterial competition 
were performed using conventional mice ((Gillor et al., 2009), (Kirkup & Riley, 2004)). In order to assess 
the ColIb-dependent competition in a more “natural” environment, streptomycin-treated mice with a 
conventional complex microbiota were co-infected with S. TmΔoriT and E. coli strains. In contrast to the 
LCM mice, EcMG1655 was found to be a poor colonizer of the conventional streptomycin-treated animals 
(not shown). Therefore, E. coli Nissle (EcNissle) was used in co-infection with S. TmΔoriT. To investigate the 
importance of the ColIb as a beneficial fitness factor in the inflamed intestine, two groups of 
streptomycin-treated mice were set up (Figure 4.3). EcNissle was administrated in co-infection with either a 
virulent colicin producer (S. TmΔoriT) or a colicin–deficient S. Tm strain (S. TmΔoriT Δcib). Both groups 
developed strong Salmonella-induced gut inflammation by day 4 p.i. (Figure 4.3E,F). Upon 
inflammation, the virulent ColIb-producing S. TmΔoriT grew to similar numbers as EcNissle (to ~108 cfu/g) 
while the ColIb-deficient S. TmΔoriT cib was outcompeted by the probiotic strain (Figure 4.3B). This 
difference is displayed likewise by the competitive index (CI; ratio of S. Tm / E. coli) (Figure 4.3D). In 
respect to the aborted ColIb-dependent competitive advantage in non-inflamed intestine of the LCM mice 
(Figure 4.2), two additional groups of conventional streptomycin-treated mice were tested. Co-infection 
of the mice was launched with EcNissle and either an avirulent ColIb-producing S. Tm (S. TmΔoriT avir), or an 
avirulent ColIb-deficient S. Tm (S. Tmavir P2 cured). Both of these groups confronted with the avirulent 
strains did not develop gut inflammation (Figure 4.3E,F). 
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Figure 4.3. Colicin-dependent competition of S. Tm and E. coli in the gut in inflammation-induced “blooms” 
in conventional mice. Streptomycin-treated conventional mice were co-infected with 1:1 mixtures of S. TmoriT Δcib 
and EcNissle , S. TmΔoriT and EcNissle, S. TmΔP2 avir and EcNissle and S. TmΔoriT avir and EcNissle. S. Tm (black) and E. coli 
(white) colonization density was determined at day 1 (A) and day 4 p.i. (B) in the feces and cecum content (Cfu/g), 
respectively. (C,D) Competitive indices (CI; ratio of S. Tm / E. coli) as determined for individual mice shown in A 
and B. Bars show the median. (E) Histopathological analysis of cecal tissue of the infected mice. Cecal tissue 
sections of the mice were stained with hematoxylin/eosin and the degree of submucosal edema, neutrophil 
infiltration, epithelial damage and loss of goblet cells was scored (Section 3.2.8). 1–3: no pathological changes; 4–7: 
moderate inflammation; above 8: severe inflammation. Bars shown mean and StD. (F) Representative hematoxylin 
and eosin (H&E)–stained cecal sections of mice shown in (E). Magnification 100-fold. Enlarged sections (squares) 
are shown in the lower panels.  
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At day 1 p.i., co-infecting strains (ColIb-producing S. TmΔoriT avir competing EcNissle) and (ColIb-deficient 
S. Tmavir P2 cured competing EcNissle) were colonizing the gut efficiently (Figure 4.3A,C). Nevertheless, in 
the absence of inflammation, they were out-numbered (to ~107 cfu/g) by the complex conventional 
microbiota re-growing by day 5 after streptomycin treatment (Figure 4.3B). Moreover, the avirulent 
ColIb-producer (S. TmΔoriT avir) gained no advantage over EcNissle (Figure 4.3D). The ratio of S. Tm / 
EcNissle (competitive index (CI)) is alerted in comparison to S. Tm / EcMG1655 (Figure 4.2B). It could be 
argued that this is due to strain-specific differences between EcMG1655 and EcNissle as well as, due to 
differences between the gnotobiotic and complex gut microbiota. Nevertheless, the experiments with the 
conventional mice confirmed that ColIb benefits S. Tm when competing against EcNissle only upon gut 
inflammation. 
 
Taken together, these results suggested that in the non-inflamed gut either expression of ColIb by S. Tm 
was down-regulated or the susceptibility to ColIb of E. coli strains was decreased. To gain further insights 
in the mechanism of colicin-dependent competition in the inflammation-induced blooms, the regulation of 
cib expression in S. Tm as well as, Ec susceptibility to ColIb were thoroughly investigated. 
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4.1.2 Production of S. Tm ColIb is induced by iron limitation and the SOS response 
in vitro 
In the cib promoter region, two binding sites for the transcriptional repressors Fur and LexA were 
identified: a 17 bp-long “Fur box” and a “LexA box” of the same length, respectively (Figure 4.4; Figure 
4.5).  
 
 
To examine the regulation of the ColIb coding gene cib, a cib promoter firefly-luciferase (luc)-reporter 
was constructed. Furthermore, an affinity-purified polyclonal rabbit-α-ColIb antiserum was generated to 
quantify ColIb expression. Demonstrated by luc-reporter assays, as well as by immunoblot, cib expression 
was strongly up-regulated upon induction of the SOS response by the antibiotic mitomycin C (0.25 µg/ml) 
(Figure 4.5B-D). Addition of 100 µM iron chelator DTPA causes depletion of Iron(III) from the culture 
 
……………………………………………………………………………………………………………………………………………………………….. 
 
 
Figure 4.4. Nucleotide sequence of S. Tmwt cib imm and its respective promoter regions. The sequence of S. 
Tmwt cib imm region was searched position of the Fur- and LexA repressor binding sites as described (Section 
3.2.6.1). The position of the Fur-box, LexA –box and major transcription start sites and their corresponding -10 and 
-35 regions are indicated, as well as the open reading frame and the prospective ribosome-binding site (S.D.). 
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media (Taylor et al., 2009). This in turn also enchanced ColIb production similar to mitomycin C. 
Combined supplementation of mitomycin C and DTPA conveyed maximal induction of ColIb production 
and secretion (Figure 4.5B-D). These observations demonstrated that repression of cib is aborted in 
response to SOS signals and iron starvation. 
 
 
 
 
4.1.3 Upregulation of Ecwt cirA under iron limitation correlates with increased ColIb 
suscpeptibility 
The outer membrane protein CirA is the receptor for both ColIa and ColIb (Buchanan et al., 2007; 
Cardelli & Konisky, 1974; Lazdunski et al., 1998). As a component of the iron uptake system cirA is 
under negative control of the iron-sensing Fur repressor (Griggs et al., 1987) (Figure 4.6). Binding of the 
specific sequence “Fur box” located in the promoter region of genes involved in iron-transport requires 
one Fe(II) accommodated to each monomer of the Fur dimer (Lee & Helmann, 2007).  
Figure 4.5. Expression of S. Tm ColIb is 
induced by iron limitation and the SOS 
response. (A) Organization of the ColIb locus 
showing location of the Fur and LexA repressor 
binding sites in the ColIb (cib) promoter and the 
immunity protein gene (imm). Overnight 
cultures of S. TmΔoriT (B) and S. TmΔoriT avir (C) 
carrying the reporter plasmid pcib-luc were re-
inoculated 1:20 in fresh LB with indicated 
supplements (0.25 µg/ml mitomycin C; 100 
mM DTPA) and grown under aeration for 4 h. 
OD600 of the cultures was normalized, bacteria 
were harvested and luciferase-activity was 
measured in bacterial lysates. Relative 
luminescence units (RLU) per unit OD600 are 
indicated. (D) Overnight cultures of indicated S. 
Tm strains were re-inoculated 1:20 in fresh LB 
with indicated supplements (0.25 µg/ml 
mitomycin C; 100 mM DTPA) and grown 
under aeration for 4 h. OD600 of the cultures was 
normalized, bacteria were harvested and ColIb 
was detected in bacterial lysates as well as in 
the culture supernatant by immunoblot using an 
affinity-purified rabbit-α-ColIb antiserum. S. 
Tm DnaK was detected as loading control.  
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A cirA promoter-firefly-luciferase-reporter and polyclonal rabbit-α-CirA antiserum were generated in 
order to investigate regulation of the cirA expression in EcMG1655. Confirmed by both, luciferase assay and 
immunoblot, iron depletion of LB medium as a result of 100 µM DTPA addition led to strong 
upregulation of cirA expression while addition of mitomycin C had no effect (Figure 4.7A,B). This 
observation verified that EcMG1655 cirA de-repression takes place in response to Fe(III)-starvation. Next, it 
was tested if expression of cirA correlates with sensitivity to ColIb-mediated killing. The EcMG1655 ΔcirA 
strain lacking the receptor was shown to be resistant to the bactericidal effect of ColIb (Figure 4.11C).  
  
 
Figure 4.6. Nucleotide sequence of Ecwt cirA and its promoter region. The sequence of Ecwt cirA region was 
analyzed for the position of the Fur-repressor binding site as described (Section 3.2.6.1). The position of the Fur-
box and major transcription start sites and their corresponding -10 and -35 regions are indicated, as well as the open 
reading frame and the prospective ribosome-binding site (S.D.). 
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Figure 4.7. E. coli cirA expression is upregulated in response to iron limitation. (A) An overnight culture of 
EcMG1655 carrying the reporter plasmid pcirA-luc was re-inoculated 1:20 in fresh LB with indicated supplements (0.25 
µg/ml mitomycin C; 100 mM DTPA) and grown under aeration for 4 h. OD600 of the cultures was normalized, 
bacteria were harvested and luciferase-activity was measured in bacterial lysates. Relative luminescence units (RLU) 
per unit OD600 are indicated. (B) Overnight cultures of EcMG1655 as well as EcMG1655 ΔcirA were re-inoculated 1:20 in 
fresh LB with indicated supplements (0.25 µg/ml mitomycin C; 100 mM DTPA) and grown under aeration for 4 h. 
OD600 of the cultures was normalized, bacteria were harvested and CirA was detected in bacterial lysates by 
immunoblot using a rabbit-α-CirA antiserum. E. coli cytoplasmic protein DnaK was detected as loading control.  
 
 
Moreover, ColIb-sensitivity was regained after complementation of EcMG1655 ΔcirA with cirA-carrying 
plasmid (Figure 4.11C). To estimate whether consecutive iron depletion would lead to increased ColIb-
sensitivity of EcMG1655, ColIb killing assays were set up. EcMG1655 was grown in M9 minimal media 
supplemented with different concentrations of FeCl3. Equal amounts of purified recombinant ColIb were 
applied. Growth in M9 media promoted maximal sensitivity of EcMG1655 to ColIb, while susceptibility 
decreased upon FeCl3 supplementation. This was consistent with reduction in CirA production by these 
cultures, as shown by immunoblot (Figure 4.8B). 
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Figure 4.8. Induction of cirA expression increases sensitivity to ColIb of E. coli. (A) EcMG1655 and EcMG1655 ΔcirA 
were cultivated in M9 medium o.n., mixed with soft agar and indicated concentrations of FeCl3 and overlaid on M9 
agar plates. Paper discs with recombinant ColIb were placed on the agar plate and the diameter of the inhibition zone 
(halo) was measured after 24 h. The detection limit (dotted line) is the size of the paper-disc (6 mm). (B) cirA 
expression of E. coli grown in vitro in M9 medium supplemented with different concentrations of FeCl3. Overnight 
cultures of EcMG1655 wt and EcMG1655 ΔcirA grown in M9 medium for 12 h were used for inoculation of 2 ml M9 medium 
supplemented with 1µM, 10µM, 0.1mM or 1mM FeCl3 and subcultured for 7 h. From each subculture, 250 µl (for an 
OD600 of 1) was taken, spun down at 4 °C, 10 min, 10, 000 rpm. CirA was detected by immunoblot in bacterial 
lysates using affinity-purified rabbit-α-CirA-antiserum. E. coli DnaK was detected as loading control. 
 
 
Further, ColIb-meditated killing of EcMG1655 grown in rich LB medium upon addition of 100 µM DTPA 
was investigated using live-dead staining and FACS (Section 3.2.1.5). High rates of killing were detected 
among bacteria grown for 1 hour in Fe(III)-depleted media and consequently challenged with the purified 
recombinant ColIb. Interestingly, same amount of ColIb was shown to be more deadly for EcMG1655 grown 
for 1 hour in the iron-depleted medium compared to bacteria enduring long-terme (4 h) iron starvation 
(Figure 4.9A). However, an increase in cirA expression as a response to addition of DTPA was confirmed 
after both, short (1 h) and long (4 h) growth (Figure 4.9B). Taken together, the results above 
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demonstrated that elevated cirA expression increases ColIb sensitivity of EcMG1655. At late time point, 
siderophores may compete with ColIb for CirA receptor. 
 
 
 
 
Figure 4.9. E. coli exposed for a short time to iron starvation is highly susceptible to ColIb-mediated killing. E. 
coli strains; EcMG1655 wt and EcMG1655 ∆cirA were inoculated in 3 ml LB medium, grown for 12 h and subsequently used 
for inoculation of subculture I supplemented with 100 µM DTPA, which was grown for either 1, or 4 h. (A). 
Subculture I was diluted and normalized to an OD600 of 0.01 in LB medium supplemented with colistin sulphate 
(killing control) or ColIb-His and incubated for 2 h. Thereafter, bacteria were stained with DiBaC4 and analyzed by 
FACS, % DiBaC4-positive bacteria of the bacterial population is shown. (B) CirA in the cell lysates of subculture I 
(grown for 1 h or 4 h) was detected by immunoblot using rabbit-α-CirA-antiserum. The black arrow points an 
unspecific protein recognized by the rabbit-α-CirA-antiserum. 
 
  
Results 
65 
 
 
4.1.4 ColIb-dependent competition of S. Tm and Ecwt in vitro is boosted by iron 
starvation and SOS-stress 
Co-culture experiments were performed in vitro to further address the importance of the environmental 
conditions for ColIb-dependent competition between S. TmΔoriT and EcMG1655. The ColIb-producer (S. 
TmΔoriT) was co-cultured with EcMG1655 or EcMG1655 ΔcirA under different conditions (Figure 4.10).  
 
 
 
Figure 4.10. ColIb dependent competition of S. Tm and E. coli in vitro. Overnight cultures of S. TmΔoriT and 
EcMG1655 (A, D, G, J), S. TmΔoriT Δcib and EcMG1655 (B, E, H, K) and S. TmΔoriT and EcMG1655 ΔcirA (C, F, I, L) were 
diluted and normalized to an OD600 of 0.05 for each strain in fresh LB with indicated supplements (0.25 µg/ml 
mitomycin C; 100 µM DTPA). Cfu/ml of both strains was determined at 0 h, 4 h, and 8 h after start of the subculture. 
Red lines: S. Tm strains, blue lines: E. coli strains. Dotted line: detection limit (2000 cfu/ml). 
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Additionally, competition between S. TmΔoriT Δcib and EcMG1655 was tested. Similar growth rates were 
observed for S. TmΔoriT and Ecwt co-cultured in the absence of supplements. After 8 h, S. TmΔoriT overgrew 
EcMG1655 by ~7-fold (mean titer S. TmΔoriT: 1.7 x 109 cfu/ml and EcMG1655: 2.3 x 108 cfu/ml) (Figure 
4.10A). In contrast, EcMG1655 was outnumbered by several orders of magnitude when either DTPA (7 x 
107-fold), mitomycin C (1 x 104-fold) or both supplements (6 x 106-fold) were added to the co-culture 
(Figure 4D,G,J). Furthermore, comparable growth of the competitors was observed in the absence of 
ColIb (S. TmΔoriT Δcib) or its receptor CirA (EcMG1655 ΔcirA) independent of the conditions (Figure 
4.10B,C,E-L). This indicated that S. Tm overgrowth in vitro was clearly ColIb-dependent. Interestingly, 
there was a discrepancy between the comparable ColIb expression levels (Figure 4.5D), but the more 
exuberant killing of EcMG1655 upon addition of DTPA compared to the mitomycin C supplementation. 
These observations argued that iron depletion has a greater impact for ColIb-dependent competition (i.e. 
by enhancing EcMG1655 cirA expression resulting in increased susceptibility to ColIb). Further, S. Tm cib 
mutant and the EcMG1655 cirA mutant were complemented with plasmids carrying the respective genes 
missing leading to a reversed phenotype, as shown by ColIb killing assay (Figure 4.11A,C) and 
immunoblot (Figure 4.11B,D). Complemented strains were further tested in co-culture experiments. In 
absence of inducers, EcMG1655 ΔcirA pcompl. cirA was overgrown by S. TmΔoriT (Figure 4.12A) and EcMG1655 was 
completely outcompeted by S. TmΔoriT Δcib pcompl. cib after 8 hours (Figure 4.12C). This could be due to the 
difference between the complemented and the background trains. Nevertheless, upon addition of inducers 
similarly to the respective wild type strain EcMG1655 ΔcirA pcompl. cirA was outcompeted by S. TmΔoriT (Figure 
4.12D,G,J), but grew unaffected by S. TmΔoriT Δcib (Figure 4.12E,H,K). Likewise, S. TmΔoriT Δcib pcompl. cib 
was overgrowing EcMG1655 as result of iron depletion, mitomycin C supplementation, or both (Figure 
4.12F,I,L). These results further supported ColIb-dependent overgrowth of S. Tm as well as, CirA-
required killing of Ec on the account of ColIb. 
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Figure 4.11. Characterization of plasmid-based complementation of S. TmoriT Δcib and EcMG1655 ΔcirA mutant 
strains. (A) Plasmid-based complementation of the ColIb-deficient S. Tm mutant S. TmoriT Δcib. S. TmoriT, S. TmoriT 
Δcib and S. TmoriT Δcib pcompl. cib  were spotted on LB agar plates containing mitomycin C and incubated o.n. to induce 
ColIb secretion. EcMG1655 was cultivated in LB medium o.n., mixed with soft agar and overlaid on the agar plates. (C) 
Plasmid-based complementation of the CirA-deficient EcMG1655 ΔcirA mutant. S. TmoriT, and S. TmoriT Δcib were spotted 
on LB agar plates containing mitomycin C and incubated o.n. to induce ColIb secretion. EcMG1655 ΔcirA and EcMG1655 
ΔcirA pcompl. cirA  were cultivated in LB medium o.n., mixed with soft agar and overlaid on the agar plates. The 
experiments were done in triplicates and the diameter of the ColIb inhibition zone (halo) was measured after 24 
hours. The detection limit (dotted line) is the average size of the S. Tmwt colony. Characterization of plasmid-based 
complementation of S. TmoriT Δcib and EcMG1655 ΔcirA mutant strains by Western Blot was done. Overnight cultures of 
indicated S. Tm (B) and EcMG1655 (D) strains were re-inoculated 1:20 in fresh LB with indicated supplements (0.25 
µg/ml mitomycin C; 100 µM DTPA) and grown under aeration for 4 h. OD600 of the cultures was normalized, 
bacteria were harvested and ColIb was detected in bacterial lysates as well as in the culture supernatant by 
immunoblot using an affinity-purified rabbit-α-ColIb antiserum. S. Tm DnaK was detected as loading control. 
EcMG1655 CirA was detected in bacterial lysates by immunoblot using a rabbit-α-CirA antiserum. E. coli cytoplasmic 
protein DnaK was detected as loading control. 
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Figure 4.12. ColIb dependent competition of complemented S. Tm and E. coli mutant strains in vitro. 
Overnight cultures of S. TmΔoriT and EcMG1655 ΔcirA pcompl.cirA  (A, D, G, J), S. TmΔoriT Δcib and EcMG1655 ΔcirA pcompl.cirA  (B, 
E, H, K) and S. TmΔoriT Δcib pcompl.cib and EcMG1655 (C, F, I, L) were diluted and normalized to an OD600 of 0.05 for 
each strain in fresh LB with indicated supplements (0.25 µg/ml mitomycin C; 100 µM DTPA). Cfu/ml of both 
strains was determined at 0 h, 4 h, and 8 h after start of the subculture. Red lines: S. Tm strains, blue lines: E. coli 
strains. Dotted line: detection limit (2000 cfu/ml). Plasmid-based reconstitution of cib and cirA to the mutant strains 
leads to an over-complementation apparent by ColIb-dependent killing of E. coli in LB in the absence of 
supplements which is attributed to the multi-copy nature of the complementation-plasmid (A, C). 
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4.1.5 Inflammation-induced enterobacterial blooms foster cib and cirA expression in 
vivo  
Initial co-infection experiments in mice established that colicin-dependent competition was taking place 
only in the inflamed gut. In vitro S. Tm and EcMG1655 grew alike independent of ColIb upon sufficient iron 
and no activator of the SOS response. In contrast, Fe(III)-limitation or DNA damaging mitomycin C 
promoted S. Tm overgrowth, based on ColIb production by the pathogen and cirA expression by E. coli. In 
consistence with these observations it could be argued that ColIb-dependent dominance of S. Tm over 
EcMG1655 in the inflamed gut could be attributed likewise to the increased production of ColIb by S. Tm, or 
up-regulation of the colicin receptor CirA by E. coli, or both. To verify this, expression of EcMG1655 
receptor (cirA) and S. Tm ColIb (cib) using firefly-luciferase reporter-constructs was evaluated in the 
streptomycin mouse colitis model.  
 
Figure 4.13. S. Tm ColIb and and the E. coli ColIb receptor CirA are induced in the inflamed gut. To measure 
in vivo regulation of E. coli cirA expression, streptomycin-treated LCM-mice were co-infected with 1:1 mixtures of 
S. TmΔoriT avir (avirulent) or S. TmΔoriT (wildtype) and the luciferase-reporter strain EcMG1655 pcirA-luc (A, C). To measure 
in vivo regulation of S. Tm cib expression, streptomycin-treated LCM-mice were co-infected with S. Tmavir 
(avirulent) or with S. Tmwt (wildtype) and the luciferase-reporter strain S. TmΔoriT pcirA-luc (B, D). Bacteria were 
harvested from cecal content and luciferase-activity was measured in cecum content (A, B). Relative luminescence 
units (rlu) per 108 cfu of the reporter strain are indicated (C, D). Gut inflammation as determined by pathological 
score of cecal tissue sections of the infected mice. 1–3: no pathological changes; 4–7: moderate inflammation; above 
8: severe inflammation. Bars show the median. Arrow in A and C points at one animal with atypically mild 
inflammatory symptoms.  
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Virulent (S. TmΔoriT or S. Tmwt) pathogen inflicting gut inflammation was administrated to LCM mice. To 
test expression of the reporters in non-inflammatory conditions LCM mice were infected with the 
avirulent S. TmΔoriT avir or S. Tmavir strains. Co-infection with EcMG1655 carrying the pcirA-luc-reporter plasmid, 
granted assesssment of cirA expression by EcMG1655 (Figure 4.13A,C). Regulation of S. Tm cib expression 
was tested by co-infection with the avirulent S. TmΔoriT avir carrying the pcib-luc-reporter plasmid (Figure 
4.13B,D). In contrast to the non-inflammatory conditions, significantly increased luciferase levels were 
detected for both the pcirA-luc- and the pcib-luc-reporters in the inflamed intestine (Figure 4.13A-D). These 
findings confirmed the initial conception of increased side by side ColIb production by S. Tm and CirA-
dependent susceptibility of EcMG1655 as a response to the gut inflammation. Thus, disclosing the means in 
which inflammation promotes ColIb-dependent competition of S. Tm and commensal E. coli. 
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4.2 Prophage-mediated ColIb release 
4.2.1 Activation of temperate phages affects ColIb release in S. Tm 
Along with the activation of ColIb expression, the SOS-response promotes numerous other events in the 
jeopardized bacterial cell. Facing the risk of the host-cell death, temperate phages enter the lytic mode 
(N.J. Dimmock, 2001). DNA damage in bacteria leads to the activation of RecA coprotease (RecA*) 
which in turn triggers self cleavage of LexA repressor followed by de-repression of genes involved in the 
SOS response (Little & Mount, 1982). The lambdoid prophage repressor protein CI is adapted to 
recognize host RecA* as a signal for impaired cell viability. RecA* directed cleavage of CI promotes 
successive expression of prophage genes required for assembly and lysis-directed release of new phage 
particles. Phage-mediated cell lysis could either conduct leakage of the cytoplasmic compounds through a 
holin-formed pore in the inner membrane or trigger instant release of the whole cytoplasmic content as a 
result of massive membrane disruption (Desvaux, 2012). The mechanism for release of ColIb is unclear. It 
was hypothesized that upon phage-mediated lysis ColIb may be released alongside the rest of the 
cytoplasmic content. 
To address this, release of ColIb was compared between the S. Tm SL1344 strain (S. TmMA6118) lysogenic 
for four temperate phages (Gifsy-1, Gifsy-2, SopEΦ and ST64B) (Figueroa-Bossi & Bossi, 2004) and its 
isogenic prophage-cured derivatives S. Tm∆G1∆G2, S. Tm∆G1∆G2∆ST and S. Tm∆Ph, lacking all four 
prophages(Alonso et al., 2005), in a ColIb-dependent killing assay (“halo assay”) using the ColIb-
sensitive E. coli strain EcMG1655 (Nedialkova et al., 2014). Comperable inhibition zones were observed for 
S. TmMA6118 and S. Tm∆G1∆G2 (cured from Gifsy-1, Gifsy-2 prophages) (Figure 4.14). In contrast, S. 
Tm∆G1∆G2∆ST cured from three prophages (Gifsy-1, Gifsy-2 and ST64B) displayed a significant decrease in 
halo size (Figure 4.14). This was even more pronounced in case of the quadruple prophage mutant S. 
Tm∆Ph.  
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Decreased halo size could be the result of reduced ColIb release or of attenuated growth of the producing 
strain. Therefore the growth dynamics of the four S. Tm strains upon addition of 0.5 µg/ml mitomycin C 
was analyzed. Initial experiments were performed in Erlenmeyer flasks in 10 ml culture volume (Figure 
4.15). In the absence of mitomycin C, all four strains grew at equal rate. Addition of mitomycin C led to 
an overall decrease of growth (600 ηm) of all strains. 
 
 
 
Figure 4.14. Prophage depletion leads to 
decrease in ColIb-dependent killing. S. Tm 
strains: S. TmMA6118 (red), S. Tm∆G1∆G2 (blue), S. 
Tm∆G1∆G2∆ST (violet), S. Tm∆Ph (green) were spotted 
on a LB agar plate supplemented with 0.25 µg/ml 
mitomycin C. Plates were incubated o.n. to induce 
production of ColIb and phage lytic mode. Next, 
plates were overlaid with EcMG1655 (grown in 10 ml 
LB medium and mixed with LB soft agar). After 12 
hours incubation, the ColIb inhibition zone (halo) 
was measured. The detection limit (dotted) line 
denotes the average diameter of S. Tm colony. 
 
 
 
Figure 4.15. Prophage deletion results in slightly diminished cell lysis. S. Tm strains: S. TmMA6118 (red), S. 
Tm∆G1∆G2 (blue), S. Tm∆G1∆G2∆ST (violet), S. Tm∆Ph (green) grown for 12 h in LB medium were separately diluted 
and normalized to an OD600 of 0.0025 in 10 ml fresh LB (subcultures I). Subcultures I (grown in Erlenmeyer 
flasks for 3 h) were used for inoculation of 10 ml LB (subculture II) without (A) or without 0.25 µg/ml 
mitomycin C (B). Subcultures II were grown for 6 h. OD600 values of the subculture were measured each hour. 
Bars shown mean and StD. The OD600 values (6 h) separately analyzed for the non induced and mitomycin C-
induced cultures are displayed no significant difference (p>0.05) (ANOVA test). 
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However, no significant difference in growth of the four strains was observed. Interestingly, cultivation of 
the bacteria in a smaller volume (200 µl) in 96-well plates led to a notable enhancement of bacterial lysis 
upon addition of mitomycin C (Figure 4.16B). Cell density values decreased as soon as 2 hours after 
addition of mitomycin C for S. TmMA6118, but also for the S. Tm∆G1∆G2 indicating that activation of the 
Gifsy-phages only has a minor impact on prophage-induced S. Tm lysis. In contrast, S. Tm∆G1∆G2∆ST and S. 
Tm∆Ph growth was not significantly affected 4 hours after induction. This suggests that either SopEΦ or 
ST64B alone, or both prophages together promote extensive lysis.  
Next, ColIb production and release by S. TmMA6118 and prophage-mutant strains was analyzed by 
immunoblot. For the analysis of intra-bacterial and secreted ColIb levels, a culture-volume normalized to 
an equal OD600 was used. ColIb–release into supernatant was detected in an equal volume of culture 
supernatant (not normalized). Colicin expression, in response to mitomycin C, was comparable in the 
lysates of the four strains grown in Erlenmeyer flasks (Figure 4.17A). In the culture supernatant, ColIb 
was detected for S. TmMA6118 and S. Tm∆G1∆G2. In contrast, no release of ColIb was detected for S. 
Tm∆G1∆G2∆ST and S. Tm∆Ph. 
 
 
 
Figure 4.16. Prophage deletion results in significant reduction of the cell lysis. . S. Tm strains: S. TmMA6118 (red), 
S. Tm∆G1∆G2 (blue), S. Tm∆G1∆G2∆ST (violet), S. Tm∆Ph (green) were grown for 12 h in LB medium, separately diluted 
and normalized to an OD600 of 0.025 in 3 ml fresh LB (subcultures I). After 2 h growth in glass tubes, on a wheel 
rotor, subcultures I were diluted and normalized to an OD600 of 0.2 in LB medium (subcultures II) without (A) or 
supplemented with 0.5 µg/ml mitomycin C (B). Subcultures II were grown in 96-well plate for 4 h measuring OD600 
each hour. Bars shown mean and StD.  The OD600 values (4 h) separately analyzed for the non induced and 
mitomycin C-induced cultures are significantly different (***p<0.0001) (ANOVA test). Statistical analysis by 
unpaired Student's t-test for non induced cultures: S. TmMA6118 and S. Tm∆G1∆G2 (p>0.05), S. TmMA6118 and S. 
Tm∆G1∆G2∆ST (***p<0.0001), S. TmMA6118 and S. Tm∆Ph (*** p<0.0001). Statistical analysis by unpaired Student's t-
test for mitomycin C-supplemented cultures: S. TmMA6118 and S. Tm∆G1∆G2 (*p<0.05), S. TmMA6118 and S. Tm∆G1∆G2∆ST 
(** p<0.006), S. TmMA6118 and S. Tm∆Ph (*** p<0.0001). 
 
Results 
74 
 
 
 
 
Figure 4.17. ColIb secretion is reduced in prophage-deficient strains. Subcultures II of S. Tm strains: S. TmMA6118 
(red), S. Tm∆G1∆G2 (blue), S. Tm∆G1∆G2∆ST (violet) and S. Tm∆Ph (green) were grown in Erlenmeyer flasks. Cultured for 
6 h bacteria were harvested from subculture II (Section 3.2.2.2). (A) ColIb was detected in cell lysates and culture 
supernatants by immunoblot using affinity-purified rabbit-α-ColIb-antiserum. S. Tm DnaK was detected as loading 
control. (B) Bactericidal activity of extracellular ColIb was tested. Paper disks soaked with sterile spent culture 
supernatant (mitomycin C supplemented (0.25 µg/ml) subculture II (6) h) were set on LB agar plates overlaid with 
EcMG1655 (grown in LB medium and mixed with soft agar). Following 12 h incubation, ColIb inhibition zone (halo) 
was measured. The detection limit (dotted) line indicates the size of the paper disks. 
 
 
Of note, DnaK was detected in the supernatant fraction alongside with ColIb. This suggests that indeed 
ColIb may be not actively secreted, but rather is released by phage-mediated bacterial lysis. Similar results 
were obtained for strains grown in a 96-well plate (Figure 4.18A,B). To determine ColIb-levels in 
bacterial cultures in 96-well plates, pellet fraction was not normalized to an equal OD600. This way, the 
relative bacteria-associated and released ColIb-levels can be directly compared. These results again 
showed that ColIb secretion mainly correlated with the lysis triggered by the SopEΦ and (or) ST64B 
prophages.  
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Figure 4.18. Temperate phage induction enhances ColIb release. Subculture II of S. Tm strains: S. TmMA6118 
(red), S. Tm∆G1∆G2 (blue), S. Tm∆G1∆G2∆ST (violet), S. Tm∆Ph (green) were grown for 4 h in a 96-well plate without (A) 
or with addition of mitomycin C (C) (Section 3.2.1.3). Next, bacteria were harvested from 100 µl of subculture II 
and ColIb was detected in cell lysates and culture supernatants by immunoblot using affinity-purified rabbit-α-ColIb-
antiserum. S. Tm DnaK was detected as loading control. The relative quantity of ColIb and DnaK was determined by 
densitometry using Image Lab software (Bio-Rad). The ratio of relative quantity of ColIb (found in the supernatant) 
divided by the relative quantity of DnaK (found in the bacterial lysate) for non induced (B) and mitomycin C-
induced (D) culture is shown. 
 
 
Next, it was assessed, weather ColIb released in the culture supernatant in the course of the prophage-
mediated lysis retains full bactericidal activity. Therefore, culture supernatant was tested in the colicin-
killing assay. In consistence with the previous observations, only extracellular fractions of S. TmMA6118 and 
S. Tm∆G1∆G2 cultures supplemented with mitomycin C mediated killing of EcMG1655 (Figure 4.17B; 
Figure4.19). No inhibition zone was observed for supernatant of S. Tm∆G1∆G2∆ST and S. Tm∆Ph cultures, 
suggesting that they don’t contain active ColIb. Taken together, these results suggested that induction of 
the bacterial SOS response leads to activation of the lytic stage of ST64B and SopEΦ prophages, thereby 
enhancing the release of bactericidal ColIb into the surrounding environment. 
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4.2.2 SopEΦ does not contribute to ColIb release in S. TmMA6118 
Lysis genes are expressed in the final phase of the phage lytic. In the course of virion morphogenesis a 
small phage-encoded protein termed holin accumulates in the inner membrane of gram negative bacteria. 
When reaching a critical concentration, holins form a micro-scale hole in the inner membrane. Next, 
phage encoded muralyitic enzymes termed endolysins pass through the holin-formed membrane lesion 
and degrade the peptidoglycan. Finally, a third class of lysis proteins termed spanins trigger outer 
membrane disruption and subsequently bacterial lysis (Young, 2013). Lysis genes arranged as a “cassette” 
are highly conserved across lambdoid phage genomes (Wang et al., 2000). Therefore, they can be 
identified by homology searches. Based on the observation that SopEΦ- or (and) ST64B–deficient S. Tm 
strains release significantly less ColIb, it was reasoned that deletion of the lysis genes of these phages 
would be sufficient to cause a decreased ColIb release. Using the lambda Red recombinase system 
(Datsenko & Wanner, 2000) SopEΦ lysis genes in strains S. TmMA6118 and S. Tm∆G1∆G2 were replaced by a 
chloramphenicol resistance cassette (Figure 2.1A,B; Table 30). ColIb-mediated killing of EcMG1655 by S. 
Tm∆lysSϕC and S. Tm∆G1∆G2∆lysSϕC was attenuated compared to the respective background strains (Figure 
4.20A).  
 
Figure 4.19. Bactericidal activity of extracellular 
ColIb is reduced in prophage-depleted strains. 
Mitomycin C supplemented (0.5 µg/ml) subcultures 
II of S. Tm strains: S. TmMA6118 (red), S. Tm∆G1∆G2 
(blue), S. Tm∆G1∆G2∆ST (violet) and S. Tm∆Ph (green) 
were grown in a 96-well plate for 4 h (Section 
3.2.1.3). Next, bacteria were harvested and 
bactericidal activity of extracellular ColIb was 
tested (Section 3.2.3.3). Paper disks soaked with 
sterile spent culture supernatant were set on LB 
agar plates overlaid with EcMG1655 (grown in LB 
medium and mixed with soft agar). Following 12 h 
incubation, ColIb inhibition zone (halo) was 
measured. The detection limit (dotted) line indicates 
the size of the paper disks. 
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Figure 4.20. Replacement of SopEΦ lytic genes with a cat cassette leads to attenuated growth. (A). S. Tm 
strains: S. TmMA6118 (red), S. Tm∆G1∆G2 (blue), S. Tm∆lysSϕC (dotted red) and S. Tm∆G1∆G2∆lysSϕC (dotted blue) were 
spotted on a LB agar plate supplemented with 0.25 µg/ml mitomycin C. Plates were incubated o.n. to induce 
production of ColIb and phage lytic mode. Next, plates were overlaid with EcMG1655 (grown in LB medium and 
mixed with LB soft agar). Following 12 hours incubation, the ColIb inhibition zone (halo) was measured. The 
detection limit (dotted) line denotes the average diameter of S. Tm colony. Subculture II of S. Tm strains: S. 
TmMA6118 (red squares), S. Tm∆G1∆G2 (blue squares), S. Tm∆lysSϕC (black rhombs, red connecting lines) and S. 
Tm∆G1∆G2∆lysSϕC (black rhombs, blue connecting lines) were grown in LB in a 96-well plate without (B) or 
supplemented with 0.5 µg/ml mitomycin C (C). OD600 of the subculture II was measured each hour. Mean and SD of 
replicates are shown. 
 
 
However, both S. Tm∆lysSϕC and S. Tm∆G1∆G2∆lysSϕC displayed impaired growth both in presence and absence 
of mitomycin C (Figure 4.20B,C). This could explain the decrease in ColIb-mediated killing of EcMG1655 
observed in the “halo” assay (Figure 4.20A). The attenuated growth kinetics of S. Tm∆lysSϕC and S. 
Tm∆G1∆G2∆lysSϕC could be due to a polar effect caused by the introduction of the cat-cassette or disruption of 
the lysis genes (in case they would be required for bacterial growth). To test this, the chloramphenicol-
resistance cassette, flanked by FRT-sites (Datsenko & Wanner, 2000) was eliminated from the S. Tm∆lysSϕC 
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and S. Tm∆G1∆G2∆lysSϕC using the Flp-recombinase. Additionally, SopEΦ lysis genes of S. Tm∆G1 ∆G2 were 
substituted with a FRT-flanked kanamycin-resistance cassette. The newly generated strains grew at rates 
similar to the background strains, suggesting that the chloramphenicol resistance cassette was the reason 
for the impaired growth of S. Tm∆lysSϕC and S. Tm∆G1∆G2∆lysSϕC. Interestingly, comparison between growth 
kinetics of a S. Tm strain and isogens carrying a chloramphenicol-resistance cassette in the flagella genes 
did not shown any difference (data not shown), suggesting that attenuated growth caused by introduction 
of chloramphenicol-resistance is related specifically to the SopEΦ lysis genes. However, this was not 
further investigated. S. Tm∆lysSϕ, S. Tm∆G1∆G2∆lysSϕ and S. Tm∆G1∆G2∆lysSϕK displayed ColIb-mediated kilning 
phenotypes comparable to the background strains (Figure 4.21).  
 
 
 
 
 
 
Figure 4.21. SopEΦ does not significantly 
contribute to the ColIb-dependent killing. S. Tm 
strains: S. TmMA6118 (red), S. Tm∆G1∆G2 (blue), S. 
Tm∆lysSϕ (red, vertical stripes), S. Tm∆G1∆G2∆lysSϕ (blue, 
vertical stripes) and S. Tm∆G1∆G2∆lysSϕK (blue, horizontal 
stripes) were spotted on LB agar plate containing 0.5 
µg/ml mitomycin C and incubated overnight. Next, 
plates were overlaid with EcMG1655 (grown in LB 
medium and mixed with LB soft agar) and incubated 
for 12 h. Further, ColIb inhibition zone (halo) was 
measured. The detection limit (dotted) line indicates 
the average diameter of S. Tm colony. 
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Figure 4.22. SopEΦ does not siginificantly contribute to the lysis. Subcultures II of S. Tm strains: S. TmMA6118 
(red squares), S. Tm∆G1∆G2 (blue squares), S. Tm∆lysSϕ (red circles), S. Tm∆G1∆G2∆lysSϕ (blue circles), S. Tm∆G1∆G2∆lysSϕK 
(blue triangle) and S. Tm∆Ph (green squares) were grown for 4 h in a 96-well plate without (A) or supplemented with 
0.5 µg/ml mitomycin C (B). OD600 of the subculture II was measured each hour. Bars shown mean and StD. OD600 
values (4 h) of the mitomycin C-induced cultures are significantly different (***p<0.0001) (ANOVA test). Statistical 
analysis by unpaired Student's t-test for mitomycin C-supplemented cultures: S. TmMA6118 and S. Tm∆G1∆G2 (p>0.05), 
S. TmMA6118 and S. Tm∆Ph (***p<0.0001), S. TmMA6118 and S. Tm∆lysSϕ (**p<0.006), S. Tm∆G1∆G2 and S. Tm∆G1∆G2∆lysSϕ 
(p>0.05), S. Tm∆G1∆G2 and S. Tm∆G1∆G2∆lysSϕK (p>0.05). 
 
 
Upon induction with mitomycin C, strains lacking SopEΦ lysis genes lysed to the same degree as S. 
TmMA6118 and S. Tm∆G1∆G2 (Figure 4.22B). Furthermore, upon induction similar amounts of ColIb were 
produced and released by S. Tm∆lysSϕ, S. Tm∆G1∆G2∆lysSϕ and the background strains as detected by 
immunoblot (Figure 4.23). This suggests that SopEΦ lysis genes do not contribute to ColIb release.  
Further, a prophage-deficient S. Tm strain (S. TmA36) and its SopEΦ lysogen (S. TmM4) were used to 
compare ColIb-release. Both strains were transformed with the p2cm by conjugation. No significant 
difference in ColIb-dependent “halo” size was detected (Figure 4.24). In conclusion, no evidence for the 
contribution of SopEΦ-mediate lysis to the release of ColIb was found. 
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Figure 4.23. Release of ColIb is not affected by the lytic activity of SopEΦ prophage. Subculture II of S. Tm 
strains: S. TmMA6118, S. Tm∆G1∆G, S. Tm∆lysSϕ, S. Tm∆G1∆G2∆lysSϕ, S. Tm∆G1∆G2∆lysSϕK and S. Tm∆Ph were grown for 4 h in 
a 96-well plate without (A) or with addition of mitomycin C (C) (Section 3.2.1.3). Next, bacteria were harvested 
from 100 µl of subculture II and ColIb was detected in the cell lysate and culture supernatant by immunoblot using 
affinity-purified rabbit-α-ColIb-antiserum. S. Tm DnaK was detected as loading control. The relative quantity of 
ColIb and DnaK was determined by densitometry using Image Lab software (Bio-Rad). The ratio of relative quantity 
of ColIb (found in the supernatant) divided by the relative quantity of DnaK (found in the bacterial lysate) for non 
induced (B) and mitomycin C-induced (D) culture is shown. 
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4.2.3 Deletion of ST64B lysis genes leads to decreased ColIb-release in S. Tm∆G1∆G2 
background strain 
Decreased cell lysis and impaired ColIb release by S. Tm∆G1∆G2∆ST suggested that ST64B prophage might 
be involved in ColIb-release. To investigate this further, three lysis-related genes of the ST64B prophage 
encoding, a hypothetical holin, lysozyme and lysis related protease were replaced with a kanamycin 
resistance cassette in strains S. TmMA6118 and S. Tm∆G1∆G2 (Figure 2.1C,D; Table 31). Indeed, deletion of 
the putative ST64B putative lysis genes led to diminished ColIb-mediated killing of the susceptible E. coli 
strain (Figure 4.25).  
 
 
Figure 4.24. ColIb-dependent killing is not 
influenced by SopEΦ prophage. S. Tm strains: S. 
TmA36 (vertical black stripes), S. TmM4 (horizontal 
black stripes), S. Tmwt p2cm (red), S. TmA36 p2cm 
(vertical red stripes), S. TmM4 p2cm (horizontal red 
stripes) were spotted on LB agar plate containing 
0.5 µg/ml mitomycin C and incubated overnight. 
Next, plates were overlaid with EcMG1655 (grown in 
LB medium and mixed with LB soft agar). 
Following incubation for 12 h, ColIb inhibition zone 
(halo) was measured. The detection limit (dotted) 
line denotes the average diameter of S. Tm colony. 
Figure 4.25. Deletion of ST64B prophage lysis 
genes leads to decrease in ColIb-dependent 
killing S. Tm strains: S. TmMA6118 (red), S. 
Tm∆G1∆G2 (blue), S. Tm∆lysST (red striped), S. 
Tm∆G1∆G2∆lysST (blue striped) and S. Tm∆Ph (green) 
were spotted on LB agar plate supplemented with 
0.5 µg/ml mitomycin C. ColIb producers were 
grown o.n. and then overlaid with EcMG1655 (grown 
in LB medium and mixed with LB soft agar). 
Following incubation for 12 h, the ColIb inhibition 
zone (halo) was measured. The detection limit 
(dotted) line indicates the average diameter of S. 
Tm colony. 
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Interestingly, this effect was only significant for the Gifsy-1 and Gifsy-2 deficient S. Tm strain (S. 
Tm∆G1∆G2∆lysST) and not for the S. Tm∆lysST (Figure 4.25). However, in the growth assay upon induction 
with mitomycin C, S. Tm∆lysST lysis was significantly reduced compared to the S. TmMA6118 (Figure 
4.26B). In contrast, S. Tm∆G1∆G2 ∆lysST and S. Tm∆Ph strains was not affected by addition of mitomycin C 
(Figure 4.26B).  
 
 
 
Figure 4.26. Cell lysis is impaired in strains with deleted lysis genes of ST64B prophage. Subculture II of S. Tm 
strains: S. TmMA6118 (red square), S. Tm∆G1∆G2 (blue square), S. Tm∆lysST (red rhomb), S. Tm∆G1∆G2∆lysST (blue rhomb) 
and S. Tm∆Ph (green square) were grown for 4 h in a 96-well plate without (A) or supplemented with 0.5 µg/ml 
mitomycin C (B). OD600 of the subculture II was measured each hour. Bars shown mean and StD. OD600 values (4 h) 
of the mitomycin C-induced cultures are significantly different (***p<0.0001) and no significant difference was 
found for the non induced cultures (p>0.05) (ANOVA test). Statistical analysis by unpaired Student's t-test for non 
induced cultures: S. TmMA6118 and S. Tm∆G1∆G2 (p>0.05), S. TmMA6118 and S. Tm∆Ph (**p<0.01), S. TmMA6118 and S. 
Tm∆lysST (p>0.05), S. Tm∆G1∆G2 and S. Tm∆G1∆G2∆lysST (*p<0.05). Statistical analysis by unpaired Student's t-test for 
mitomycin C-supplemented cultures: S. TmMA6118 and S. Tm∆G1∆G2 (p>0.05), S. TmMA6118 and S. Tm∆Ph (**p<0.003), 
S. TmMA6118 and S. Tm∆lysST (*p<0.05), S. Tm∆G1∆G2 and S. Tm∆G1∆G2∆lysST (***p<0.0001). 
 
 
No ColIb release was detected for S. Tm∆G1∆G2∆lysST and S. Tm∆Ph strains (Figure 4.27B). Finally, the 
impaired colicin release was confirmed by the reduced or fully lost bactericidal activity displayed by the 
extracellular fractions of S. Tm∆lysST or S. Tm∆G1∆G2∆lysST mitomycin C supplemented cultures (Figure 
4.27B). Together, these results identified the ST64B temperate phage as a key-player in the process of 
ColIb release in S. Tm SL1344. Remarkably, the ST64B impact was further augmented by the Gifsy-
phages. 
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Figure 4.27. Deletion of ST64B prophage lysis genes leads to decrease in extracellular ColIb. Subcultures II of 
S. Tm strains: S. TmMA6118 (red), S. Tm∆G1∆G2 (blue), S. Tm∆lysST (red striped), S. Tm∆G1∆G2∆lysST (blue striped) and S. 
Tm∆Ph (green) were grown for 4 h in a 96-well plate without (A) or with addition of mitomycin C (C) (Section 
3.2.1.3). Next, bacteria were harvested from 100 µl of subculture II and ColIb was detected in the cell lysate and 
culture supernatant by immunoblot using affinity-purified rabbit-α-ColIb-antiserum. S. Tm DnaK was detected as 
loading control. The relative quantity of ColIb and DnaK was determined by densitometry using Image Lab software 
(Bio-Rad). The ratio of relative quantity of ColIb (found in the supernatant) divided by the relative quantity of DnaK 
(found in the bacterial lysate) for non induced (B) and mitomycin C-induced (D) culture is shown. 
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4.2.4 ColIb release by S. Tm∆G1∆G2∆lysST is not enhanced by SopEΦ-mediated lysis. 
In order to test whether deletion of SopEΦ lysis genes would result in further reduction of ColIb release in 
the background strain S. Tm∆G1∆G2∆lysST, the ∆lysST allele (lysis genes replaced with kanamycin resistance 
cassette) was introduced into S. Tm∆G1∆G2∆lysSϕ via P22-transduction. Both S. Tm∆G1∆G2∆lysSϕ∆lysST and S. 
Tm∆G1∆G2∆lysST exhibited similar ColIb-dependent halo sizes with the EcMG1655 strain (Figure 4.29).  
 
 
 
 
Figure 4.29. Deletion of SopEΦ lysis genes has no 
effect on ColIb-dependent killing by S. Tm∆G1∆G2 
∆lysSϕ∆lysST. S. Tm strains: S. TmMA6118 (red), S. Tm∆G1∆G2 
(blue), S. Tm∆G1∆G2∆lysST (blue striped), S. 
Tm∆G1∆G2∆lysSϕ∆lysST (orange striped) and S. Tm∆Ph 
(green) were spotted on LB agar plate supplemented 
with 0.5 µg/ml mitomycin C. ColIb producers were 
grown o.n. and thereon overlaid with EcMG1655 (grown 
in LB medium and mixed with LB soft agar). 
Following incubation for 12 h, the ColIb inhibition 
zone (halo) was measured. The detection limit (dotted) 
line indicates the average diameter of S. Tm colony. 
Figure 4.28. Bactericidal activity of extracellular 
ColIb is reduced in S. Tm∆G1∆G2∆lysST. Mitomycin C 
supplemented (0.5 µg/ml) subcultures II of S. Tm 
strains: S. TmMA6118 (red), S. Tm∆G1∆G2 (blue), S. 
Tm∆lysST (red striped), S. Tm∆G1∆G2∆lysST (blue striped) 
and S. Tm∆Ph (green) were grown in a 96-well plate for 
4 h (Section 3.2.1.3). Next, bacteria were harvested and 
bactericidal activity of extracellular ColIb was tested 
(Section 3.2.3.3). Paper disks soaked with sterile spent 
culture supernatant were set on LB agar plates overlaid 
with EcMG1655 (grown in LB medium and mixed with 
soft agar). Following 12 h incubation, ColIb inhibition 
zone (halo) was measured. The detection limit (dotted) 
line indicates the size of the paper disks. 
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Comparison of the growth dynamics of these strains in liquid cultures with or without mitomycin C 
showed that elimination of SopEΦ lysis genes did not further reduce lysis of S. Tm∆G1∆G2∆lysST (Figure 
4.30B). Furthermore, no ColIb release was detectable for both, S. Tm∆G1∆G2∆lysST and S. Tm∆G1∆G2∆lysSϕ∆lysST, 
as demonstrated by immunoblot (Figure 4.31). Interestingly, weak extracellular bactericidal activity was 
observed for S. Tm∆G1∆G2∆lysST, but not for S. Tm∆G1∆G2∆lysSϕ∆lysST (Figure 4.32). 
 
 
 
Figure 4.30. Deletion of SopEΦ lysis genes has no effect on S. Tm∆G1∆G2 ∆lysSϕ∆lysST lysis. Subculture II of S. Tm 
strains: S. TmMA6118 (red squares), S. Tm∆G1∆G2 (blue squares), S. Tm∆G1∆G2∆lysST (blue rhombs), S. Tm∆G1∆G2∆lysSϕ∆lysST 
(orange rhombs) and S. Tm∆Ph (green squares) were grown for 4 h in a 96-well plate without (A) or with addition of 
mitomycin C (0.5 µg/ml) (B). OD600 of the subculture II was measured each hour. Bars shown mean and StD. OD600 
values (4 h) of the mitomycin C-induced (***p<0.0001) and non induced (**p<0.002) culture are significantly 
different (ANOVA test). Statistical analysis by unpaired Student's t-test for non induced cultures: S. TmMA6118 and S. 
Tm∆G1∆G2 (**p<0.002), S. TmMA6118 and S. Tm∆Ph (*p<0.05), S. Tm∆G1∆G2 and S. Tm∆G1∆G2∆lysST (p>0.05), S. Tm∆G1∆G2 
and S. Tm∆G1∆G2∆lysSϕ∆lysST (**p<0.007), S. Tm∆G1∆G2∆lysST and S. Tm∆G1∆G2∆lysSϕ∆lysST (*p<0.05). Statistical analysis by 
unpaired Student's t-test for mitomycin C-supplemented cultures: S. TmMA6118 and S. Tm∆G1∆G2 (*p<0.05), S. 
TmMA6118 and S. Tm∆Ph (***p<0.0001), S. Tm∆G1∆G2 and S. Tm∆G1∆G2∆lysST (***p<0.0001), S. Tm∆G1∆G2 and S. 
Tm∆G1∆G2∆lysSϕ∆lysST (***p<0.0001), S. Tm∆G1∆G2∆lysST and S. Tm∆G1∆G2∆lysSϕ∆lysST (*p<0.05). 
 
 
In conclusion, deletion of the SopEΦ lysis genes did not influence the ColIb release of a S. Tm mutant 
lacking Gifsy-1, Gifsy-2 and the lysis genes of ST64B prophage. 
In combination with the results that transduction of SopEΦ into a prophage-deficient S. Tm strain did not 
increase its ability to release ColIb, these data suggest, that SopEΦ-mediated lysis does not contribute to 
ColIb release in S. Tm SL1344. 
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Figure 4.31. ColIb release by S. Tm∆G1∆G2∆lysST is not further affected by the deletion of SopEΦ lysis genes. 
Subcultures II of S. Tm strains: S. TmMA6118 (red), S. Tm∆G1∆G2 (blue), S. Tm∆G1∆G2∆lysST (blue striped), S. 
Tm∆G1∆G2∆lysSϕ∆lysST (orange striped) and S. Tm∆Ph (green) were grown for 4 h in a 96-well plate without (A) or with 
addition of mitomycin C (C) (Section 3.2.1.3). Next, bacteria were harvested from 100 µl of subculture II and ColIb 
was detected in the cell lysate and culture supernatant by immunoblot using affinity-purified rabbit-α-ColIb-
antiserum. S. Tm DnaK was detected as loading control. The relative quantity of ColIb and DnaK was determined by 
densitometry using Image Lab software (Bio-Rad). The ratio of relative quantity of ColIb (found in the supernatant) 
divided by the relative quantity of DnaK (found in the bacterial lysate) for non induced (B) and mitomycin C-
induced (D) culture is shown.  
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4.2.5 ColIb-dependent competition of S. Tm against EcMG1655 in vitro is strongly 
enhanced by prophage-mediated lysis 
The presence of prophages and their encoded lysis genes strongly affects ColIb-release by S. Tm in vitro. 
Next, it was determined whether prophages may also increase S. Tm fitness in direct competition against a 
colicin-sensitive opponent. Of note, it was found that pRSF1010-SL1344 plasmid, which confers 
resistance to streptomycin, was present in S. TmMA6118 but not in its phage-cured isogens S. Tm∆G1∆G2, S. 
Tm∆G1∆G2∆ST and S. Tm∆Ph. Therefore, pRSF1010-SL1344 was isolated from S. TmMA6118 and transformed 
in S. Tm∆Ph (S. Tm∆Ph smR) and S. Tm∆G1∆G2∆lysST (S. Tm∆G1∆G2∆lysST smR) strains. The ColIb-sensitive,  
EcMG1655 amp was co-cultured with S. TmMA6118 and the respective mutants in LB or cib-inducing conditions 
(100 µM DTPA and (or) 0.5 µg/ml mitomycin C) (Figure 4.33). The strain lacking all four prophages (S. 
Tm∆Ph smR) and a Gifsy-1, Gifsy-2 double mutant carrying a mutation in the ST64B lysis genes (S. 
Tm∆G1∆G2∆lysST smR) were employed. To better assess the competitive advantage of S. Tm over EcMG1655 amp, 
the CI (ratio of S. Tm / E. coli) was determined under all conditions (Figure 4.34).  
 
 
 
Figure 4.32. No bactericidal activity of ColIb 
was detected for S. Tm∆G1∆G2∆lysSϕ∆lysST. 
Subcultures II of S. Tm strains: S. TmMA6118 
(red), S. Tm∆G1∆G2 (blue), S. Tm∆G1∆G2∆lysST (blue 
striped), S. Tm∆G1∆G2∆lysSϕ∆lysST (orange striped) 
and S. Tm∆Ph (green) were grown in a 96-well 
plate for 4 h (Section 3.2.1.3). Next, bacteria 
were harvested and bactericidal activity of 
extracellular ColIb was tested (Section 3.2.3.3). 
Paper disks soaked with sterile spent culture 
supernatant were set on LB agar plates overlaid 
with EcMG1655 (grown in LB medium and mixed 
with soft agar). Following 12 h incubation, ColIb 
inhibition zone (halo) was measured. The 
detection limit (dotted line) indicates the size of 
the paper disks. 
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Figure 4.33. Temperate phages enhance ColIb-dependent competitive advantage of S. Tm. S. Tm (red triangles) 
and E. coli strains (blue squares) were grown separately for 12 h in LB medium and thereafter diluted and 
normalized to an OD600 of 0.025 in 3 ml fresh LB (subculture I). After 2 h growth the subcultures I were diluted and 
normalized to an OD600 of 0.4 in LB medium with or without supplements (100 µM DTPA, 0.5 µg/ml mitomycin C, 
or both) (Subculture II). Further, the subculture II of S. TmMA6118 and EcMG1655 amp (A,E,I,M), S. Tm∆G1∆G2∆lysST smR 
and EcMG1655 amp (B,F,J,N), S. TmΔPh smR and EcMG1655 amp (C,G,K,O), S. TmΔoriT Δcib and EcMG1655 amp (D,H,L,P) were 
mixed (1:1) to a final volume of 200 µl/well and grown in a 96-well plate for 6 hours. The cfu/ml of both strains 
were determined at 0 h, 3 h and 6 h after the addition of supplements by plating on selective agar to distinguish 
EcMG1655 amp and S. Tm strains. The detection limit (20 cfu/ml) is indicated with a line. Bars shown mean and StD.  
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In absence of supplements, all combinations of competing EcMG1655 amp and S. Tm strains grew to similar 
densities after 6 h (mean titer of S. TmMA6118: 1.05 x 109 and EcMG1655 amp: 2.4 x 108; S. Tm∆G1∆G2∆lysST smR: 
7.53 x 108 and EcMG1655 amp: 2.93 x 108; S. Tm∆Ph smR 1.05 x 109 and EcMG1655 amp 4.6 x 108) (Figure 
4.33A,B,C).  
 
 
Figure 4.34. Competitive index of the co-culture assays. CI (ratio of S. Tm / E. coli) were determined at 6 h 
growth of the co-cultures (Figure 4.33) of; S. TmMA6118, S. Tm∆G1∆G2∆lysST smR, S. TmΔPh smR or S. TmΔoriT Δcib with 
EcMG1655 amp in absence of inducers (A), supplemented with 100 µM DTPA (B), 0.5 µg/ml mitomycin C (C), or both 
(D). Values are Log10 transformed and the geometric mean is shown with a line. Statistical analysis by unpaired 
Student's t-test was done: *p<0.05. 
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As shown before (Nedialkova et al., 2014) EcMG1655 amp does not exhibit any colonization disadvantage 
against S. Tm (Figure 4.33D,H,L,P). In contrast to S. TmΔoriT cib, S. TmMA6118 outcompeted EcMG1655 amp by 
6-fold, while prophage-deficient strain S. Tm∆Ph exhibited only 2-fold higher numbers compered to 
EcMG1655 amp (Figure 4.34A). Fe(III) depletion by DTPA, which induces cib expression, lead to 7.4 x 10-
fold higher cfu of S. TmMA6118 compared to EcMG1655 amp, but almost 10 times lower values (7.9-fold) in 
case of prophage-deficient S. Tm∆Ph smR (Figure 4.34B). Addition of mitomycin C and concomitant 
induction of both, cib expression and prophage activation (Figure 4.33I,L) led to a 8 x 102-fold higher cfu 
of S. TmMA6118 (Figure 4.34C). Under the same conditions, S. Tm∆Ph smR outcompeted EcMG1655 amp only by 
2.3 x10-fold. Furthermore, addition of both supplements (Figure 4.33M,O) lead to overgrowth of S. 
TmMA6118 over EcMG1655 amp by 4.5 x 105-fold. In contrast, EcMG1655 amp was outcompeted by S. Tm∆Ph smR 
only by 7.8 x 103-fold (Figure 4.34D). Similar results were observed for S. Tm∆G1∆G2∆lysST smR as S. Tm∆Ph 
smR in competition with EcMG1655 amp (Figure 4.33B,F,K,N). 
In summary, these results argued that functional lytic activity of temperate phages strongly facilitates the 
ColIb-dependent competition against a colicin-sensitive competitor, in particular upon activation of SOS 
response. 
 
4.2.6 Phage transduction boosts release of ColIb by a prophage-deficient E. coli 
strain. 
To further support the concept of prophage-enhanced release of ColIb, it was investigated whether 
transduction of a colicin producing strain with a functional prophage would lead to enhancement of colicin 
release. To this end, the shiga-like toxin–producing lambdoid prophage 933W isolated from an 
enterohemorrhagic E. coli strain (O'Brien et al., 1984) was used. The stx2A and stx2B genes (encoding the 
Shiga toxin 2 subunits) are located downstream of the phage late promoters (pR') followed by the lysis 
genes a S (holin)-like and a R (endolysin)-like gene (Neely & Friedman, 1998). Hence, transition of the 
prophage to the lytic mode results in expression of stx(2)AB genes along with the lysis genes (Wagner et 
al., 2001). Reporters of p(R') were constructed by lysogenisation of EcMG1655 with a modified 933W 
prophage containing a firefly-luciferase gene replacing either the gene stx2A alone or the stx2A plus the 
downstream located S- and R-like genes. Next, the ColIb plasmid p2cm was introduced into EcMG1655 or its 
lysogenic variants with intact (EcStx) or deleted phage lysis genes (EcStx∆SR). ColIb-mediated killing of 
EcMG1655 was only observed for EcStx p2cm but not for EcStx∆SR p2cm and EcMG1655 p2cm (Figure 4.35). 
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Figure 4.36. Deletion of the phage lysis gene leads to significant decrease of the lysis. Subculture II of E. coli 
strains: EcMG1655 (rhomb), Ec p2cm (triangle), EcStx p2cm (circle) and EcStx∆SR p2cm (inverted triangle) were grown for 5 
h in a 96-well plate without (A) or with addition of mitomycin C (0.5 µg/ml) (B). OD600 of the subculture II was 
measured each hour. Bars shown mean and StD. OD600 values (5 h) of the mitomycin C-induced (***p<0.0001) and 
non induced (***p<0.0001) culture are significantly different (ANOVA test). Statistical analysis by unpaired 
Student's t-test for non induced cultures: Ec p2cm and EcStx p2cm (**p<0.002), Ec p2cm and EcStx∆SR p2cm (p>0.05), and 
EcStx p2cm and EcStx∆SR p2cm (***p<0.0001). Statistical analysis by unpaired Student's t-test for mitomycin C-
supplemented cultures: Ec p2cm and EcStx p2cm (***p<0.0001), Ec p2cm and EcStx∆SR p2cm (***p<0.0001), and EcStx 
p2cm and EcStx∆SR p2cm (***p<0.0001).  
 
 
Upon induction with mitomycin C (0,5 µg/ml) lysis of EcStx p2cm was detected (Figure 4.36B), which 
correlated with release of active ColIb into the culture supernatant (Figure 4.37A). A variant lacking S- 
and R-like genes (EcStx∆SR p2cm) did not lyse in the presence of mitomycin C and no extracellular ColIb 
was detected by immunoblot or bactericidal activity tests. 
Figure 4.35. Prophage-mediated cell lysis is required 
for ColIb-dependent killing. E. coli strains: EcMG1655 
(vertical stripes), EcP2 (white), EcStx p2cm (checkered, 
small) and EcStx∆SR p2cm (checkered, large) were spotted 
on LB agar plate supplemented with a prophage and 
ColIb expression activator mitomycin C (0.5 µg/ml). 
Plates were incubated o.n. and thereon overlaid with 
EcMG1655 (grown in LB medium and mixed with LB soft 
agar). After 12 hours incubation, ColIb inhibition zone 
(halo) was measured. The detection limit (dotted) line 
indicates the average diameter of E. coli colony. 
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Figure 4.37. Active ColIb is released only by a lysogen with intact phage lysis genes. (A). Mitomycin C 
supplemented subculture II of E. coli strains: EcMG1655 (vertical stripes), Ec p2cm (white), EcStx p2cm (checkered, 
small) and EcStx∆SR p2cm (checkered, large) were grown for 5 h in 96-well plates. Further, 100 µl were taken from 
subculture II and spun down. ColIb was detected by immunoblot in bacterial lysates and culture supernatants using 
affinity-purified rabbit-α-ColIb-antiserum. E. coli DnaK was detected as loading control. (B) Bactericidal activity of 
extracellular ColIb was tested (Section 3.2.3.3). Paper disks soaked with sterile spent culture supernatant (subculture 
II (5 h) supplemented with mitomycin C (0.5 µg/ml)) were set on LB agar plates overlaid with EcMG1655 (grown in 
LB medium and mixed with soft agar). Following 12 h incubation, ColIb inhibition zone (halo) was measured. The 
detection limit (dotted) line indicates the size of the paper disks. 
 
 
Expression of the prophage late genes was induced in both, EcStx p2cm and EcStx p2cm, as confirmed by 
firefly-luciferase assay. Significantly higher levels of extracellular luciferase activity was detected for 
EcStx p2cm, which correlated with deficient lysis of EcStx∆SR p2cm (Figure 4.38A,B). Taken together, these 
results fully supported the assumption that release of ColIb, is enhanced by temperate phage-implemented 
lysis. 
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Figure 4.38. Deletion of the lysis genes prophage 933W leads to significant attenuation of the lysis. Subcultures 
II of E. coli strains: EcMG1655 (vertical stripes), Ec p2cm (white), EcStx p2cm (checkered, small) and EcStx∆SR p2cm 
(checkered, large).were grown for 5 h in 96-well plates. Non-induced cultures are displayed in black and these 
supplemented with mitomycin C in red color. After 4 h, bacteria were harvested from 100 µl subculture II and 
luciferase-activity was measured in bacterial lysates (A) or culture supernatants (B). Relative luminescence units 
(RLU) are indicated. The detection limit (dotted) line represents the background luminescence detected in Ec p2cm. 
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5 Discussion 
5.1 Colicin production and sensitivity upon inflammation-induced 
Enterobacteriaceae blooms  
Intestinal inflammation leads to dysbiosis which is characterized by the shift of obligate anaerobic bacteria 
(Bacteroidetes and Firmicutes) dominating a healthy microbiota to otherwise low numbered facultative 
anaerobic bacteria belonging to the Enterobacteriaceae family (Eckburg et al., 2005; Stecher et al., 
2013b; Winter et al., 2013a). Expansion of Enterobacteriaceae including E. coli takes place upon 
intestinal inflammation triggered by enteric pathogens (S. Tm, Citrobacter rodentium) (Lupp et al., 2007; 
Stecher et al., 2007a; Stecher et al., 2012). Furthermore, Enterobacteriaceae are increased in the intestine 
of patients with inflammatory bowel diseases (Crohn's disease) (Walker et al., 2011). Pathogenic and 
commensal Enterobacteriaceae overgrow in the inflamed gut as they have developed adaptation 
mechanisms to exploit inflammation-derived metabolites, such as ethanolamine and the anaerobic electron 
acceptors nitrate and tetrathionate (Thiennimitr et al., 2011; Winter et al., 2010; Winter et al., 2013b). 
Competing for the available nutrients in the intestine, distinct Enterobacteriaceae strains employ various 
competition strategies. Our study revealed that colicin production is an effective fitness trait of 
Enterobacteriaceae in inflammation-inflicted blooms. The current study showed that both production of 
ColIb and concomitant upregulation of the ColIb receptor-CirA take place only in the inflamed gut. This 
leads to a tremendous fitness gain of the ColIb producer over the sensitive strain. In vitro, cib is 
upregulated under iron limitation conditions and by SOS response induction, which will be reviewed in 
the context of the inflamed intestine. Next, this discussion will focus on colicins acting as a “Trojan horse” 
of the siderophore-uptake machinery, which is induced in the inflamed gut. Finally, the importance of the 
intestinal inflammation as a new environmental niche, favoring colicinogenic bacteria, will be discussed.  
 
5.1.1 Environmental conditions leading to colicin expression upon inflammation  
Iron limitation, a defense-measure against pathogen infection, is mediated by several host factors in the 
inflamed intestine. For instance, the iron-binding protein lactoferrin is secreted by the epithelial cells into 
Discussion 
95 
 
 
gastric fluids. Further, it is delivered and released at the site of inflammation by degranulating neutrophils 
(Legrand et al., 2005). Another protein secreted by neutrophils, Lcn-2, restricts growth of commensal E. 
coli and relatives, relying on iron-uptake via catechol siderophores, such as ferric-enterochelin. Lcn-2 
binds enterochelin and thereby couples with the siderophore-mediated iron acquisition (Flo et al., 2004; 
Goetz et al., 2002). Of note, some Gram-negative pathogens (S. Tm and pathogenic E. coli) produce a 
glucosylated derivative of enterochelin, termed salmochelin, along with a salmochelin-specific secretion 
and uptake system. Lcn-2 can not bind the ferric-salmochelin complex and thus is unable to interfere with 
the salmochelin-based iron acquisition of Enterobacteriaceae (Fischbach et al., 2006). Therefore, 
induction of inflammation and concominant secretion of Lcn-2 is a competitive strategy of S. Tm against 
commensal E. coli (Raffatellu et al., 2009). Albeit being an essential element, high concentrations of iron 
can be toxic for the cell. Due to the Fenton chemistry, iron catalyzes generation of hydroxyl radicals, 
which destroy various cellular components. Therefore, bacterial iron uptake and storage systems need to 
be tightly regulated. This is governed by the global Fur repressor (Braun & Hantke, 2011). Iron-bound Fur 
dimers occupy consensus sequences (Fur box) located in the promoters of multiple genes involved not 
only in iron homeostasis, but also in oxidative stress and acid resistance responses, as well as virulence 
factors expression. Depletion of iron leads to disengagement of the iron-free repressor and de-repression 
of Fur-regulated genes (Braun & Hantke, 2011; Carpenter et al., 2009). The cib promoter contains a Fur 
box and ColIb expression is upregulated upon iron limitation (Section 4.1.2). Therefore, it could be 
expected that inflammation-driven iron limitation would lead to induction of ColIb production. 
Furthermore, cib expression, as with most other colicins, is regulated by a second repressor, LexA. De-
repression of LexA takes place upon induction of the SOS response by various agents such as UV light, 
DNA-damaging antibiotics (mitomycin C, ciprofloxacin) and cell-wall active β-lactams (Kelley, 2006). 
Inflammatory mediators likewise induce the SOS response, e.g. hydrogen peroxyde along with other ROS, 
which are products of neutrophil oxidative activity (Segal, 2005). In addition, pro-inflammatory cytokine 
stimulation of the intestinal epithelium leads to upregulation of iNOS and production of RNS. (Winter et 
al., 2013a). In a recent study, expression of stress-related proteins, such as GroL, RecA, and NfuA by 
intestinal E. coli was shown to be induced upon inflammation (Schumann et al., 2012). Of note, NfuA, as 
a protein involved in biogenesis of iron-sulfur clusters, is engaged in survival upon conditions of oxidative 
stress and iron starvation (Angelini et al., 2008). Therefore, the upregulation of nfuA in vivo further 
confirms that both iron deprivation and production of inducers of SOS response takes place in the 
inflamed intestine. These environmental changes in the inflamed intestine might be the trigger of cib 
expression observed in the Salmonella colitis model (Figure 4.13). 
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5.1.2 Colicins: The Trojan horse of iron-siderophore uptake system employed in the 
competition between close relatives in the inflamed gut 
Expression of E. coli cirA encoding an outer membrane receptor protein is likewise induced upon 
inflammation (Figure 4.13). CirA mediates a TonB-dependent uptake of monomeric catecholate 
siderophores, several bacteriocins and bacteriophages. Expression of genes encoding both, CirA and the 
TonB-ExbB-ExbD protein complex is repressed by Fur protein (McHugh et al., 2003; Nikaido & 
Rosenberg, 1990; Noinaj et al., 2010). Depletion of iron in vitro resulted in gradually increased sensitivity 
of E. coli to ColIb, which was directly proportional to increased amounts of CirA (Figure 4.8). 
Furthermore, iron limitation provided a significant competitive advantage to ColIb-producing S. Tm 
against a colicin-sensitive E. coli strain in vitro (Figure 4.10). Interestingly, that was significantly higher 
compared to SOS response induction alone or in combination with iron depletion. Notably, iron limitation 
and SOS response induction alone resulted in comparable amounts of ColIb produced by S. Tm (Figure 
4.5). Furthermore, de-repression of both LexA and Fur led to higher ColIb concentrations than iron-
dependent Fur release alone. Taken together these results argue that elevated CirA production by E. coli is 
of more importance for the ColIb-dependent competition of S.Tm and E. coli, than the amount of ColIb 
produced by S. Tm.  
Of note, it was observed, albeit not further investigated, that a ColIb-sensitive strain is resistant against 
very high concentrations of recombinant ColIb (data not shown). A similar observation was made for 
ColIa and attributed to the colicin uptake process (Jakes & Finkelstein, 2010). Two CirA molecules are 
required for ColIa uptake: one for ColIa binding and a second molecule for ColIb translocation through 
the outer membrane. Consequently, if all available receptors are occupied by bound ColIa molecules, there 
are no free receptors left to execute ColIa translocation (Jakes & Finkelstein, 2010). 
Another observation made in the current study further supports the importance of high numbers of CirA to 
ensure ColIb action. ColIb-sensitivity of EcMG1655 differed depending on the time during which bacteria 
were cultured at low iron concentrations. Short time iron starvation resulted in increased ColIb-
susceptibility. In contrast, although more CirA was produced compared to the short term culturing, upon 
extended iron deprivation, significantly less bacteria were killed by ColIb (Figure 4.9). This effect could 
be linked to the competition between the natural ligands (catecholate siderophores) and colicins for the 
common receptor (Cascales et al., 2007). Further investigations are required to confirm that siderophores 
compete with colicin-receptor interaction and thereby prevent colicin-mediated killing. 
EcNissle showed reduced ColIb-sensitivity compared to EcMG1655 in vitro and in vivo (Figure 4.1;Figure 
4.3). This is maybe another hint for the crucial role of CirA-mediated colicin-sensitivity. Recently it was 
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shown that probiotic EcNissle suffers less from iron limitation in the inflamed intestine, compared to 
EcMG1655. This was attributed to the multiple iron uptake systems of EcNissle, particularly to the salmochelin 
uptake system conferring resistance to Lpc-2 (Behnsen et al., 2013). Therefore, it might be suggested that 
this efficient iron acquisition could result in downregulation of CirA and consequently decreased ColIb-
susceptibility. Nevertheless, cirA expression of both EcNissle and EcMG1655 was not evaluated in the course 
of this work to further support this notion.  
Interestingly, a ColIb homologue ColIa was found frequently in combination with microcin V in human 
faecal E. coli isolates (Prof. Dr. Margaret A. Riley & Chavan, 2007). The ColIa promoter contains a CRP 
binding sequence, a LexA box (identical to ColIb) and a Fur box (identical to ColIb, with an exception of 
one nucleotide) (Mankovich et al., 1986). Microcins are small size (<10 kDa) colicin-like antimicrobial 
peptides, expressed upon nutrient depletion or iron limitation (Duquesne et al., 2007). Frequently 
expressed by enteric pathogens, microcin V is induced at low iron concentrations and likewise acts via the 
CirA receptor (Braun et al., 2002; Pinou & Riley, 2001). It was proposed that a combination of ColIa and 
microcin V is required for colonization of two distinct ecological niches: the nutrient-depleted lower 
intestinal tract, which promotes CRP-cAMP-mediated upregulation of ColIa expression, and on the other 
side, generally iron-depleted extra-intestinal body sights inducing microcin V production (Prof. Dr. 
Margaret A. Riley & Chavan, 2007). Our results suggest that inflammatory conditions in the intestine 
could be another niche where a strain could benefit from the ColIa and microcin V couple. 
Other bacteriocins likewise exploit iron-siderophore uptake receptors, such as the ferric enterobactin 
receptor FepA (colicin D and colicin B), the ferrichrome receptor FhuA (colicin M), the yersiniabactin 
receptor FyuA (pesticin) and the CirA receptor (ColIa). Furthermore, several microcins, such as E492, 
H47 and M, bind siderophore receptors FepA, Fiu, CirA and IroN (Braun et al., 2002), suggesting that 
enhanced killing of bacteriocin-sensitive competitors upon low iron concentrations could be a common 
strategy of bacteriocin producers. This concept is further supported by the increased bacteriocin (pyocin 
S2)-sensitivity of a targeted strain (Pseudomonas aeruginosa), observed upon iron limitation (Ohkawa et 
al., 1980). Nevertheless, it should be tested if other colicins induced exclusively by SOS response, follow 
this scenario in the inflamed intestine. 
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5.1.3 Intestinal inflammation as a new environmental niche favouring colicinogenic 
bacteria 
Colicins were found in 24% of human and 33% of other mammalian intestinal E. coli isolates, (Riley, 
2011). This high frequency was explained by the importance of colicins for invasion and establishment of 
a bacterial population in the gut, protection of the resident microbiota against invading strains (e.g. 
pathogens), restriction of neighboring cell growth and promotion of microbial diversity (Kirkup & Riley, 
2004; Riley, 2011). Furthermore, colicins are expected to be an important feature of probiotic E. coli 
strains (Gillor et al., 2009). 
Despite the evident benefits, colicinogeny is a costly trait associated with metabolic expenses by 
replication and maintenance of the colicin plasmid, colicin production and finally lethality by colicin 
release (Riley, 2011). Therefore, transcription of many colicin genes is tightly repressed by two 
overlapping LexA binding sites and in some cases additional negative regulatory mechanisms (Butala et 
al., 2012). In the absence of exogenous DNA damage, colicin expression was observed only for a small 
fraction (~3%) of the colicinogenic population (Mulec et al., 2003). The latter was attributed to a 
spontaneous SOS response activation, differential affinity of the repressor to the LexA box, fluctuating 
LexA concentrations as well as the involvement of additional transcriptional repressors (Kamensek et al., 
2010; Mrak et al., 2007). 
Despite the extensive research, conditions affecting the balance of colicinogeny “pros and cons” remained 
unclear. Only a part of the experimental in vivo studies confirmed that bacteriocins expression confers a 
benefit to the colicinogenic strain. A colicin producer dominated over its sensitive adversary during a 
long-term colonization experiment (5-16 weeks) in the mouse intestine (Gillor et al., 2009; Kirkup & 
Riley, 2004) and E. coli expressing microcin V outcompeted a microcin-sensitive strain after 24-72 h 
growth (McCormick et al., 1989; Wadolkowski et al., 1988). In contrast, other studies failed to show that 
production of colicin is of any advantage for colonization of healthy (noninflamed) intestine after 1-6 
weeks (Craven et al., 1971; Kelstrup & Gibbons, 1969). Colicin production was even detrimental for a 
colicinogenic E. coli competing against the colicin-sensitive strain (Ikari et al., 1969). The lack of 
phenotype for colicinogeny was attributed to colicin inactivation by intestinal proteolytic enzymes 
(Kelstrup & Gibbons, 1969) and the block of energy dependent colicin-uptake upon anaerobiosis (Braun 
et al., 1980; de Graaf, 1973; Kelstrup & Gibbons, 1969). In agreement with these studies, ColIb-
expressing S. Tmavir did not outcompete a colicin-sensitive EcMG1655 in the noninflamed mouse intestine 
(Figure 4.2). However, S. Tmwt retains a ColIb-dependent competitive advantage in the inflamed intestine, 
due to the SOS response induction by inflammation-derived ROS and RNS. Along with the host-mediated 
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iron-limitation, SOS response leads to increased production of ColIb. Even more important, upon 
inflammation ColIb-sensitive strain was outcompeted by the producer (S. Tmwt) due to the increased 
sensitivity of EcMG1655. Therefore, our current work highlights the importance of the environmental 
conditions in vivo for the colicin-dependent competition.  
The mammalian colon represents a structured environment with localized interactions, which favors 
colicinogenic bacteria (Majeed et al., 2011). E. coli strains could form biofilms via secretory IgA-
mediated adhesion to the epithelial surface (Orndorff et al., 2004), growing on mucin-derived sugars 
(Chang et al., 2004). It has been shown that a colicinogenic bacteria could outgrow a colicin-sensitive 
strain competing in structured environment (e.g. agar plate and biofilms) (Chao & Levin, 1981). In 
contrast, growing in a well-mixed liquid culture with randomly distributed nutrients (i.e. equally well 
accessible by both competitors), the producer strain is outcompeted by the faster growing colicin-sensitive 
rival because the latter is not suffering from the burden of colicin production (Chao & Levin, 1981; Greig 
& Travisano, 2008). Furthermore, high initial numbers of the colicin-producing strain were found to be 
another prerequisite for the success of a colicinogenic strain. Later studies on Saccharomyces cerevisiae 
producing K1 toxin (killing K1-sensitive S. cerevisiae) confirmed the importance of high densities of both 
producing and toxin-sensitive strains, because numerous producers release a high amount of the toxin, 
which easily finds sensitive-bacteria presented at high numbers (Greig & Travisano, 2008). Furthermore, 
it was shown that high abundance of nutrients supports invasion of the yeast killer strain, compensating 
the fitness costs of the K1 production (Brown et al., 2009; Wloch-Salamon et al., 2008). The discussed 
environmental settings should be even more important for the success of a colicin-producing strain, 
because the latter is undergoing a cell lysis, in contrast to S. cerevisiae, where K1 secretion is not lethal 
for the producer (Cascales et al., 2007; Wloch-Salamon et al., 2008). Thereby, the exuberant growth of 
Enterobacteriaceae thriving on the inflammation-derived metabolites (Thiennimitr et al., 2011; Winter et 
al., 2010; Winter et al., 2013b) sets up the inflamed intestine as an environment favoring the colicin-
producing bacteria over the colicin-sensitive competitors.  
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Figure 5.1. Model for the role of colicins for bacterial competition in inflammation-induced blooms. (A) Under 
homeostatic conditions, Enterobacteriaceae (blue, green) are reduced in numbers as they are kept in check by the 
obligate anaerobic microbiota (violet-blue). Under this condition, colicin expression as well as expression of the 
colicin surface receptors are relatively repressed (high iron, no triggers of the SOS response). (B) Upon induction of 
an inflammatory response, gut microbial ecology is altered leading to enterobacterial blooms. Neutrophils 
transmigrate into the gut lumen and produce iron-depleting agents (lipocalin, lactoferrin) and reactive oxygen and 
nitrogen species (ROS, RNS). This triggers SOS-and Fur-dependent transcriptional responses in Enterobacteriaceae 
and colicin- and colicin-receptor expression is induced. Thereby, the inflammatory response drives colicin-dependent 
enterobacterial competition. 
 
 
In summary, the current work identifies inflammation-induced Enterobacteriaceae blooms as a new 
ecological niche favoring colicin-dependent competition. This is illustrated by a model, where both colicin 
expression by the producer and colicin sensitivity of the competitor, are upregulated upon Salmonella-
elicited inflammation (Figure 5.1). Moreover, high density of the competitors, along with the abundant 
resources upon inflammation (Stecher et al., 2007a; Stecher et al., 2013b), promotes colicin-mediated 
competitive advantage of the producer over the colicin-sensitive strain. 
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5.2 The novel concept of phage-mediated colicin release  
Despite the interest in colicin’s biology and possible medical application of these toxins, up to date, it is 
not know how numerous colicins belonging to group B colicins are released. Our study showed that 
induction of temperate phages encoded within S. Tm genome leads to cell lysis and release of various 
cellular components, including the ColIb. Moreover, it was observed that prophages display differential 
contributions to the cell lysis and release of ColIb. Along with these findings, the importance of an 
accurate timing of production of colicin and prophage induction would be discussed. Finally, this 
discussion will focus on the impact of prophages on colicin-dependent bacterial fitness.  
 
5.2.1 The enigma of the release of group B colicins 
Up to date, the mechanism of release of group B colicins remains an open question. In contrast, release of 
group A colicins of various sizes (20-60 kDa) is associated with the action of a conserved lysis protein 
encoded within the colicin operon. The lysis protein is proposed to assist colicin accumulation in the 
periplasm and subsequent extracellular release of a small amount of colicin, defined as “basal” colicin 
release (Cascales et al., 2007; Chen et al., 2011). As shown for colicin A and E7, at the second stage lysis 
proteins could interact with colicins, outer membrane porins (OmpC or OmpF), as well as with the outer 
membrane phospholipase A (OMPLA) (Cavard, 2004). Lysis protein-mediated activation of OMPLA 
leads to membrane permeabilization and a secondary massive release of the colicin followed by cell death 
(Cascales et al., 2007; Chen et al., 2011). Hitherto, no release mechanism is known for the majority of 
group B colicins (including ColIb), which do not encode a lysis protein (Cascales et al., 2007). 
It was observed that ColIb was detected in the culture supernatant upon supplementation of mitomycin C, 
but not DTPA (Figure 4.5), suggesting that mitomycin C induces another process leading to ColIb 
release.  
Common traits shared by colicins and lysogenic phages were discussed more than half a century ago 
(Lwoff et al., 1952). This includes: induction by SOS agents, lethality of production and attack of 
competitors via Tol- or Ton B-dependent outer membrane receptors (Brown et al., 2009; Cascales et al., 
2007). Comparison between group A colicins- and prophage-mediated cell lysis shows some similarities, 
though the exact mechanism are rather different. Release of λ prophages is mainly associated with five 
proteins leading to formation of holes in the inner membrane (holins), degradation of the peptidoglycan 
layer (muramidases) and permeabilization of the outer membrane (Rz integral membrane protein and Rz1 
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lipoprotein) (Young, 2013). Group A colicins trigger only quasilysis of the host cell, employing a single 
lysis protein, which is a lipoprotein and has no muralytic activity. Of note, some ssDNA and ssRNA 
phages encode for single lysis proteins (Young et al., 2000) suggested to be functionally and 
evolutionarily related to the colicin lysis proteins, based on sequence and structural similarity (Lau et al., 
1987). Furthermore, in support to this phage-colicin relationship, another class of bacteriocins (F- and R-
type pyocins) was shown to be phage tail proteins, evolved as bacteriocins (Nakayama et al., 2000). 
 
5.2.2 Prophage-mediated release of ColIb 
Our experiments have shown a significant decrease in colicin release by S. Tm lacking four prophages 
compared to the wild type strain (Figure 4.14). Furthermore, colicin release correlated with cell lysis of 
the wild type S. Tm (Figure 4.16; Figure 4.18). Interestingly, different phages had distinct effects on the 
ColIb release and lysis; e.g. deletion of Gifsy-1 and Gifsy-2 phages had no detectable impact, in contrast 
to the decreased ColIb release and lysis in absence of Gifsy phages along with ST64B prophage (Figure 
4.14). Differential contribution of prophages to the host physiology has been previously observed. 
Deletion of each cryptic prophage encoded by E. coli K-12 led to reduction in biofilm formation between 
3- and 11-fold. Three out of nine prophages (e14, Rac and CP4-44) mostly contributed to this effect 
(Wang et al., 2010). Of note, induction of lambdoid prophages differs depending on CI repressor 
sensitivity and concentration (Refardt & Rainey, 2010). Evaluation of four S. Tm LT2 prophages showed 
that following mitomycin C treatment Fels-1 prophage is significantly stronger induced compared to 
Gifsy-1 and Gifsy-2 (Frye et al., 2005; Garcia-Russell et al., 2009). Furthermore, Gifsy-1 temperate phage 
was found to be repressed upon DNA damage, while Gifsy-2 displayed constant low induction albeit 
mitomycin C supplementation (Garcia-Russell et al., 2009). These observations were in agreement with 
no detectable release of infectious Gifsy-1 and Gifsy-2 particles upon DNA damage, in contrast to Fels-1 
and Fels-2 prophages (Frye et al., 2005). Based on these observations, it could be suggested that ColIb 
release and cell lysis remained unchanged upon Gifsy-1 and Gifsy-2 deletion due to weak response of 
these phages to mitomycin C treatment. 
SopEΦ is a P2 phage, homologous to Fels-2 (Pelludat et al., 2003). Interestingly, despite the strong 
induction observed for S. Tm LT2 Fels-2 prophage (Frye et al., 2005), deletion of the SopEΦ lysis genes 
had no detectable impact on S. Tm lysis or ColIb release in response to mitomycin C treatment (Figure 
4.22; Figure 4.23). This could be a result of the incomplete deletion of one of the proposed lysis protein 
genes (Section 3.2.6) or the presence of yet another lysis gene that had not been annotated so far. 
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However, this is not very likely explanation, since transduction of SopEΦ did not lead to increased release 
of ColIb by S. Tm isolate A36 (Figure 4.24). Possibly, unlike Fels-2, DNA damage does not provoke 
strong induction of SopEΦ prophage. 
In contrast, cell lysis and ColIb release were decreased for S. Tm strain with lysis deficient ST64B 
prophage (Figure 4.26; Figure 4.27). These results suggest that ST64B lytic activity is induced upon 
mitomycin C supplementation, leading to cell lysis and ColIb release. Increased expression of genes of the 
ST64B prophage is detected at 3 h after mitomycin C induction (Frye et al., 2005; Garcia-Russell et al., 
2009). Furthermore, following ~10 min exposure to stress-inducing agents ST64B alone out of four 
phages displayed a slightly elevated gene expression in S. TmMA6118 (Kroger et al., 2013). Of note, the 
effect of ST64B prophage on lysis-meditated ColIb release was much more prominent in absence of 
Gifsy-1 and Gifsy-2 prophages than in S. Tm wild type. This suggests that Gifsy-1 and Gifsy-2 have an 
inhibitory effect on ST64B lysis or that activation of ST64B induces lysis by Gifsy-1 and Gifsy-2. Gifsy-1 
and Gifsy-2 prophages are under negative control of small size global repressor proteins that, unlike 
RecA-stimulated cleavage of CI, are deactivated by antirepressor proteins (Lemire et al., 2011). It has 
been shown that antirepressor protein FsoA of the lambdoid prophage Fels-1 deactivates the temperate 
phage repressor of Gifsy-2. It could be possible that a similar crosstalk takes place between an 
antirepressor of ST64B and Gifsy-1 / Gifsy-2 repressor proteins. Thereby, despite the deletion of ST64B 
lysis genes, the antirepressor is still present within the prophage genome and can activate Gifsy-1- or 
Gifsy-2-mediated lysis. The contribution of the latter two prophages could be rather insignificant 
compared to the ST64B-mediated lysis and therefore not detectable for a strain lacking Gifsy-1 / Gifsy-2 
(Figure 4.27). Alternatively, lysis proteins may enhance each other’s function. It is known that 
heterogeneous endolysins and holins can substitute each other and boost cell lysis and toxin release 
(Hodak & Galan, 2013; Wang et al., 2000). Therefore, enhancement of ST64B-assisted ColIb release by 
Gifsy-1 / Gifsy-2 prophages could be due to the additive interactions between prophage lysis proteins. 
The concept of ColIb release as a result of phage-mediated cell lysis is even better illustrated by EcMG1655 
strain carrying the ColIb plasmid p2cm and a variant of a Shiga-toxin expressing prophage 993W. 
Remarkably, in the absence of prophage or deletion of S- and R-like phage lysis genes neither cell lysis, 
extracellular ColIb, nor ColIb-directed bactericidal activity were detected for EcMG1655 (Figure 4.35; 
Figure 4.36; Figure 4.37). 
Interestingly, in contrast to the EcMG1655 strains carrying no or a lysis-deficient prophage, S. TmΔPh 
retained, albeit significantly reduced, ColIb-dependent bactericidal activity, even if no cell lysis and 
extracellular ColIb were detected (Figure 4.14). Why would S. TmΔPh be able to release tiny amounts of 
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ColIb leading to killing of the colicin-sensitive strain, unlike prophage-depleted EcMG1655? Apart from the 
functional prophages (Gifsy-1, Gifsy-2, SopEΦ and ST64B) S. Tm SL1344 encodes approximately 80 
bacteriophage-related proteins, some of them belonging to prophage remnant SLP443, degenerate 
bacteriophage SLP28 and a P4-family bacteriophage gene cluster (Kroger et al., 2012). Particularly, the 
prophage-associated genes SL1344_2210-SL1344_2219 (among them a holin-homologue SL1344_2213) 
located between the ST64B and the Gifsy-1 prophage could correspond to a SOS-induced gene cluster, 
previously detected in this region (Frye et al., 2005). Assuming that some of these genes encode lysis 
proteins, these prophage genes may be responsible for the “left-over” ColIb release observed in S. TmΔPh.  
EcMG1655 strain cured of the single inducible phage lambda contains various bacteriophage-like elements, 
among them nine cryptic prophages (Blattner et al., 1997; Canchaya et al., 2003; Wang et al., 2010). 
Moreover, some of these phages encode lysis proteins: DLP-12 (putative lipoprotein, murein 
endopeptidase and lysozyme); Rac (a prophage endopeptidase); Qin (a lysozyme and an S-like protein) 
(Blattner et al., 1997). It is unclear if any of these proteins could cause cell lysis. Nevertheless, only 
cryptic prophage e14, but not the remaining eight, can be excised upon SOS induction (Wang et al., 
2010), questioning whether the expression of the cryptic prophage lysis genes is induced by DNA 
damaging agents. Cryptic prophages are generally inactive in terms of cell lysis, phage particle production 
and plaque formation (Wang et al., 2010). This could be the reason why EcMG1655 carrying p2cm requires an 
inducible prophage with intact lysis genes to support ColIb release. Thereby, acquisition of a group B 
colicin-encoding plasmid could be expected to benefit only a recipient, which has retained functional 
prophage lysis genes within its genome.  
 
5.2.3 Prophage-independent ColIb release 
Release of colicin A, which belongs to group A colicins, was linked to production of outer membrane 
vesicles (OMV), introducing another distinct mechanism for colicin release (Cavard, 2004). Colicin A 
could block the host cell proteins of the Tol–Pal system, which is involved in outer membrane 
stabilization during cell division (Gerding et al., 2007; Kleanthous, 2010). Interception of this system 
results in production of OMV, a feature observed for tol–pal deficient strains (Bouveret et al., 2002). 
Colicins are separated into two groups (A and B), based on their ability to interact with either the TolA-
TolQ-TolR or the TonB-ExbB-ExbD systems, respectively (Kleanthous, 2010). Interestingly, alteration of 
the TolA binding site of a group A colicin (colicin U) enabled the interaction of this colicin with distinct 
components of both, Ton and Tol system (Pilsl & Braun, 1998). Nevertheless, to our knowledge, this 
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effect has not been tested for any Ton-dependent colicin. Therefore, interaction of ColIb (a group B 
colicin) with Tol proteins leading to OMV-dependent release is a rather unlikely event. Furthermore, 
EcMG1655 tol-pal mutants were shown to produce OMV (Bernadac et al., 1998), yet no detectable ColIb 
release is observed for EcMG1655 in absence of a functional prophage.  
In summary, the current study confirmed that phage-mediated cell lysis promoted colicin release. Further 
experiments would be required to determine if there are other, phage-independent ColIb release 
mechanisms. 
 
5.2.4 Time-management of ColIb release 
Colicin release via prophage-triggered cell lysis would require precise timing of colicin and phage lysis 
genes expression upon induction of the SOS response. It could be expected that to achieve an optimal 
cost–effect (cell lysis-colicin toxicity) ratio, it has to be ensured that a dying bacterium releases a maximal 
amount of colicin. Therefore, the lysis should take place only when bacteria have accumulated high 
amounts of colicin intracellularly. This concept is further supported by an observation that typhoid toxin is 
expressed before bacteriophages-like muramidase lysis protein, which is involved in the toxin release 
(Hodak & Galan, 2013). Of note, cib expression is downregulated not only by SOS response repressor 
LexA, but also by Fur repressor. Thereby, maximal benefit from the lysis could be attained upon Fur de-
repression triggered by iron limitation.  
What would be the control mechanisms of an efficient prophage-mediated colicin release? Group A 
colicin release takes place late after colicin synthesis, after reaching a critical concentration of colicin lysis 
protein. Furthermore, a terminator upstream of the lysis gene (Figure 5.2) ensures that colicin will be 
always expressed in higher amounts and earlier than the lysis protein (Cascales et al., 2007). Likewise, 
lambda prophage lysis genes belong to the group of late genes, which are tightly controlled by pR’ 
promoter and tR’ terminator. Transcription of these genes takes place at high threshold concentration of Q 
antiterminator (Court et al., 2007). DNA damage leads to sequential expression of prophage genes: initial 
expression of DNA binding components, antirepressor proteins, virulence factors and transcriptional 
regulators is followed by expression of genes involved in DNA replication, recombination, integration, 
excision and host lysis (Frye et al., 2005). The requirement for a critical concentration of holins and 
pinholins coordinates the cell lysis timing is similarly to the colicin lysis protein “high threshold” behavior 
(Cascales et al., 2007; Young, 2013). Furthermore, it was shown on a single cell level that activation of 
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the SOS response precedes prophage induction (Nanda et al., 2014). Generally, colicin expression is 
likewise correlated with SOS induction on a single cell level (Kamensek et al., 2010; Zgur-Bertok, 2012).  
How are SOS response, ColIb expression and phage activity coordinated in S. Tm? This could be 
investigated via analysis of a microarray of transcriptome sequencing following induction of the SOS 
response. Alternatively, gene reporters (green fluorescent protein (GFP)) could not only follow the timing, 
but further verify at a single cell level that all these events take place in the same bacterium (Nanda et al., 
2014). Possible candidates as reporters for the SOS response could be sulA, lexA or recA (McCool et al., 
2004; Zgur-Bertok, 2012) and ColIb activity cib reporter. Based on the strong impact of ST64B prophage 
observed, a ST64B early gene reporter and a single lysis gene reporter for the late events could be suitable 
to trace activation of prophage genes; e.g. an early gene expression reporter could be ST64B encoded 
excisionase, shown to be one of the first genes expressed upon DNA damage (Frye et al., 2005; Mmolawa 
et al., 2003). Other relevant early gene candidates could be an N antiterminator homologue, as well as O 
protein coding gene upregulated before and after the excisionase, respectively (Court et al., 2007; Frye et 
al., 2005; Mmolawa et al., 2003). 
 
 
Figure 5.2. The crosstalk between group B colicins and prophages. Release of group A colicins (encoded by cxa) 
is mediated by the action of a conserved lysis protein (encoded by cxl) encoded within the colicin operon. In contrast, 
the operon of group B colicins does not encode a lysis protein. Induction of prophages encoded with the genome of a 
colicinogenic bacterium leads to expression of cognate phage lysis genes (S, R, Rz and Rz1). The latter cause lysis 
and release of various unspecific cytoplasmic components, including group B colicins (encoded by cxa). 
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5.2.5 Impact of prophages on colicin-dependent bacterial fitness 
In vitro, competition between ColIb-producing S. Tm and colicin-sensitive EcMG1655 showed that 
prophages contribute to the colicin-dependent overgrowth of S. Tm over EcMG1655 upon supplementation of 
SOS response inducer mitomycin C (Figure 4.34). Remarkably, in the absence of mitomycin C, lysogenic 
S. Tm was slightly overgrowing the colicin-sensitive competitor, though significantly better than the 
phage deficient strain (Figure 4.34A,B). The latter observation could be explained by the spontaneously 
induced SOS response induction triggering both temperate phages and ColIb expression.  
5.2.5.1 Benefits of spontaneous SOS response induction for a colicin expressing lysogen  
Spontaneous prophage induction is limited to less than 10-5 of the population. It is harmless for the rest of 
the lysogenic bacteria, due to immunity against superinfection with the phage. This, however, will be 
deadly for non-lysogenic competitors which will be lysed by the prophage. Thereby, the spontaneous 
prophage induction benefits the host on a population level (Bossi et al., 2003). Upon nutrient limitation 
phage induction occurred in up to 0.08% of the actively replicating host population. This was correlated to 
induction of the SOS response as a result of spontaneously emerging ssDNA due to the arrest of the 
replication fork (Nanda et al., 2014). Furthermore, release of Shiga-toxin from a tiny fraction (0.005%) of 
lysogens, as a result of spontaneous Shiga-toxin encoding prophage activation, is proposed to increase 
bacterial shedding in the environment, i.e. to enhance spreading of the pathogen (Livny & Friedman, 
2004). 
Spontaneous induction of a small fraction of colicinogenic bacteria is considered an altruistic suicide that 
supports the rest of the population by killing colicin-sensitive competitors (Cascales et al., 2007). 
Therefore, it could be argued that spontaneous SOS induction, as a result of endogenous ssDNA, leads to 
phage-mediated ColIb release by a small number of colicin producers, leading to killing of colicin-
sensitive competitors. This effect should be even more pronounced upon iron limitation, due to the 
increased expression of ColIb (derepression of Fur and LexA) and increased colicin-sensitivity of the 
competitor. Accordingly, in the absence of prophages, no or too small amounts of spontaneously-induced 
ColIb would be released in order to confer benefit to the producer. This explains the higher competitive 
advantage of lysogenic compared to prophage-deficient S.Tm. 
5.2.5.2 ColIb-producing lysogen upon intestinal inflammation 
SOS induction leads to phage-mediated ColIb release by a larger part of the lysogenic population, leading 
to a distinct competitive fitness advantage of the wild type S. Tm, as it was observed in vitro (Figure 
4.34). What would be the expected situation during The lytic infection mode of prophages takes place 
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mainly in actively growing bacterial population upon nutrient-rich conditions (Court et al., 2007; Mills et 
al., 2013), such as it is the situation in the inflamed intestine (Stecher et al., 2007a). This could be an 
additional trigger for prophage activation, apart from the DNA damaging agents (ROS and RNS) released 
in the inflamed gut. Moreover, beneficial prophage-mediated ColIb release upon iron limitation and SOS 
response induction in vivo would not be a solitary event. Prophage (H-19B) encoded Shiga-toxin 1 is 
regulated by a Fur repressor (Calderwood & Mekalanos, 1987). Growing in iron-deprived intestine, H-
19B lysogenic bacteria will produce Shiga-toxin, but won’t be able to release it, unless the prophage is 
activated upon DNA damage. However, if the toxin gets released it could benefit the lysogenic population 
due to iron liberated from the erythrocytes, as a result of the Shiga-toxin-elicited intestinal hemorrhage 
(Brussow et al., 2004).inflammation-inflicted Eneterobacteriacae blooms. 
5.2.5.3 Which came first, the colicin or the prophage?  
Upon infection with a single phage, in about 99% of infected bacteria the phage will undergo a lytic cycle. 
This number decreases to about 50% in the case of an infection with more than two phages (Court et al., 
2007). In contrast, ~100% transfer rates of ColIb-encoding plasmid P2 were observed during 
inflammation-triggered Enterobacteriaceae blooms (Stecher et al., 2012). Therefore, it is likely that 
colicin plasmids get transferred into a bacterium with formerly established lysogeny, which promotes 
colicin release. Acquisition of colicin as an additional weapon would benefit an invasive lysogen 
exploiting prophages as a biological agent (Brown et al., 2009; Gama et al., 2013), i.e. expanding the 
range of targeted competitors, which could be killed either via phage lysis or bactericidal activity of 
colicins. In contrast, a non-lysogenic strain paying the cost of colicin production (e.g. metabolic load of 
protein biosynthesis) would not profit from it, because the toxin remains “locked” in the host bacterium. 
Of note, bacteria carrying multiple colicins retain only a single lysis protein gene, in order to avoid fitness 
costs of multiple lysis proteins (Prof. Dr. Margaret A. Riley & Chavan, 2007; Zgur-Bertok, 2012). 
Therefore, it could be suggested that the majority of group B colicin plasmids have lost their lysis gene, 
relying completely on the phage lysis proteins or concomitant expression of a group A colicin. Moreover, 
phage-mediated release is not specific, therefore, lysogens could benefit from uptake of various colicin 
plasmids. Similar arguments were used in support of concept of Shiga-toxin genes as a recent acquirement 
of Shiga toxin-producing E. coli (Brussow et al., 2004). Furthermore, a multiple prophage lysogen could 
be a preferable host for a colicin-encoding plasmid. Prophages display diverse induction patterns upon 
different environmental conditions; and colicins expression could be likewise controlled by other 
regulators than SOS-associated LexA (Zgur-Bertok, 2012). Thus, phage-mediated host lysis and colicin 
expression could be co-regulated in various environmental settings, ensuring competitive fitness 
advantage of the host population. 
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Figure 5.3. Release of group B colicins takes place upon phage-mediated lysis. A bacterial host carrying a colicin 
plasmid and a prophage inherits both to the next generation of bacteria. Upon activation of the SOS response both, 
the phage lytic mode (morphogenesis and release of infectious phages via lysis) and colicin expression are induced. 
Ultimately, this leads to phage-mediated lysis and release of the colicin. 
 
 
In summary, our results suggest that group B colicins are released as result of phage-mediated lysis 
(Figure 5.3). Furthermore, acquisition of an inducible prophage and a group B colicin plasmid provides a 
competitive advantage in a colicin-dependent competition. This conclusion is further supported by a 
recent study, which correlates increase of enterobacterial species in the gut with spread of colicinogeny 
and decrease in phage sensitivity (Burova et al., 2012). Based on the possibility that superinfection 
exclusion and immunity by resident temperate phage(s) could be a reason for the decreased phage 
sensitivity, this study could be a hint for a correlation between lysogeny and colicin production in 
expanding intestinal Eneterobacteriacae populations. 
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